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SUMMARY
Blood is a biological fluid that transports life-sustaining solutes throughout the body.
Separately, blood can clot to stop hemorrhaging or obstruct the arteries to cause heart at-
tacks or strokes. These critical pathophysiological processes rely on the participation of
both microscale cells and nanoscale molecules subjected to hydrodynamics. In this thesis,
we developed a coupled lattice-Boltzmann and Langevin-dynamics (LB-LD) approach, al-
lowing for simulating blood flow and clotting processes with both cellular and molecular-
level biophysical details. The research problems of interest to the thesis range from nano-
drug delivery to high-shear thrombosis. For the transport of nano-drugs in microvessels,
we demonstrated a particle size-dependent transition from Brownian-motion dominant dis-
persion to margination in microvessels. To study nanoparticle (NP) partition through mi-
crovascular bifurcations, a general particulate suspension inflow/outflow boundary condi-
tion is developed and used to discover a heterogeneous partition of the NP in response to
the Zweifach-Fung (ZF) effect. To inform macroscale drug delivery applications through
constitutive relations, we characterized the diffusion tensor of NP in sheared cellular blood
over a wide range of shear rate and hematocrit. The nonlinear hemorheological scaling of
the diffusivity was attributed to the red blood cell (RBC) morphology change in principal
directions. To elucidate the mechanisms for shear-induced platelet aggregation (SIPA), an
in silico SIPA simulator informed by the status quo single-molecule measurements is de-
veloped. It is found that SIPA is a two-stage process involving in-flow agglomeration and
capture of agglomerates to the surface. Transition from the lag time (LT) regime to rapid
platelet accumulation (RPA) was attributed to the elevation of local VWF concentration
and/or the VWF size. Some contradictory observations in the field of arterial thrombo-
sis were addressed. This thesis provided a novel paradigm for simulating blood flow and
clotting at both molecular- and cellular-scales. The multiscale in silico approach offers a
cross-scale tool for exploring novel biophysical mechanisms for vascular diseases or other
xxv
biophysical processes that are typically inaccessible to only single-molecule measurements,
fluidic assays, or single-scale computational methods. Such new perspectives may lead to




1.1 Background and significance
1.1.1 Modeling Whole Blood as a Multiscale and Multicomponent Suspension Fluid
Analysis of whole blood flow has been demonstrated through direct numerical simulation
(DNS) of the major constituents of blood including the plasma, red blood cells (RBCs)
(about 45%), and other cells (about 0.7%) such as white blood cells (WBCs) and platelets [1,
2, 3, 4, 5]. Both single RBC dynamics [1, 3, 6] and rheological properties of dense sus-
pensions of RBCs [7, 8, 9, 10] have been computationally resolved, showing promising
agreements with experimental results. Particularly, lattice-Boltzmann (LB) method for the
fluid phase coupled with the Spectrin-Link (SL) analysis of the RBC membrane as a hy-
brid mesoscopic method (LB-SL) has shown to be a suitable cellular blood flow solver [3].
However, whole blood in nature is composed of not only cells but also a large population
of functional biomolecules that are nanoscale in size. Analysis of the transport of such
nanoscale solutes in cellular blood flow remains challenging due to the large length-scale
discrepancy between nanoscale particles (NPs) ∼O(10 nm) and cells ∼O(10 µm). Further
complexities come from the intricate colloidal suspension dynamics, which highly depend
on thermal fluctuation, hydrodynamic interactions (HI) mediated through the fluid, and
particle-cell interactions. Given the multiscale nature of whole blood flow, developing a
hybrid blood flow solver including both cellular and molecular mechanisms is necessary
for the study of various blood flow phenomena that are of both biological and clinical rele-
vance.
1
1.1.2 Particle Transport in Blood Flow: from Nano-Drug Dispersion to Platelet Margination
The rapid advancement of nanotechnology and nanomaterial manufacturing has led to
emerging exposure of human cardiovascular systems to nanosized particulate matters rang-
ing from engineered nanocarriers functioning as medicine/imaging agents to aerosol pol-
lutant particulates potentially causing fatal cardiovascular disease. Both the design of opti-
mal nanocarrier systems and the prevention and control of nanoparticle (NP) toxicity rely
heavily on the knowledge of NP distribution in vascular systems. Nevertheless, the distri-
bution of NP in micro-vessels, microvascular beds and large-scale blood circulation organs
remains elusive to date and limits the bioavailability of NP systems to the human bio-
environment. Understanding the dispersive properties of solutes and cells of diverse sizes
ranging from nanometer to micrometer in blood flow shows physiological significance.
As a relevant example of microscale particle transport in blood, platelets margination has
shown to play an important role in affecting the formation of arterial thrombus [11]. Mo-
tivated by that, a plethora of studies [12, 13, 14, 15, 16, 17, 18, 19, 20] have dedicated to
unravelling the mechanistic mechanisms of margination. The platelet margination is found
to be primarily driven by the RBC-enhanced diffusion in the RBC-laden region synergis-
tically accompanied by the sink-like effect of the cell free layer (CFL). Nanoscale particle
(NP) dispersion in blood flow, on the other end of the spectrum, has recently received
considerable attention [21, 22, 23, 24] due to the fast development of nano-drug delivery
techniques that have the potential to revolutionize the traditional therapeutics due to its abil-
ity to overcome various biological barriers [25]. Although the transport of nanoscale and
microscale particles in blood have been investigated separately and understood to a great
extent, there is a need of a systematic interrogation of the particle dispersion mechanisms
across nano-to-microscale sizes using a unified computational framework within a variety
of flow structures (such as simple shear flows, tubular flows and branching flows, etc.).
2
1.1.3 Shear-Induced Platelet Aggregation Mediated by von Willebrand Factor
Acute myocardial infarction and ischemic stroke are the leading causes of morbidity and
mortality worldwide, which are induced by the formation of occlusive thrombus at the site
of atherosclerotic plaque rupture under very high shear rates ranging from 5000 to 40 000
s−1 [26, 27]. Different from the coagulation process that is explained by the classic Vir-
chow’s triad [28], arterial thrombosis is induced by an alternative high-shear thrombosis
triad composed of a pathophysiological high-shear environment, a thrombogenic surface,
and pro-thrombotic blood constituents that primarily include the platelet and the von Wille-
brand factor (VWF) [29, 11]. Pathologically, the formation of atherosclerotic plaque leads
to a vascular stenosis, causing pathologically high wall shear rates. Such high shear rate
condition causes coagulation factors such as thrombin to be generally washed out of the
clot. When the atherosclerotic plaque cap ruptures to expose the subendothelial collagen,
it provides a thrombogenic surface. The subsequent accumulation of VWF-platelet aggre-
gates on the thrombogenic surface leads to the arterial thrombosis and occlusion. Although
coagulation may stabilize a thrombus after occlusion, these coagulation factors have a ki-
netic activation rate that is much too slow to cause the occlusive thrombus. Based on the
high-shear triad, we have successfully created arterial thrombosis in vitro using a stenotic
glass capillary tube coated with fibrillar collagen [30]. The occlusion time measured with
our system matches well with pathological timescales [31, 32]. The thrombus accumula-
tion process was found to have two phases of growth [11, 30]. The initial phase, termed
the lag time (LT), features a slow accumulation of the first-layer thrombus that typically
lasts for several minutes. The subsequent phase, termed as rapid platelet accumulation
(RPA), shows a thrombus growth rate that is 4×6 times the rates at LT phase [30, 33]. Un-
derstanding the biophysical mechanisms for RPA is essential as it directly leads to occlu-




The objective of this thesis is to develop a multiscale and multicomponent blood flow com-
putational framework for simulating whole blood flow and clotting at cellular and molec-
ular scales. This high-fidelity computational framework will combine the advantages of
the state-of-the-art complex fluid solver technique based on the lattice-Boltzmann (LB)
method coupled with multiscale particulate suspension dynamics. The method is applied
to a series of blood flow and clotting problems involving particle dispersion in blood and
high-shear induced thrombosis to both gain novel, fundamental understanding of blood as
a complex biological fluid and provide clinically relevant suggestions to blood pathology.
Specifically, the following specific aims are proposed:
1. Develop a lattice Boltzmann-Langevin dynamics (LB-LD) approach for mul-
tiscale and multicomponent blood suspension flow applications incorporating
both cellular and molecular biophysics. Aim 1 will develop a two-way coupled
LB-Langevin dynamics (LB-LD) approach to resolve the multiscale particle and
polymer suspension dynamics.
2. Characterize the dispersion and distribution of nano-to-microscale particles in
cellular blood flow through micro-vessels. Aim 2 will attempt to quantitatively
show how the transport mechanism varies with particle size from the nano- to mi-
croscale.
3. Predict the partitioning of blood-borne nanoparticles through physiologic mi-
crovascular bifurcations. Aim 3 attempts to understand how NPs partition through
a single microvascular bifurcation. Incorporating RBC-NP interaction is paramount
to the predictions of NP distribution and delivery efficiency.
4. Quantify the RBC-enhanced shear-induced diffusivity of nanoparticles in a vis-
cometric blood flow as a function of shear rate and hematocrit. Aim 4 will
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develop a NP diffusivity tensor, as an accurate constitutive law, to link the local
hemorheological properties and the NP diffusion property.
5. Interrogate the biophysical mechanisms of the shear-induced platelet aggrega-
tion (SIPA) through VWF entanglement under elevated shear. Aim 5 is to un-
derstand the molecule- and cell-level biophysical mechanisms of SIPA and the rapid
platelet accumulation (RPA) that causes occlusive thrombosis, providing testable hy-
potheses to direct future experimental work to discover potential VWF-targeting ther-
apies for high-shear thrombosis.
With regard to expected outcomes, this thesis will deliver a multiscale blood flow solver
for studying general blood flow and clotting events. This work will elucidate the dispersion
and diffusion mechanisms of nanoparticles in cellular blood flow within microcirculations
by showing: the particle size-induced transition from Brownian dispersion to margination,
the Zweifach-Fung effect-induced heterogeneous partition of nanoparticles through mi-
crovascular bifurcations, and the anisotropic nanoparticle diffusion tensor in sheared blood
as a constitutive relation for large scale nanoparticle biotransport applications. The bio-
physics of SIPA will be demonstrated to explain the RPA that causes occlusive thrombosis,
pointing towards testable hypotheses for potential VWF-targeting antithrombotic therapies
specific to elevated shear.
5
CHAPTER 2
DEVELOPMENT OF A COUPLED LATTICE BOLTZMANN/LANGEVIN
DYNAMICS METHOD FOR MULTISCALE AND MULTICOMPONENT BLOOD
SUSPENSION FLOWS
In this chapter, a hybrid computational method coupling the lattice-Boltzmann (LB) method
and a Langevin-dynamics (LD) method is developed to simulate nanoscale particle and
polymer (NPP) suspensions in the presence of both thermal fluctuation and long-range
many-body hydrodynamic interactions (HI). Brownian motion of the NPP is explicitly cap-
tured by a stochastic forcing term in the LD method. The LD method is two-way coupled
to the non-fluctuating LB fluid through a discrete LB forcing source distribution to capture
the long-range HI. To ensure intrinsically linear scalability with respect to the number of
particles, an Eulerian-host algorithm for short-distance particle neighbor search and inter-
action is developed and embedded to LB-LD framework. The validity and accuracy of
the LB-LD approach are demonstrated through several sample problems. The simulation
results show good agreements with theory and experiment. The LB-LD approach can be
favorably incorporated into complex multiscale computational frameworks for efficiently
simulating multiscale, multicomponent particulate suspension systems such as complex
blood suspensions.
2.1 Introduction
Simulating suspensions of nanoscale particles or polymers is a challenging task that in-
volves resolving particle-particle interaction, thermal fluctuation and long-range many-
body hydrodynamic interactions (HI) that contribute to complex suspension microstruc-
tures [34, 35]. Conventional particle-based methods such as Molecular dynamics (MD)
[36], dissipative particle dynamics (DPD) [37], Brownian dynamics (BD) [38] and Stoke-
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sian dynamics (SD) [39] have advanced this field considerably. The MD and DPD ap-
proaches resolve the fluid particles explicitly and are often suitable for problem with rela-
tively small length and time scales. The conventional BD neglects the particle inertia the HI
effect to accommodate for computational efficiency [38]. The SD method has been a suc-
cessful computational tool to study the rheology of spherical, rigid particle suspensions. It
captures the many-body HI theoretically with excellent rheological agreement with experi-
ments [40, 41, 42]. Although it intrinsically scale cubically with the number of particles,N ,
recent attempts have been made to enhance SD to O(NlnN) or O(N) scales through sophis-
ticated computational algorithms [43, 44, 45, 46]. Nevertheless, the SD method remains to
be extended to particulate suspensions involving complex geometries/solid boundaries.
Lagrangian-Eulerian direct-coupling approaches have shown good potential to handle
complex particle geometry and capture suspension of submicron-sized particles including
Brownian effect and HI with intrinsically linear scalability. The inception of this class of
approach starts by adding the so-called Landau-Lifshitz stress [47] to the fluid phase and
coupling the subsequent fluctuating hydrodynamics (FH) method with the Newtonian dy-
namics for colloidal particles. The FH method explicitly captures the thermal fluctuations
in the fluid phase and implicitly gives rise to the Brownian motion of suspended fine par-
ticles. Theoretical proofs [48, 49] have shown that the fluctuating stresses exerted on the
particle render the particle equation of motion into a Langevin equation, in which the hy-
drodynamically induced random force term directly satisfies the fluctuation-dissipation the-
orem (FDT). Following the idea of FH, Ladd [50] proposes a fluctuating lattice-Boltzmann
(FLB) method to handle Brownian motion of colloidal particles. The method captures the
many-body HI in both concentrated and dilute regime with O(N) scale [51]. In order to
satisfy the FDT, the FH-rooted method needs to directly resolve the fluid-solid interface
to satisfy the no-slip boundary condition. However, this requirement poses heavy compu-
tational expense when it comes to simulating a large number of particles or concurrently
handling particles with disparate length scales. To overcome this limitation, Dunweg [52,
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53] couples the FLB method with a MD-type approach for point particles through a simple
Stokesian friction term. Similar approaches were later developed and applied to studying
the DNA translocation through nano-pores [54, 55, 56]. In this approach, thermal noises
are included in both the fluid phase and particle phase. As a consequence, this method can
not capture the temperature scale (thus the Brownian motion) directly and advocates an
empirical rescaling of the friction coefficient. More recently, Mynam et al. [57] show that
such empirical operation can be neglected by omitting the thermal fluctuation in the fluid
phase while keeping the fluctuation in the particle phase.
Following the idea of coupling fluctuating particles dynamics with non-fluctuating hy-
drodynamics, we develop a coupled lattice Boltzmann/Langevin dyanmics (LB-LD) ap-
proach to simulate nanoscale particle and polymer suspensions in the presence of both
thermal fluctuation and many-body HI. Different from the work in Mynam et al. [57], we
couple the two phases through a forcing source distribution term [58] that can recover the
Navier-Stokes equation in the physical time scale [59]. Moreover, through multiple sample
problems, we demonstrate that the two-way coupled LB-LD approach not only captures the
Brownian motion directly (consistent with [57]) but also resolves the long-range HI favor-
ably. Through careful numerical treatment, we also demonstrate the effective applicability
of the LB-LD approach to both nanoscale particle and polymer suspension problems. On
the computational performance side, an Eulerian host algorithm is proposed to conduct lo-
calized neighboring particle search and interaction. This algorithm takes advantage of the
existing Eulerian LB nodes and the sub-grid nature of the Lagrangian particles. With this
approach, the overhead of particle dynamics (through LD) is shown to scale linearly with
respect to the number of particles while adding negligible overhead to the LD framework.
Since the particle dynamics is essentially resolved in a sub-grid fashion, the LB-LD ap-
proach can be easily coupled with direct-numerical-simulation (DNS) suspension solvers
to tackle multiscale, multicomponent particulate suspension flows. One example of such
flows is blood flow suspended with numerous, interacting nanoscale biomolecules and mi-
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The method for the fluid phase with suspended particle interaction is based on the three-
dimensional LB method developed in Aidun et al. [63, 64, 2]. The LB method solves the
discretized Boltzmann equation in velocity space through the propagation of the particle
distribution functions fi along the discrete lattice velocities ei and the collision operation of
the local distributions to be relaxed to the equilibrium distribution f (0)i . The collision term
is simplified to the single-relaxation-time (SRT) Bhatnagar-Gross-Krook (BGK) collision
operator [65], while the more generalized multi-relaxation-time (MRT) [66] and entropic
[67, 68, 69, 70] collision operators can be also adopted to gain higher numerical stability.
The temporal evolution of the particle distribution function with a single relaxation time
takes the form of
fi(r−∆tei, t+ ∆t) = fi(r, t)−
∆t
τ
[fi(r, t)− f (0)i (r, t)] + fSi (r, t), (2.1)
where τ is the single relaxation time scale associated with the rate of relaxation to the local
equilibrium, and fSi is a forcing source term introduced to account for the discrete external
force effect [58]. The specific formalism for fSi is presented in §3.2.2. This method has a
pseudo-sound-speed of cs=∆r/(
√
3∆t) and a fluid kinematic viscosity of ν=(τ −∆t/2)c2s,
where ∆t is the time step and ∆r is the unit lattice distance. The positivity of ν requires
τ>∆t/2. In the LB method, time and space in Equation (2.1) are normalized by ∆t and
∆r such that ∆tLB=∆rLB=1 are applied to advance the system. Details of the mapping




, the Mach number, Ma=u/cs1), the LB equation recovers the Navier-Stokes equation
[71] with the equilibrium distribution function in terms of local macroscopic variables as
f
(0)
i (r, t) = ωiρ[1 +
1
c2s
(ei · u) +
1
2c4s
(ei · u)2 −
1
2c2s
(u · u)], (2.2)
where ωi denotes the set of lattice weights defined by the LB stencil in use. The macro-
scopic properties such as the fluid density, ρ, velocity, u and pressure p can be obtained via















i (r, t)eiei = pI + ρuu, (2.3c)
where I is the identity tensor. The current study adopts the D3Q19 velocity set; that is 3
dimensions and 19 discrete velocity vectors,
i.e.
, Q = 19. Along the rest, non-diagonal, and diagonal lattice directions, ωi is equal to
1/3, 1/18, and 1/36, and |ei| is equal to 0, ∆r/∆t, and
√
2(∆r/∆t), correspondingly. The
LB method is extensively validated [63, 64, 72, 2] and proved to be suitable for the direct
numerical simulation (DNS) of dense suspensions of both rigid particles and deformable




Particles suspended in a fluid system are subjected to the impacts of the randomly fast-
moving liquid molecules. When particle size is below micron-scale, such instantaneously
fluctuating momentum transferred from the solvent molecules spurs the particle to yield
irregular movements, known as the Brownian motion. The dynamics of such Brownian









where mp is the mass of the particle of index i. Provided the particle’s initial position, rp,0,
the displacement of the particle can be updated by integrating the particle velocity with





The right-hand-side (RHS) of Equation (2.4) can be decomposed into three system-
atic forces that drive the motion of the particle. The conservative force, Cip, specifies the
interparticle or particle-surface interaction force that exerted on particle i. It is often ap-










where U(Rij) is the pairwise inter-particle potential, and Rij is a directional vector, Rij =
rip − rjp, connecting particles i and j. The ingredients of U(Rij) carry different formalism
depending on the physical origins of the potential forces, which is discussed in detail in
§2.2.4. The frictional force Fip is assumed to be proportional to the relative velocity of the
particle with respect to the local viscous fluid [18],
Fip = −ζ[uip(t)− u(rip, t)], (2.6)
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where up denotes the particle velocity, and u(rp, t) is the interpolated fluid velocity at the
position where the center of the particle resides. Equation (2.6) ensures the Galilean invari-
ance of the particle-fluid system. The details on calculating u(rp, t) through interpolation
are illustrated in §3.2.2. The friction coefficient, ζ , is determined by the Stokes’ drag law,
ζ = 3πµdpψ, (2.7)
where µ is the dynamic viscosity of the liquid, and ψ is the particle shape factor that is set
to one in this study to account for spherical shape effect. The stochastic force term, Sp,
implicitly accounts for the thermal fluctuation of the solvent, and explicitly gives rise to the
Brownian motion of the particle. Through the equipartition principle and the integration of
the Langevin equation [75], the stochastic force can be related to the friction, reflecting a
balance between the random thermal fluctuation and the frictional dissipation,
i.e.
, the FDT [76]. Specifically, the Cartesian component of the stochastic force exhibiting a
zero mean with the covariance determined by the FDT, which reads
〈Sip,α(t)〉 = 0, (2.8a)
〈Sip,α(t)S
j
p,β(t)〉 = 2kBTζδijδαβδ(t− t
′), (2.8b)
where α, β ∈ {x, y, z}, i and j run through all the particle indices, δij and δαβ are Kro-
necker deltas, δ(t − t′) is the Dirac-delta function, kB is the Boltzmann constant, T is the
absolute temperature of the fluid bath, and the angle brackets denote the average over the
ensemble of realizations of the random variables. Equations (2.8b) statistically state that
the Cartesian component of Sp exhibits a Gaussian distribution with a zero mean.
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Time scales and numerical treatment
A colloidal system is physically enriched with multiple critical time scales, including (i) the
short atomistic time scale, τa ∼ 10−12 sec, that is related to the frequency of rapid collisions






which accounts for the time for the hydrodynamic momentum to diffuse over a distance of





over which the particle velocity decays to the algebraic long-time tail regime, and (iv) the





which measures the time the particle has diffused its own radius. To fully resolve the HI
among particles, τν needs to be much shorter than τB, i.e., the Schmidt number Sc =
τB/τν 1, allowing viscous momentum to diffuse much faster than the particle Brownian
diffusion time scale [75]. In the current study, Sc lies in the range of 250∼1500 for the par-
ticle size (50∼300 nm) considered as follows. To avoid excessive computational expense
when solving the LE, it is also ideal to advance the LD system with the same time step ∆t
as that of the LB system. However, this requires conditional treatment of the LE to maintain
stability requirement. A Stokes number, defined as St=τr/∆t, can be introduced to char-
acterize the relative importance of the short-time particle inertial effect. When St <1, i.e.,
the LE is advanced based on a time step greater than the particle relaxation time scale, the
over-damped LE can be solved to avoid introducing sub-time steps. Under such condition,
the particle motion is expected to be inertia-free and tightly follow the local fluid stream-
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line. When St≥1, i.e., the LE is updated with a time interval comparable to or shorter than
the particle relaxation time scale, the under-damped LE needs to be solved to retain the
short-time particle inertia during each time step. Under such condition, the particle tends
to deviate from the streamline due to inertial effect. Since the LB evolution equation is only
first-order accurate in time, a forward-differencing Euler scheme with first-order accuracy
is employed to solve the discretized LE. Therefore, the velocity and displacement of the
Brownian particle can be advanced, according to the St number conditions, by
up(t+ ∆t) = u(rp, t) +
1
ζ
[Cp(t) + Sp(t)], (St < 1) (2.12a)
up(t+ ∆t) = up(t) +
∆t
mp
{Cp(t) + Sp(t)− ζ[up(t)− u(rp, t)]}, (St ≥ 1) (2.12b)
where the two discretized forms of the LE become equivalent when St=1. Through stabil-
ity analysis, it can be shown that the condition, |1 − ∆tζ/mp| ≤1, i.e., St≥0.5, needs to
be satisfied for the discretized under-damped LE to be numerically stable. The conditional
treatment as shown in equations (2.12a-2.12b) directly satisfies this numerical stability
criterion and avoids compromising to sub-time steps [52, 53, 77, 57]. The Gaussian distri-
bution associated with the stochastic force Sp(t) is realized via a random number generator
based on the Box-Muller transformation [78].
2.2.3 Particle-fluid coupling
To directly capture the many-body HI mediated by the fluid phase, the interaction between
the Brownian particle and the fluid is resolved by coupling the LD method to the LB method
in a two-way fashion. The hydrodynamic force exerted on the particle, FHp , can be system-
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Figure 2.1: 2-D representation of a nanoscale particle (yellow) located at position rp in a
lattice cell. The lattice node r̂ is at the diagonal position of lattice node r, and α denotes
one of the Cartesian components.
atically decomposed into a frictional component and a stochastic component [52] as
FHp = Fp + Sp = −ζ[up(t)− u(rp, t)] + Sp(t), (2.13)
which is applied to partially drive the particle dynamics through the LE. Meanwhile, since
Fp and Sp are both originated from the collision between the particle and liquid molecules,
FHp (instead of Fp) should be assigned back to the fluid phase to conserve momentum for
the entire particle-fluid system. Provided each particle or monomer is treated as a point
particle and moves continuously in the lattice domain, as shown in Fig. 2.1, both the
construction of the fluid velocity at the center of the particle and the redistribution of the
inter-phase momentum need to employ certain interpolation or extrapolation schemes.
Two options of distance-based spatial distribution stencils with different orders of ac-
curacy have been implemented in the current approach. For the simple trilinear stencil [52,







which is of first-order accuracy and only reads the coordinates of the first-layer, neighboring
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lattice nodes owned by the particle-resided lattice cell. For the stencil via Peskin’s method









which yields second-order accuracy and involves two layers of lattice nodes surrounding
the particle. Peskin’s stencil has also been successfully applied to LB method with the ex-
ternal boundary force (EBF) [80] to resolve the curved fluid-solid boundary, which shows
better accuracy and efficiency compared to the standard bounce-back (SBB) method. The
following studies employ the trilinear stencil for simplicity. By employing the weight func-




w(r, rp)u(r, t), (2.16)
where Nc denotes the group of nodes on the lattice cell occupied by the particle. The
same weight function can be applied to the construction and distribution of the reactionary
impulse due to the particle-fluid interactions. Specifically, the reactionary impulse density
[64], during each time step, can be assigned to the surrounding lattice nodes as




where J(r, rp) is the impulse density to be assigned to the lattice node, r, due to particle-
fluid interaction at the particle position, rp, at each time step. A local forcing source distri-
bution term, fSi (r, t), based on the method proposed in He et al. [58] can then be calculated
as
fSi (r, t) =
ωiJ(r, rp) · ei
c2s
. (2.18)
Instead of modifying the local equilibrium distribution functions as shown in previous stud-
ies [52, 57], the current approach, similar to the EBF method [80], modifies the general LB
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evolution equation into Equation (2.1) by adding the forcing distribution function fSi (r, t),
which is shown to approximate the Navier-Stokes equation in the physical time scale [59].
The same forcing term has been applied to the studies of DNA translocation through nano-
pores [54, 55, 56]. However, those studies use zeroth order spatial distribution schemes
and introduce thermal fluctuation in both fluid and solid phases, which is not aligned with
the LB-LD approach proposed in the current study.
2.2.4 Particle-particle interactions
Interparticle potential for suspended particles
The inter-particle interactions between unconnected particles are assumed to follow the
classic Derjaguin-Landau-Verwey-Overbeek (DLVO) theory that includes both the stan-
dard van der Waals potential [81] and the electrostatic contribution to the overall DLVO
potential, as advocated in Schunk et al. [82]. For the attractive component of the van der














where Acc is the Hamaker constant that is set to Acc = 4π2kBT according to [82]. The
repulsive component of the van der Waals potential adopts the integrated Lennard-Jones






R2ij − 7dpRij + 13.5d2p
(Rij − dp)7
+









where σ is the repulsive scaling factor that can be set to σ = dp/10 as suggested in previous
studies [82, 84]. Together with the screened electrostatic potential, UE [82], the total DLVO
potential can be calculated as UDLV O = UA + UR + UE . In the following study (§2.3.3),
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neutral electrostatic effects are considered, i.e., UE = 0. However, the charge effect can be
incorporated through various electrostatic models [82, 60].
Interparticle potential for chain of particles
In the case of polymer chains, particles (beads) are connected by elastic springs to form
bead-spring chains. To account for the inter-bead cohesive effect and the bead volume-
exclusion effect, the standard Lennard-Jones (LJ) potential is employed according to
ULJ(Rij) = ε̃kBT [(
dp
Rij
)12 − 2( dp
Rij
)6], (2.21)
where ε̃ is the scaling factor of the LJ potential well depth, which can be tuned to adjust the
cohesiveness of the polymer chain. In the following simulations, ε̃ is set to 1.8 to obtain
the best fit to the experimental data discussed in §2.3.5. Equation 2.21 is truncated at a
cut-off distance Rcij=8dp to limit the bound for neighboring bead search but still preserve
the major cohesive effect between adjacent beads. The cohesive strength among beads
plays a critical role in regulating the conformation of self-associable polymers, such as von
Willbrand factors (vWF) [85]. The inter-bead connectivity is established through a finitely










where Rii′ is the center-to-center distance between bead i and its neighbor i′ = i + 1
(or i − 1), k̃ is the scaling factor of the spring tensile elasticity, and ∆Rmax denotes the
maximum bond extension. Here, ∆Rmax is chosen to be 0.25dp to limit the extension of
the polymer chain [53]. The spring scaling factor, k̃, is set to 200.0 as suggested in [85].
Unlike the linear Hookean connectivity model used in other studies [85, 87], the FENE
spring captures the hyperelastic-like behavior when the polymer bond elongation reaches
its maximum.
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2.2.5 Mapping between physical units and LB units
All equations and variables thus far are introduced in physical units for consistency. To
follow the convention of the LB method, the time, length, and density/mass units of the
entire LB-LD system need to be mapped to LB units in the simulations [2]. The map-
ping is performed such that t, r, and ρ are normalized by ∆t, ∆r, and ρ, respectively.
Therefore, the unit lattice distance, time step, and fluid density in LB units are obtained as
∆rLB=∆tLB=ρLB=1. The normalized single relaxation time scale and the corresponding
LB viscosity are τLB=τ/∆t and νLB=(2τLB − 1)/6, respectively. As mentioned in §2.2.1,
the LB single relaxation time, τLB, needs to satisfy τLB >0.5 to produce positive viscosity.






)2 for time, ∆r
∆rLB
=333 nm
for length, and ρ
ρLB
=1000 kg/m3 for density. The time mapping ratio depends on the fluid
kinematic viscosity and the LB single relaxation time in use. The fluid density is selected
to be 1000 kg/m3 and the viscosity 1.2 cP . The temperature is set to T = 310K. It should
be noted that the current mapping strategy is based on the SRT LB method. However, more
flexibility can be obtained to match a broader spectrum of fluid and thermal properties
with the MRT and entropic LB method [66, 67, 68, 69]. For clarity, the LB counterparts
of previously introduced quantities in physical units are denoted with the subscript ‘LB’
hereafter.
2.2.6 Eulerian-host algorithm
Previous hybrid approaches for simulating particle suspensions have been reported to scale
linearly with respect to the number of particles, N , [52, 53, 57]. However, when sim-
ple search (SS) (i.e., the exhaustive pairwise search) algorithm is applied to unconnected
particle-particle interactions, the scaling of the particle dynamics could still degrade to
O(N2), which consequently undermines the overall scalability of the method. To over-
come this issue, two types of algorithms have been proposed in the MD community. The
Verlet neighbor list (VNL) algorithm [88] limits the pair search to a list of Nnl adjacent
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Figure 2.2: Schematics of the EH algorithm: (A) Once an updated particle position is
obtained, the coordinates of the particle is sent to its nearest EH; (B) A single particle
interacts with its neighboring EHs that contain the coordinates of the adjacent particles;
(C) Typical date structures of the Eulerian host.
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particles for a given particle, which reduces the search scaling to O(NNnl); however, the
construction of the neighbor list still scales as O(N2), which undermines the overall effi-
ciency when N becomes reasonably large. The cell linked list (CLL) algorithm [89] parti-
tions the simulation domain into cellular domains, and each particle only interacts with the
particles within the same cell. The CLL algorithm truly scales as O(N) but requires extra
computational infrastructure to handle domain decomposition.
Inspired by the merit of both VNL and CLL algorithm and noticing the Eularian na-
ture of the LB method, we propose a linear short-range particle-pair search algorithm that
makes use of the Eulerian LB nodes as information hosts for the Lagrangian particles.
As illustrated in Figure 2.2 (A), during each LB time step, the updated information of
each sub-grid particle can be stored in a data structure on its nearest LB node, which is
denoted as an Eulerian host (EH). When performing particle-particle short-distance inter-
actions, each particle only interacts with its surrounding EHs that carry the information of
the neighboring particles within a cut-off distance, as illustrated in Figure 2.2 (B). Each
EH could contain information such as the number of particles, the index of each particle
and even the coordinate of each particle, as indicated in Figure 2.2 (C). The complexity of
the data structure for EHs varies depending on the concentration of the sub-grid particles.
Specifically, when the particle volume fraction is low, i.e., each EH only contains 1∼2
particles, data structure of type I can be used with the information of particle coordinates
included; when the particle volume fraction is high, i.e., each EH could contain more than
two particles, data structure of type II can be used to avoid excessive memory allocation
for each LB node. The benefit of using EHs of type I is that the particle information can
be directly communicated together with the LB fluid node information during MPI per-
mutations. Therefore, no separate MPI communications are needed for the particle phase.
However, when type II EH is applied, separate MPI communications for the particle phase
are necessary since the particle coordinates are stored separately from the LB fluid nodes
information. For the case with dilute particle concentrations, EHs of type I data structure
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Table 2.1: Scaling performance comparison between the Eulerian-host algorithm and the
simple search algorithm.
Number of Particles, N 0 100 1 000 10 000
TWCT (s), EH 464.3 470.3 522.2 1 050.7
TWCT (s), SS 300.7 307.2 565.8 21 857.7
LD overhead (s), EH 0 6.0 57.9 568.5
LD overhead (s), SS 0 6.4 265.1 8 442.4
Figure 2.3: The Langevin-dynamics(LD) overhead and the total wall clock time (TWCT)
using the Eulerian-host (EH) algorithm or simple-search (SS) algorithm plotted against the
number of particles in log-log scale. The EH algorithm is shown to scale linearly with
respect to the number of particles, N, in contrast to the quadratic scale of the SS algorithm.
are adopted.
The particle-number scalability of the LB-LD approach embedded with the EH algo-
rithm is tested by simulating different number (N=0, 100, 1000, and 10000) of particles
under a wall-bounded shear flow within a 503 LB domain. For each case, five runs are
sampled to obtain an averaged total wall clock time. All the cases are tested for 10 000
LB steps in serial mode on the TACC Stampede-2 supercomputer. Each computing node is
configured by one Intel Xeon Phi 7250 processor, which has a base frequency 1.4 GHz and
contains 68 cores. The total wall clock time (TWCT) for each case and the corresponding
overhead associated with LD operations are tabulated in Table 2.1. The LD overhead for
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Figure 2.4: The flow chart of the current LB-LD method embedded with the EH algorithm
to handle short-distance, unconnected particle-particle interaction.
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cases with N > 0 is calculated by subtracting the corresponding TWCT with that of the
N=0 case. As plotted in Figure 2.3, the EH algorithm compared to the SS algorithm shows
slightly higher TWCT when N≤100. This is understandable since the introduction of EHs
adds overhead to the update of the Eulerian LB domain. However, as the number of parti-
cles increase, the EH cases starts to show much lower TWCT compared to the SS cases. In
fact, when N=10 000, the TWCT with EH algorithm becomes more than one magnitude
lower than that with the SS algorithm. A linear scalability curve, generated by setting the
overhead equal to the number of particles, is also plotted as a reference. The results clearly
show that the LD overhead with EH algorithm scales almost linearly with the number of
particles ∼O(N), while the simple search algorithm exhibits ∼O(N2) scales.
Both the construction of EHs and the interaction with EHs are localized, therefore scal-
ing asO(N). For interactions among 100 nm NPs, a search of neighboring 8 EHs is shown
to be enough to cover all the nearby particles within the cut-off distance. As the particle
size increases, a slight expansion of the search range is needed, which however doesn’t
undermine the O(N) merit. When the particle is encountered with a periodic boundary,
a wrapping operation is needed to ensure the availability of EHs. By applying the EH
algorithm, the particle-particle interaction can be conveniently handled together with the
particle-fluid coupling procedures. The EH algorithm provides the localized data structure
for the particle dynamics of Lagrangian nature, which is fundamentally more convenient
for parallelization. Figure 2.4 depicts the flow chart of the current LB-LD method with the
EH algorithm embedded with the LB-LD two-way coupling scheme. Both the rectangular
blocks in Figure 2.4 denote the processes of force calculation and particle-fluid/particle in-




The validity and accuracy of the LB-LD approach to capturing the dynamics of nanoscale
particle and polymer suspensions subject to both the thermal fluctuation and HI are demon-
strated through several sample problems. First, the momentum relaxation of an isolated
particle is presented to show the correctness of the particle-fluid coupling. Then, the self-
diffusion of colloidal particles in infinite dilution is demonstrated to show the direct capture
of Brownian motion. As follows, the hindrance of particle diffusion in concentrated col-
loidal suspension is discussed to shown the validity of the short-distance particle-particle
interaction model. The self-globularization process of a cohesive polymer chain and the
shear-induced unfolding of a collapsed polymer globule are further presented to show the
applicability of the LB-LD model to nano-polymer suspension dynamics subject to HI ef-
fects. All cases adopt a LB relaxation time τLB=1 unless otherwise prescribed.
2.3.1 Momentum relaxation of an isolated particle
The fluid-particle coupling is first verified by analyzing the slowing-down process of an
isolated particle with an initial momentum in a quiescent viscous fluid. A cubic LB domain
with periodic boundary condition enforced in each direction is selected for all the simu-
lations. Three computational domains with different dimensions (503, 703, and 1003) are
considered to study the domain size dependency. A particle of mass mp,LB=29.3 with an
initial velocity up,LB (0)=0.01 along the X direction is released in the center of the domain.
By setting τLB=0.51 and dp=100 nm, a friction coefficient ζLB=0.48 is prescribed to dissi-
pate the kinetic energy of the particle. Given St > 1, under-damped LE is solved for this
problem.
The deterministic response of the particle momentum relaxation is first presented by
omitting the Brownian effect. The inset of Figure 2.5 (a) shows a snapshot of the flow
field induced by the decelerating particle right after its release. Such double vortex flow
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structure has also been observed in previous numerical studies [90, 35]. The time evolution
of the particle velocity normalized by the initial velocity for three domain sizes are de-
picted in Figure 2.5 (a), where the corresponding asymptotic behaviors are also presented
for comparison. At short-time scales, i.e., when t/τr < 10, the particle velocity decays
exponentially for all three domain sizes, which also agrees well with the asymptotic short-
time exponential decay behavior, exp(−t/τr). At long-time scales, Alder et al. [90] show
the particle velocity should eventually decay according to a power law scale, (t/τr)−3/2,
known as the long-time tail behavior, which reflects the fluid-particle coupling effect. As
shown in Figure 2.5 (a), the long-time tail behavior is not significant for the 503 domain
size, where instead a plateau is observed right subsequent to the exponential decay. How-
ever, as the domain size increases to 1003, the long-time tail behavior appears to be more
pronounced. The eventual flattening of all cases manifests the fluid and particle eventually
translate at the same velocity as a result of the periodicity of the finite LB domain and the
conservation of momentum for the particle-fluid system. The same problem with domain
size of 1003 is further simulated using the over-damped LE with zero particle inertia, as
also depicted in Figure 2.5 (a). As expected, the particle velocity directly relaxes to the
long-time tail regime without yielding the exponential decay behavior. The jittering of the
relaxation curves for the zero-inertia case is due to the temporal discretization effect and
can be eliminated by reducing the time step [52, 57].
According to the FDT, the stochastic relaxation behavior of a Brownian particle should
be in accordance with the deterministic relaxation behavior of the particle under the same
flow condition with no Brownian effect. This can be demonstrated by adding the Brownian
noise to the previous deterministic case. For simplicity, the stochastic force is only applied
to the particle along the +X direction, thus the motion of particle is constraint in a one-
dimensional fashion. The particle velocity relaxation process can be quantified by the
normalized velocity autocorrelation function (VAF), 〈up(t)up(0)〉/u2p(0), which reduces to
up(t)/up(0) for the deterministic case. In Figure 2.5 (b), the particle VAF for cases with or
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Figure 2.5: The momentum relaxation process of a point particle with an initial disturbance
in periodic LB fluid domains of different sizes (a) under deterministic condition or (b)
subject to stochastic noise effects.
without Brownian effect is plotted against the LB time. The VAF curve for the stochastic
case is obtained by averaging over an ensemble of ten independent runs. Overall good
agreements between the stochastic case and the deterministic case are obtained. These
results show the particle-fluid coupling and the FDT are correctly captured using the current
LB-LD method.
2.3.2 Brownian diffusion in dilute colloidal suspensions
Previous analysis [48, 49] show that once the fluid phase satisfies the FDT through FH, the
particle dynamics is automatically rendered to yield the FDT through the particle-fluid cou-
pling. However, when both the particle and fluid phase are introduced with fluctuation that
satisfies the FDT individually [52, 53], the coupled system requires an empirical rescaling
of the particle mobility to produce the correct temperature and hence the Brownian effect.
Below, we study the self-diffusion of colloidal particles in the dilute regime to show that
the current LB-LD approach, which introduces thermal fluctuation solely to the particle
phase, directly captures the correct Brownian effect.
Colloidal suspensions in the dilute regime with five particle sizes, dp = 10, 30, 100, 300
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Figure 2.6: (a) The mean squared displacements for various particle sizes in dilute concen-
traions. (b) Normalized self-diffusivity of colloidal particles as a function of particle size at
infinite dilution. The symbols are the simulation results. The line is the theoretical results
based on the Stokes-Einstein relation.
and 900 nm, are simulated independently to evaluate the long-time particle diffusivity.
Since only the long-time diffusion is of concern, the over-damped LE is employed in this
study. By sampling the mean-squared displacement (MSD) of the Brownian particle, the







at t/τr  1, where the angle brackets denote an ensemble of 1 000 particles in one simu-
lation. All cases are simulated in a periodic cubic domain with dimensions of 1003. This
setup ensures the particle volume concentration being kept below 0.1%. The theoretical






which is a nice, compact manifestation of the FDT by quantitatively relating the particle
thermally induced diffusive behavior to the dissipative property of the particle-fluid system.
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Figure 2.6 (a) shows the transient growth of the particle MSD for different particle size.
All the cases exhibit linear temporal growth of the MSD due to the neglecting the of the
particle inertia. Besides, as the particle size decreases, an increase of the MSD is observed
at the same instance. Figure 2.6 (b) further plots the dimensional long-time particle dif-
fusivity versus the particle size. The inset in Figure 2.6 (b) shows a typical example of
the particle trajectory. The particle long-time diffusivity predicted by the LB-LD simula-
tion shows excellent agreement with the Stokes-Einstein theory. This observation proves
that the LB-LD approach, which only introduces thermal fluctuation in the particle phase,
directly captures the Brownian motion without the any empirical adjustment.
2.3.3 Hindered particle diffusion in concentrated colloidal suspensions
In concentrated colloidal particle suspensions under quiescent flow condition, the particle
self-diffusion is often hindered due to the frequent, short-distance particle-particle interac-
tions. The hindered particle long-time diffusivity, D∞ is known to be sensitive to the num-
ber of particles, N , considered in the system [91]. To correct for such finite-size effects,
Ladd et al. [91] proposes a correction of the long-time diffusivity to link the N -particle















where Dt(N) is the particle self-diffusivity measured with a N -particle system at time t, µ
is the viscosity of the pure liquid and µφ is the viscosity of the particle suspension at various
concentrations. To further validate the LB-LD model, we simulated concentrated colloidal
suspension with particle size of dp = 600 nm and particle packing fractions ranging from
φ =0 to 42%. Three problem sizes are considered with particle number N = 1073, 1637
and 2096. The periodic compuational cube for each setup is adjusted according to the
particle packing fraction. The long-time diffusivity is measured at t/τB = 1.0, which
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Figure 2.7: (a) The mean squared displacements at various particle packing fractions with
N = 1073. (b) The normalized self-diffusivity of colloidal particles as a function of particle
volume concentration. Experimental results, theory and particle-scale simulation results are
also plotted for comparison purpose.
is shown to be the least time needed in order to reach the long-time diffusivity plateau
[82]. It should be noted that the t/τB = 1.0 criteria, somewhat empirical, might need
future verification to ensure the full long-time regime arrived. The measured diffusion
coefficients, Dt(N), are further corrected based on Equation 2.25, where the suspension
viscosity adopts the values reported in [84].
Figure 2.7 (a) shows the evolution of the particle MSD for various particle packing
fractions with N = 1073. A clear decrease of the MSD slope with increasing particle con-
centration is observed. Figure 2.7 (b) further presents the normalized long-time diffusivity
against the particle packing fraction. Results from existing simulation studies [40, 92, 93,
84], experimental measurements [94] and theory [95] are also plotted for comparison. At
zero particle packing fraction, all results agree excellently with the theoretical Brownian
diffusivity. At non-zero particle packing fraction, the BD method [92, 93], which com-
pletely neglects the effect of the fluid-solid coupling, shows the largest deviation from both
experiment and theory. By improving the contact modeling, the LD model [84] exhibits
improved accuracy. The SD method [40] shows excellent accuracy since it fully resolves
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both the near-field and far-field HI. The LB-LD method, which empolys the DLVO con-
tact modeling and includes the fluid-mediated effect through two-way coupling, show good
agreement with both the experiment and theory at low (φ = 0.1) and high (φ = 0.4) parti-
cle packing fraction. The small deviation at moderate concentration (φ = 0.2 ∼ 0.3) might
be related to the exclusion of the lubrication effect, which plays a vital role at semidilute
particle suspensions [96]. Overall, the LB-LD method shows satisfactory accuracy given
its simplicity in handling the many-body long-range and short-range interactions.
2.3.4 Self-globularization of a cohesive polymer chain
Polymer chains, such as deoxyribonucleic acid (DNA) [97] and von Willebrand factor
(vWF) [85], tend to form a collapsed globule conformation in a quiescent solvent. The
mechanistic drivers for this process primarily include the Brownian motion and the intra-
cohesiveness between adjacent monomers. The polymer longest relaxation time (LRT), τp,
can be used to characterize the rate of the self-globularization process. The LRT is known
to increase with the polymer length defined as the number of monomers, N . Specifically,
under free-draining (FD) condition wherein the many-body HI is neglected, the polymer
LRT suggested by [98], τp,R , scales as
τp,R ∼ O(N2.0); (2.26)
when including the effect of HI, the polymer LRT, τp,Z , according to [99] should scale as
τp,Z ∼ O(N1.5). (2.27)
The self-globularization process of a single polymer chain in a quiescent flow under FD
or HI conditions is interrogated using the current LB-LD approach. Four polymer lengths,
N=20, 40, 60 and 80, are considered to obtain a scaling observation. The diameter of each
monomer is set to dp=60 nm. A periodic computational domain with dimensions of 1003 is
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Figure 2.8: Temporal evolution of normalized MSE, 〈R2x〉/d2p, for various polymer length
(N = 20 ∼ 80) under either HI or FD condition. The left inset shows the streched state
of the polymer chain, while the right inset shows the globular state (after relaxation) of the
polymer chain.
Figure 2.9: (a) The instantaneous shifted MSE data points and the corresponding exponen-
tial curve fittings for polymers of various length N=20, 40, 60, and 80, under hydrody-
namic interaction conditions. Only the data points at 〈Rx〉/(Ndp) ∼ 0.3 are considered
for the curve fitting procedure. The curve fitting is performed for all points satisfying
〈Rx〉/(Ndp) ≤ 0.3. (b) Polymer longest relaxation time τp as a function polymer length
N .
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selected to minimize the periodic boundary effect. The polymer extension, Rx, defined as
the polymer projection length along the X direction (streamwise direction), is introduced to
quantify the instantaneous conformation of the polymer. The over-damped LE is employed,
given the time scale of the polymer conformational change is much larger than the particle
relaxation time scale. Figure 2.8 plots the normalized mean-square polymer extension
(MSE), 〈R2x〉/d2p, versus normalized time, t/τB. Each curve is obtained through ensemble
average over three independent runs with the same polymer length. The insets of Figure
2.8 demonstrate the initial and final conformation of a polymer chain with N = 20. For
both the FD and HI cases, longer polymers (largerN ) take longer time to reach equilibrium
globular conformation. Additionally, polymers of the same length under HI conditions tend
to tend to form a globule conformation more rapidly compared to under FD conditions. The
underlying mechanism causing this time-scale discrepancy between HI and FD conditions
is that the flow pattern induced by the polymer itself leads to smaller relative velocity and
hence smaller drag force exerted on each monomer [100].
The polymer relaxation time τp can be quantitatively evaluated by fitting the instanta-
neous MSE, [〈R2x〉 − 〈R2x,eq〉]/d2p, with an exponential function form in the final relaxation
regime when 〈Rx〉/Ndp ≤ 0.3, as suggested in [101]. The obtained exponential curve
satisfies the following expression
〈R2x〉 − 〈R2x,eq〉
d2p
= Ae−t/τp , (2.28)
where A is a fitting constant, and the denominator of the exponent readily gives τp. Figure
2.9 (a) presents the exponential curve fittings for the instantaneous [〈R2x〉−〈R2x,eq〉]/d2p data
points at 〈Rx〉/Ndp ≤ 0.3 under HI condition. The corresponding exponential functions
are denoted beside each curve as shown in Figure 2.9 (a). Same curve fitting procedure is
also performed for the FD case to obtain the LRT of the polymer chain under FD condition,
which is not shown here for clarity. The obtained τp for both FD and HI cases are further
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Figure 2.10: The temporal evolution of the normalized mean extension of a single polymer
chain (model vWF) subject to various shear rates in an unbounded simple shear flow.
plotted against the polymer length N in Figure 2.9 (b), where the two straight lines are
the best power-law fits for τp,R and τp,Z data points, respectively. The relaxation time τp of
the single polymer chain captured based on the LB-LD approach show scaling exponents of
1.98 and 1.52 for the FD and the HI conditions, respectively. These scaling behaviors agree
nicely with the theoretical scaling arguments [98, 99]. These results show the conforma-
tional dynamics of a single polymer chain subject to many-body HI is favorably captured
through the current LB-LD approach. It also confirms the significance of including the
effect of HI for simulating nanoscale particulate suspensions.
2.3.5 Shear-induced unfolding of a collapsed polymer chain
When subject to shear flow above certain critical shear rate, the collapsed biopolymer
chains (e.g. vWF, DNA, etc.) tend to be unfolded and exhibit periodic stretch/coil confor-
mation changes while tumbling [97, 85, 87]. Such shear-induced unfolding phenomenon
of the collapsed polymer chain is a manifestation of the competition between the viscous,
elongational flow effect and the intra-monomer cohesive effect [85]. In this section, we
further validate the LB-LD approach by simulating a single vWF strand subject to differ-
ent shear rates and comparing its conformational statistics with existing experimental data.
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To exclude the confinement effect, the Lees-Edwards boundary condition [102, 74] is em-
ployed to impose the unbounded simple shear flow. Shear rates, ranging from 1 to 8 000
s−1, are considered to replicate the flow conditions considered in the experiment [87]. The
vWF strand is modeled as a 200-bead (i.e. N = 200) polymer chain. Each bead represents
a dimer (repeating unit of a vWF polymer chain) with a diameter of dp = 160 nm closely
matching measured dimer size reported in [103]. The selected bead size and bead number
yield a contour length of 32 µm for the model vWF, which is also close to the actual size of
the vWF considered in the experiment [87]. All computations adopt a periodic LB domain
with dimensions of 60×30×30 µm3 in the flow, the velocity-gradient and the vorticity
directions, respectively.
The conformation state of a single polymer chain under shear flow can be quantified
by the normalized mean polymer extension (ME) in the streamwise direction, 〈Rx〉/Ndp,
where the ensemble average of the polymer extension is performed in time. As shown in
Figure 3.3, the instantaneous polymer extension exhibits fluctuation over time. Moreover,
the magnitude of the fluctuation and the ME increase with shear rate changing from 1 000
s−1 to 8 000 s−1. Figure 2.11 plots the ME of the polymer chain versus shear rate in
both dimensional and dimensionless units. A Weissenberg number, defined as Wi = γ̇τB,
is employed as the nondimensional shear rate. It is shown that the ME measured in the
LB-LD simulation compares favorably well with the experimental measurements reported
in Schneider et al. [87]. Particularly, a range of critical shear rates (5 000 ∼6 000 s−1)
around which the polymer chain exhibits an abrupt increase of the ME is well captured
in the LB-LD simulation. The insets in Figure 2.11 presents the representative polymer
conformations under simple shear flow. As expected, below critical shear rate, the vWF
polymer remains in a compact globular conformation; while above critical shear rate, the
vWF polymer undergoes periodically stretched/coiled conformational transitions. The sim-
ulation results reported in [85] using Brownian dynamics are also adopted for comparison,
where the critical shear rate is shown to be well captured. However, their simulation de-
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Figure 2.11: Unfolding of a single polymer chain under a critical shear rate. The measured
polymer mean extension using a microfluidic device by [87] is adopted to validate the LB-
LD model. The simulation results reported in [85] are also plotted for comparison. The
right vertical axis (dimensional) applies to experimental results and the LB-LD results; the
left vertical (dimensionless) axis applies to all three sets of results.
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viates from the experimental results in terms of normalized mean extension particularly at
low shear rates, which is due to the shorter contour length (N = 50) considered in their
model vWF. Since the vWF model parameters (except N ) considered in the LB-LD poly-
mer model is close to the ones employed in [85], the results also qualitatively confirm the
weak polymer length dependence of the critical shear rate as concluded in [85]. The good
agreement between the LB-LD simulation and experiment results for the shear-induced un-
folding process of vWF strand again show the validity of the current LB-LD approach in
capturing the conformational dynamics of long-chain polymers under shear flow.
2.4 Summary
A hybrid Eulerian-Lagrangian approach coupling the non-fluctuating LB method and a
LD method is developed to simulate suspensions of nanoscale particles and long-chain
polymers including the effects of thermal fluctuation, many-body HI, and particle-particle
short-distance interactions with linear particle-number scalability. The LB-LD approach is
verified and validated with both thoery and experiment. An EH algorithm is also developed
to handle the short-range pairwise particle search and interaction, which ensures localiza-
tion and hence linear scalability of the method while performing particle neighbour search.
The LB-LD approach embedded with the EH algorithm is purely local and can be read-
ily extended for parallelization. Liu2018JFM The LB-LD approach confirms the idea of
coupling non-fluctuating LB method with LD method to directly capture the correct Brow-
nian diffusion without empirical rescaling of the particle mobility [57]. Furthermore, the
current method demonstrates that the long-distance many-body HI can be directly included
via the LB-LD two-way coupling scheme, which was not shown in [57]. Compared to us-
ing mobility matrix approach to capture HI [85], the direct two-way coupling approach, in
addition to being more efficient, also has the flexibility of including the modified HI effects
subject to complex geometries/boundaries [24, 118]. Besides, the two-way coupled LB-
LD approach embedded with the DLVO potentials allows simulating nanoscale particulate
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suspension across dilute-to-dense concentrations with good accuracy.
Liu2018JFM Since the entire nanoscale particulate suspension dynamics are resolved
through sub-lattice techniques, the LB-LD method is particularly suitable for multimodal
particulate suspension applications that involve particles, polymer chains and capsules with
disparate length scales [24, 118], where DNS of such systems is computationally pro-
hibitivoute. One example is the simulation of multiscale, multicomponent complex blood
flow by coupling the LB-LD method with cellular blood solvers, where the dynamics and
deformation of both microscale blood cells (e.g. red blood cell, platelet, etc.) and nanoscale
molecules and bioproteins (e.g., vWF, albumen, etc) can be simulated concurrently with
neither refining the grids nor introducing sub-timesteps. In Figure 2.12, we present a simu-
lation snapshot demonstrating a simulation of multiscale and multicomponent whole blood
through a 40 µm microvessel. This simulation captures a concentrated poly-dispersed sus-
pension tubular flow of 40% volume fraction of deformable red blood cells (red),∼1% vol-
ume fraction of rigid platelets, 3×1010/ml vWF and 1×109/ml nanoscale particles under
a wall shear rate of 2000 s−1. The development of the LB-LD method forms a multiscale
computational framework to tackle biophysical suspension flow problems across nano-to-
microscale, such as high-shear induced thrombus formation in blood [11], which will be
discussed in following chapters.
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Figure 2.12: The side view (top) and frontal view (bottom) of complex whole blood flow
through a microvessel with a 40 µm diameter, simulated using the LB-LD method coupled
with the spectrin-link method [3]. A total of 427 deformable red blood cells (RBCs) (red
capsules) are resolved in the simulation, resulting in a 40% heamatocrit. The platelet (white
oblate capsules)-RBC number ratio is ∼ 1/20. The vWF (light blue strands) molecule
number concentration is ∼ 3 × 1010/ml. The wall shear stress is 2000 s−1. All above
parameters match the blood physiological condition. The nanoparticle (yellow particles)
number concentration is ∼ 1× 109/ml consistent with the typical dosage used in vivo.
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CHAPTER 3
DISPERSION OF NANO-TO-MICROSCALE PARTICLES IN CELLULAR
BLOOD FLOW THROUGH MICRO-VESSELS.
Transport of solid particles in blood flow exhibits qualitative differences in the transport
mechanism when the particle varies from nanoscale to microscale size comparable to the
red blood cell (RBC). The effect of microscale particle margination has been investigated
by several groups. Also, the transport of nanoscale particles (NPs) in blood has received
considerable attention in the past. This study attempts to bridge the gap by quantitatively
showing how the transport mechanism varies with particle size from nano- to microscale.
Using a three-dimensional (3D) multiscale method, the dispersion of particles in microscale
tubular flows is investigated for various hematocrits, vessel diameters and particle sizes.
NPs exhibit a nonuniform, smoothly-dispersed distribution across the tube radius due to
severe Brownian motion. The near-wall concentration of NPs can be moderately enhanced
by increasing hematocrit and confinement. Moreover, there exists a critical particle size
(∼1 µm) that leads to excessive retention of particles in the cell-free region near the wall,
i.e., margination. Above this threshold, the margination propensity increases with the parti-
cle size. The dominance of RBC-enhanced shear-induced diffusivity (RESID) over Brow-
nian diffusivity (BD) results in 10 times higher radial diffusion rates in the RBC-laden
region compared to that in the cell-free layer, correlated with the high margination propen-
sity of microscale particles. This work captures the particle size-dependent transition from
Brownian-motion dominant dispersion to margination using a unified 3D multiscale com-
putational approach, and highlights the linkage between the radial distribution of RESID
and the margination of particles in confined blood flows.
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3.1 Introduction
Blood is a complex fluid suspended with multiple species, primarily including red blood
cells (RBCs), platelets, white blood cells and various biomolecules (such as von Willebrand
factors, albumin, fibrinogen, etc.). In microvessels under physiological flow conditions,
RBCs migrate towards the center of the tube and leave a cell-free layer (CFL) near the
wall [105, 106]. Such phenomenon, well known as the Fahraeus-Lindquist effect [107],
contributes to the hemorheological heterogeneity of the blood flow. Unraveling the disper-
sion properties of solutes and cells of various sizes ranging from nanometer to micrometer
in such heterogeneous blood flows under vascular confinement can potentially lead to op-
timal design of drug carriers and better understanding, intervention and control of vascular
diseases.
As a relevant example of microscale particle transport in blood, platelets margination
has shown to play an important role in affecting the rate of clot formation in hemostasis
and thrombosis [11]. Motivated by that, a plethora of studies over the past decades have
dedicated to unravel the mechanistic mechanisms of margination or segregation of mi-
croscale particles/cells in blood(-like) flows through perfusion experiements [12, 108, 109,
13], continuum-level modeling [14, 15] and direct numerical simulations [16, 17, 18, 110,
19, 111, 13, 20, 112, 113]. The platelet margination is found to be primarily driven by the
cross-stream hydrodynamic fluctuation [17, 18, 114] or equivalently the RBC-enhanced
shear-induced diffusion [15, 111] in the RBC-laden region synergistically accompanied by
the sink-like effect of the CFL [111].
Nanoscale particle (NP) dispersion in blood flow, on the other end of the spectrum, has
recently received considerable attention due to the fast development of nano-drug delivery
techniques that have the potential to revolutionize the traditional therapeutics [115]. Al-
though the effective diffusivity of nanoscale solutes in blood flow were measured decades
ago [116], it is not until the past several years multiscale particle-level simulation tech-
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niques [117, 23, 22, 24] become feasible. Tan et al. [117] apply a coupled Brownian dy-
namics and immersed finite-element (FE) method to study the influence of RBCs on the NP
dispersion in blood flows, showing substantial margination behavior for 100 nm particles.
Through both in vivo and in silico techniques, Lee et al. [23] show that submicron parti-
cles (>500 nm) can marginate while NPs (∼100 nm) are mostly trapped in the RBC-laden
region. Muller et al. [22] performed two-dimensional (2D) simulations and suggest that
microscale particles compared to submicroscale particles show better margination propen-
sity. Liu et al. [24] developed a multiscale complex blood solver and evaluate the role of
BD versus RESID in affecting the biodistribution of NPs. Recently, Liu et al. [118] char-
acterize the complete 3-D diffusivity tensor of NP in blood under various shear rates and
hematocrits, which can be employed to modeling large-scale NP biotransport applications.
Although the transport of both nanoscale and microscale particles in blood have been
understood to a large extent, there is still a lack of a systematic interrogation of the parti-
cle dispersion behavior across nano-to-microscale sizes using a unified computational ap-
proach. Consequently, questions such as whether nanoscale particles exhibit margination
qualitatively the same as microscale particle still remains controversial. A recent effort
by Cooley et al. [119] using in vitro experiment and 2D in silico simulation to under-
stand the cross-length-scale particle margination and adhesion propensity has set an ex-
ample for a unified understanding of the nano-to-microscale particle dispersion in blood
flows. However, the general physical mechanisms behind the multiscale particle disper-
sion/margination phenomenon in blood are still not presented; besides, the 2D simulation
could still overlook the 3D nature of the tubular blood flow phenomena.
In this work, we employ a recently developed 3D multiscale and multicomponent blood
flow solver [3, 24, 120, 118] to tackle the dispersive characteristics of spherical, rigid par-
ticles with sizes spanning nano-to-microscale in a tubular blood flow. Particle suspension
dynamics in the presence of thermal fluctuation, RBC-particle direct and hydrodynamic
interactions and wall-bounded confinement effect are captured under a unified 3D compu-
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tational framework. The strong correlation between the non-uniform distribution of par-
ticle radial diffusivity and the equilibrium distribution of particle radial concentration is
highlighted to gain mechanistic understanding of the occurrence of particle-size-induced
dispersion-to-margination transition.
3.2 Methodology
The numerical method used to simulate the bi-disperse particle-RBC suspensions confined
in a tubular flow is through a multiscale and multicomponent complex blood flow method
[24, 118] that couples the lattice-Boltzmann/Spectrin-link (LB-SL) method [3] with the
lattice-Boltzmann/Langevin-dynamics (LB-LD) method [120]. This method leverages the
off-lattice nature of the LB-LD approach and the efficiency of the course-grained SL RBC
membrane method to concurrently simulate the dynamics of across nano-to-microscale par-
ticles and microscale deformable capsules with a fixed LB lattice resolution [24, 120]. The
hybrid LB-LD-SL method has previously been verified with theory [24, 120] and validated
against experiments [3, 7, 118]. Fig 4.1 demonstrates a nanoscale particle-RBC bidisperse
suspension flow through a 40 µm vessel, where the computational methods for each mod-
ule are denoted accordingly and presented in detail as follows.
3.2.1 Spectrin-link method
The modeling of RBC dynamics and deformation is through the coarse-grained spectrin-
link (SL) membrane method [Pivkin2008, 121] coupled to the LB method [3]. The hybrid
LB-SL method has been extensively validated against experimental measurements and is
capable of capturing both the deformation and dynamics of single RBC [3] and the rheology
of RBC suspensions at physiological hematocrit [7] with good accuracy and efficiency.
In the LB-SL model, the RBC membrane is modeled as a triangulated network with
a collection of vertices mimicking actin vertex coordinates. The Helmholtz free energy
of the network system, E, including in-plane, bending, volume and surface area energy
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Figure 3.1: Nano-to-microscale particle transport in cellular blood flow through microves-
sels. The fluid phase is simulated using the lattice-Boltzmann (LB) method [2]. The defor-
mation and dynamics of red blood cells (RBCs) are simulated by coupling a course-grained
spectrin-link (SL) method with LB method [3]. The multiscale (nanoscale to microscale)
particles (yellow) are simulated via a coupled LB-Langevin dynamics (LD) method [24,
120]. The particle-RBC interaction and inter-cell interactions are resolved through various
contact modeling techniques [8, 74, 24, 118].
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components [122], is given by
E = EIP + EB + EΩ + EA, (3.1)
where the in-plane energy, EIP , characterizes the membrane shear modulus through a
worm-like chain (WLC) potential [123] coupled with a hydrostatic component [121]; the
bending energy, EB, specifies the membrane bending stiffness, which is essential in char-
acterizing the equilibrium RBC biconcave morphology [122, 121]; the volumetric contraint
energy, EΩ, and the area constraint energy, EA, preserve the RBC volume and area conser-
vation, respectively, when subject to external forces.












where vn is the velocity of the vertice at the position xn andM is taken as the fictitious mass
of the RBC that is evaluated as the total mass of the cell divided by the number of vertices,
Nv [19, 118]. The number of vertices used to discretize the RBC membrane is Nv=613,
which has shown to yield adequate resolution to resolve the hydrodynamic forces [8] and
capture single RBC dynamics [3] and concentrated RBC suspension rheology [7] when
coupled with the LB method. fLBn specifies the forces on the vertex due to the fluid-solid
coupling. fCCn are the forces due to cell-cell interactions. The forces due to the Helmholtz





The SL method is solved by integrating equations 3.2 at each LB time step using a first-
order-accurate forward Euler scheme in consistency with the LB evolution equation to
avoid excessive computational expense [3, 24].
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3.2.2 Fluid-RBC coupling
The coupling between fluid and RBC is accomplished through the ALD fluid-solid inter-
action scheme [64]. In this method, the momentum transfer at the fluid-solid interface is
accounted for by applying the bounce-back operation along lattice links that cross solid
surfaces. As a result, the no-slip condition is enforced by adjusting the PDFs of the fluid
nodes at the end point of a link along the i direction through
fi′(r, t+ 1) = fi(r, t
+)− 6ρωiub · ei, (3.4)
where i′ is the direction opposite to i, fi(r, t+) is the post-collision distribution, and ub
is the solid velocity at the intersection point with the link. The fluid force exerted on the




ei, t) = 2ei[fi(r, t
+) + 3ρωiub · ei′ ], (3.5)
which is applied to the advancement of the RBC dynamic equation through equation 3.2.
3.2.3 Contact modeling
The short-distance interactions between particle and RBC or between particle and the ves-
sel wall is through Morse potential that forbids particles from penetrating the RBC mem-
brane or the vascular wall. This contact model has previously been used in the charac-
terization of the NP long-time diffusion tensor in an unbounded sheared blood, where the
calculated NP diffusivity compares favorably with experimental measurements [118]. The
Morse potential function is given as
UM(r) = De[e
−2β(r−r0) − 2e−β(r−r0)], (r ≤ r0) (3.6)
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Figure 3.2: Time change of the average radial location of the microscale particles simulated using the
multiscale LB-LD-SL method [24, 118] and the DNS approach [19]. The tube diameter is 20 µm; the wall
shear rate is 1000 s−1; the hematocrit is 20%. Particles with diameters of dp=1.5 or 2.5 µm have been selected
for comparisons. The inset shows snapshots (frontal views) of 1.5 µm particle distribution in tubular blood
flows at tγ̇w=2000 simulated using the DNS method [19] (left) or the LB-LD-SL multiscale approach [24,
118] (right).
where r is the normal distance between the particle center to the RBC surface, r0 is a cut-
off distance in which no interaction forces are present, De is the potential well depth and β
is a scaling factor. The Morse potential is imposed when r ≤ r0 to preserve the repulsive
effect. Model parameters are adjusted to match the measured inter-cell potential energy, as
discussed in [24, 118]. Specifically, the scaling factor is set to β = 2 µm−1, the surface
energy has a value of De = 107kBT and the equilibrium distance is set to r0 = dp/2 +
10 nm. This simple contact model, bridging the LB-LD approach [24, 120] and the LB-SL
method [3, 7], can capture the margination phenomenon of microscale particles comparably
well as the DNS approach does [3, 111]. Fig 3.2 presents the temporal evolution of the
ensemble average of the radial displacement of microscale particles, 2〈rp〉/dp, where the
particle margination process through the LB-LD-SL approach and that via DNS compares
favorably well especially when approaching the equilibrium stage (tγ̇w ≥2000).
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3.2.4 Evaluation of the particle radial concentration






where N denotes all LD particles in the simulation and Lv is the length of the tube. The
radial bin width, ∆r, is set to one tenth of the tube radius to accurately resolve the radial
profiles of the particle concentration distribution [19]. The bulk ensemble-averaged par-
ticle number concentration can be calculated as 〈Cn〉=4N/πd2vLv, which is later used to
normalize the pariticle local concentration.
3.2.5 Evaluation of the particle radial diffusivity
The particle radial diffusivity is evaluated through a moving time-origin measurement [84]
of the particle mean squared displacement (MSD) based on a fixed sampling time interval
(STI). The STI is properly chosen to exclude the short-time ballistic regime [24, 120]. By
measuring the radial MSD of particles at a radial location r, the local instantaneous particle
radial diffusivity can be evaluated according to
Drr(r, t) =
∑





where N denotes all LD particles in the simulation and ∆t is chosen to be 1000 in lattice
units [118]. Same technique can be applied to measure the radial distribution of RESID,
DRBCrr (r, t), where the BD is excluded by setting Sp = 0. The bulk ensemble-averaged par-




; similarly, the bulk





equilibrium counterparts of the particle radial diffusivity are denoted as 〈Drr〉 and 〈DRBCrr 〉
without time dependence.
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3.3 Results and Discussion
3.3.1 Problem Setup
The physical problem of particle-RBC suspension flow through a straight tube can be de-
fined by the vessel diameter, dv, the systemic hematocrit, φ, the particle diameter, dp, the
wall shear rate, γ̇w, and temperature, T , given fixed RBC properties (hydrodynamic radius,
aRBC , and membrane shear modulus, G). Apart from the hematocrit, the corresponding
non-dimensional parameters are the confinement ratio, d∗v =
aRBC
dv
, which determines the








, which describes the competition between the shear-induced diffusion
and the Brownian diffusion; and the capillary number, Ca = µγ̇waRBC
G
, which defines the
deformability of the RBC capsule.
In this work, we consider d∗v ranging from 0.07∼0.29, corresponding to typical diame-
ters of arterioles [124]. The particle-cell size ratio considered ranges from d∗p=0.003∼0.86,
covering typical size of biomolecules and cells (such as von Willebrand factor, vWF, and
platelet) in blood flows. Given the low sensitivity of platelet margination to shear rate [111],
a physiologically relevant wall shear rate, γ̇w=1000 s−1, typical in arterioles or capillaries
is considered for all cases. The fluid viscosity is set to the same as blood plasma, µ= 1.2
cp. The temperature is set to the body temperature, T= 310 K. The RBC membrane has
a shear modulus of G=0.0063 dynes/cm. The effective hydrodynamic radius of RBC is
aRBC= 2.9 µm. As a result, the dependence on Pe is determined by d∗p. The deformability
of RBC is fixed with CaG=0.55.
All simulations are initialized with the particles and RBCs uniformly and randomly
mixed in the tube, except the particles are only seeded at 2r/dv ≤ 0.6. Periodic boundary
conditions are imposed on the two ends of the tube. The tube has a length of Lv/aRBC ≥ 10
to ensure the periodic boundary treatment exerting negligible effect on the particle/cell
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Figure 3.3: Temporal change of (a) particle number percentage and (b) particle radial diffusivity at
different radial locations. Here, the particle number percentage, n(r)/N , is defined as the number of particles
within certain peripheral layer, n(r), normalized by the total particle number, N . Simulation is performed
with dp=100 nm, dv=20 µm and γ̇w=1000 s−1. Simulation reaches equilibrium after tγ̇w ∼ 2000.
transport. This is paper focuses on the dispersive characteristics at equilibrium, albeit the
transient effects may play a significant role in the particle distribution in microvascular bi-
furcating structures[124, 125, 126, 127, 128]. The equilibrium conditions are determined
by tracking the particle accumulation at each radial location until it plateaus. As an exam-
ple in Fig 3.3, we present the temporal change of particle number percentage and radial
diffusivity at different radial locations; where the particle number percentage, n(r)/N , is




normalized by the total particle number, N , within the simulation domain. The simulation
is performed with dp=100 nm, dv=20 µm and φ=0.2. The equilibrium state is arrived at
tγ̇w ∼ 2000, when the mean values of both n(r)/N and Drr(r)/DB remain unchanged
with respect to time.
3.3.2 Dependence on confinement
We first interrogate the dispersion characteristics of NPs under different confinement ratios
controlled by adjusting vessel diameters in the range of dv=10∼40 µm (corresponding to
d∗v=0.29∼0.073), which corresponds to typical size of arterioles or capillaries in human
[124]. The particle size is fixed to dp=100 nm. The wall shear rate is set to γ̇w=1000 s−1
and the systemic hematocrit is set to φ=0.2, which are within the range of physiological
hemorheological ranges in human arterioles or capillaries [124]. The number of particles
simulated in the microvessels are N=4000, 1000 and 250 from large to small vessels, re-
spectively, to conserve the particle volume concentration.
Figure 3.4: NP and RBC distribution at equilibrium within microvessels of different diameters dv = 40
(top), 20 (middle) or 10 (bottom) µm at φ = 0.2 and γ̇w = 1000 s−1. Left columns show the side views of
the microvessels; right columns show the end views of the microvessels.
Fig 3.4 presents the simulation snapshots of NP and RBC equilibrium distribution in
microvessels under various confinement conditions. Qualitatively, the RBC dynamic mode
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changes from tank-treading/tumbling dominant to parachuting dominant [3], as the vessel
diameter decreases from 40 to 10 µm. Such an increase of confinement does not alter the
radial distribution of shear rate significantly but does change the radial distribution of lo-
cal hematocrit to a large extent, as shown in Fig 3.5a and 3.5b. Specifically, for the case
with dv=40 µm, the RBC-laden region shows a relatively uniform distribution except near
the center of the tube where the shear rate is close to zero. Consequently, the NP concen-
tration, Cn(r), at 0<2r/dv<0.2 appears twice the bulk average NP concentration, 〈Cn〉,
while Cn(r) near the wall exbhit slightly lower values than 〈Cn〉. As the vessel diame-
ter decreases to 20 µm, the dimensionless CFL thickness δCFL/dv increases from ∼0.2 to
∼0.4, i.e., the RBC-laden region becomes relatively more focused. Moreover, the local
hematocrits get intensified especially at the inner boundary of the CFL and near the tube
axis. These hemorheological changes substantially affect the equilibrium radial distribu-
tion of Cn(r)/〈Cn〉. As a result, the location of peak NP concentration shifts towards the
CFL region, as shown in Fig 3.5c. Further confining the system to dv=10 µm, allowing
only one train of RBCs parachuting through the vessel, appears to slightly enhance the
peak concentration of NP at the CFL region while decreasing the NP concentration at the
RBC-laden region. Previous microfluidic experiments by [129] also show the enhance-
ment of the number percentage of particles adhered to the wall when the width of a ∼40
µm channel is reduced by half.
The distributions of the NP radial concentration can be better understood by evaluating
the NP radial diffusivity, as depicted in Fig 3.5d. The NP diffusivity in the velocity-gradient
direction based on the theoretical NP diffusion rate evaluated in an unconfined shear-flow
setting [118] is also plotted for comparison using the local shear rate and hematocrit at
specific radial location for the dv=40 µm case. In general, increasing the confinement
reduces the magnitude of NP radial diffusivity, where the unconfined case shows up to
two folds the radial diffusivity, Drr(r)/DB, of the dv=40 µm case. Besides changing the
magnitude of Drr(r)/DB, adjusting confinement ratio also alters the radial distribution
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Figure 3.5: Radial distribution of (a) shear rate, (b) hematocrit, (c) NP equilibrium distribution and (d) NP
dispersion rate for various confinement ratios at γ̇w = 1000 s−1, φ = 0.2 and dp = 100 nm. The radial
diffusivity based on the empirical correlation of NP diffusion tensor [118] in a unconfined simple shear flow
is plotted in (d) for comparison, where the calculation adopts the local hemorheological parameters specific
to the radial locations for the dv=40 µm case. Error bars denote the standard deviation.
of Drr(r)/DB. For the dv=40 µm case, the NP radial diffusivity shows high values near
the CFL inner boundary and low value in the RBC-laden region, which is similar to the
Drr(r)/DB distribution in the unconfined case. This distribution of Drr(r)/DB seems to
be the cause of the low concentration of NPs near the CFL region and the high concentration
at the RBC-core region. The increase of confinement (decrease of vessel diameter to 20
or 10 µm) renders the radial location of high Drr(r)/DB to move towards the RBC-laden
region, which appears to be responsible for the shift of the high NP concentration region
towards the CFL, as observed in the high confinement cases (dv=10 and 20 µm).
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Overall, the increase of confinement ratio enhances the NP near-wall concentration by
inhibiting the NP diffusion near the wall. This however does not warrant the margination
of NPs, given no excessive NP concentration (Cn(r) < 1.5〈Cn〉) is observed near the wall
as the vessel confinement increases to capillary scale. It is noted that when vessel size
decreases to capillary scale, retention of microscale particles in the RBC-induced recircu-
lation is reported [130], which however is not observed in the current study with NPs under
the studied hemorheological conditions.
3.3.3 Dependence on hematocrit
Changing hematocrit significantly modifies the apparent viscosity of blood [131, 7] and
could drastically influence the RBC-enhanced shear-induced diffusivity of NPs in sheared
blood flow [118]. To understand how the variation of systemic hematocrit in microvessels
changes the local hemorheology and hence the NP radial distribution, we investigate the
hematocrit dependence of the NP radial dispersion behavior under various systemic hema-
tocrits in the range of φ=0∼0.3. For the cases considered here, we select a fixed vessel
diameter of dv=20 µm and a NP size of dp=100 nm. The wall shear rate is set to γ̇w= 1000
s−1. The number of NPs are set to N=1000.
Fig 3.6 plots two snapshots of NP-RBC distribution in a 20 µm vessel, where the
high hematocrit case (φ=0.3) exhbits a thinner CFL compared to the low hematocrit case
(φ=0.15) as expected. Fig 3.7a and 3.7b present quantitative analysis of the hemorhe-
ological response to the change of systemic hematocrit, where the increase of systemic
hematocrit affects the radial distribution of both the local shear rate, γ̇(r), and the local
hematocrit, φ(r), which are two competing drivers for the particle cross-stream migration.
On one hand, it alters the flow structure from a Poissuelle-type flow towards a plug-type
flow; as a result, the local shear rate in the RBC-laden region decreases, which drives the
Brownian particles to the tube center. One the other hand, it increases the local hematocrit
in the RBC-laden region, which drives the particles to migrate to the wall.
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Figure 3.6: NP and RBC distribution at equilibrium in a 20 µm microvessel with φ = 0.15 (top) or
φ = 0.30 (bottom) at γ̇w = 1000 s−1 and dp = 100 nm. Left column shows the isometric view of the
tubular blood flow; right column shows the end view of the microvessels.
The adjustment of the two competing effects lead to certain variation of the NP radial
distribution, as presented in Fig 3.7c. At φ=0, the NP dispersion is purely driven by the
Brownian diffusivity and the shear-gradient driven dispersion. The former is isotropic,
while the latter tends to drive the particle towards low shear region [129]. As a result, the
NP distribution shows a high NP concentration in the core and a low concentration near the
wall. Increasing the systemic hematocrit generally alters the NP distribution such that the
high NP concentration region shifts to the CFL. Interestingly, a slight increase of φ from
0 to 0.05 appears to be enough to shift this paradigm of NP distribution, leading to about
3-fold decrease of NP concentration at the core and ∼1.5 folds increase of NP near wall
concentration. Further increasing φ slightly increases the near wall NP concentration but
also increases the NP concentration at the RBC-laden region. Correspondingly, in Fig 3.7d,
the Drr(r) value (especially in the RBC-laden region) shows a non-monotonic change with
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Figure 3.7: Radial distribution of (a) shear rate, (b) hematocrit, (c) NP equilibrium distribution and (d) NP
dispersion rate for various hematocrits at γ̇w = 1000 s−1, dv = 20 µm and dp = 100 nm. Error bars denote
the standard deviation.
respect to φ, which first increases by up to 3 folds as φ rises to 0.05 and gradually gets
inhibited to be close to the theoretical Brownian diffusivity as φ further increases to 0.3.
The inhibition of NP radial diffusiviy at high hematocrit can be explained by the excessive
local φ(r) and low γ̇(r), as shown in Fig 3.7a and 3.7b.
Therefore, low systemic hematocrits appear to be optimal to enhance the NP near-wall
concentration in microvessels, owing to the relatively high local shear rates and moderate
local hematocrits that does not inhibits the NP dispersion in the tubular core. Nevertheless,
changing hematocrit does not lead to the margination of NP.
56
3.3.4 Dependence on particle size
So far we have focused on the long-time dispersion behavior of NPs in microvessels under
various confinement ratios and hematocrit conditions. In these cases, particles do not show
margination behavior. Instead, a non-uniform radial distribution of particles is observed
with the particle concentration near the wall being less than 1.5 times the bulk average
concentration. Besides, the near-wall concentration of NP is dynamically conserved at
equilibrium, accompanied by the cross-migration of NPs between the CFL and the RBC-
laden region due to severe Brownian effect[24].
In this section, we consider the size-dependent dispersion behavior of nano-to-microscale
particles in microvessels. Particles with sizes ranging from dp=10∼2500 nm are consid-
ered, covering particles ranging from nanoscale biomolecules such as vWFs in globular
conformation to microscale cells such as platelets. The vessel diameter is fixed to dv= 20
µm. The wall shear rate is set to 1000 s−1. The systemic hematocrit is kept at φ=0.2.
To maintain the volumetric concentration of the particle phase in the dilution limit (i.e.,
 1%), the number of large particles considered in the system is reduced accordingly
but kept above 50 to ensure statistical significance as suggested in previous margination
study [19].
Fig 3.8 presents the equilibrium distributions of RBCs and particles. Qualitatively,
NPs show non-uniformly dispersed distribution across the vessel, where NPs at any ra-
dial position can disperse to a random radial location given enough time owing to severe
Brownian effect. These features are qualitatively different from the margination behavior
of microscale particles, where ecessive concentration and retention of particles in the CFL
can be observed [19, 111]. Fig 3.9a further depicts the radial distribution ofCn(r)/〈Cn〉 for
various particle sizes. As the particle size increases above 1 µm, the CFL region exhibits a
prominently high particle concentration. Specifically, for particles with a diameter dv=2.5
µm, a five times bulk average particle concentration, Cn(r) ≈ 5〈Cn〉, can be observed at
the CFL region. These observations are consistent with the microfluidic perfusion experi-
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Figure 3.8: Particle and RBC distribution at equilibrium with particles size being nanoscale (top) or mi-
croscale (bottom) at φ = 0.2, dv = 20 µm and γ̇w = 1000 s−1. Left column shows the isometric view of the
tubular blood flow; right column shows the end view of the microvessels.
ment by [132], where the number percentage of particles adhered to the wall gets increased
by 5∼7 times as the particle size changes from nanoscale to microscale. The change of
the particle number concentration at the CFL, CCFLn , versus that at the RBC-laden region,
〈Cn〉non−CFL, as a function of particle size is further plotted in Fig 3.9b. When the particle
size is below 1 µm, the CCFLn /〈Cn〉non−CFL value shows weak dependence on the particle
size; which only shows a slight increase from 1.0 to about 1.5 as dp changing from 10 nm to
1000 nm. As particle size exceeds 1 µm, the CCFLn /〈Cn〉non−CFL value increases abruptly
and margination occurs. Particle size dp=1 µm seems to be a critical watershed that divides
the dispersion state and the margination state, as denoted in Fig 3.9b.
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Figure 3.9: (a) The radial distribution of particle number concentration normalized by the bulk av-
erage number concentration of the particles for different particle sizes at φ = 0.2, dv = 20 µm and
γ̇w = 1000 s
−1. (b) The particle number concentration in the CFL normalized by that in the RBC-laden re-
gion, CCFLn /〈Cn〉non−CFL, plotted against particle size. The yellow area shows the dispersion (no margina-
tion) regime; the pink area show the margination regime. (c) The radial distribution of particle radial diffu-
sivity normalized by the Brownian diffusivity for various particle sizes. (d) The ensemble-averaged particle
radial diffusivity plotted against particle sizes; the diffusivity ratio, 〈DRBCrr 〉, is also plotted with the vertical
axis on the right. Error bars denote the standard deviation.
To shed light on the size-dependent dispersion behavior of particles in tubular blood
flows, the distribution of particle radial diffusivity, Drr(r)/DB, is plotted in Fig 3.9c. For
NPs, the Drr(r)/DB distribution tends to be uniform due to the dominance of isotropic
Brownian diffusivity. As the particle size increases above one micronmetre, the RBC-laden
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region shows prominent enhancement ofDrr(r)/DB compared to the CFL. Moreover, both
at the CFL edge (2r/dv ∼ 0.8) and close to the tube center (2r/dv ∼ 0.2), the magnitude of
Drr(r)/DB peaks and the inner peak is more pronounced than the peak close to the CFL.
For the 2500 nm particles, the inner peak shows more than ∼10 times Drr(r)/DB values
of that at the CFL. The radial distribution of Drr(r)/DB seems to be inversely correlated
to the radial distribution of Cn(r)/〈Cn〉 in terms of the radial location, suggesting that the
margination of microscale particles is probably due to the large magnitude difference in
Drr(r)/DB between the RBC-laden region and the CFL region.
In Fig 3.9d, we plot the ensemble-averaged radial diffusivity, 〈Drr〉, as a function of
the particle size. The ensemble average is performed among all particles located at var-
ious radial locations at equilibrium state. For small dp, the 〈Drr〉 value asymptotically
matches the Stokes-Einstein relation due to the dominance of Brownian diffusion. Increas-
ing the particle size decreases the effect of thermal fluctuation and leads to the deviation
of 〈Drr〉 from DB. The value of 〈Drr〉 eventually plateaus at the microscale size regime,
where the RESID is dominant over BD. The bulk ensemble-averaged RESID, 〈DRBCrr 〉,
seems to be weakly dependent on the particle size, similar to the particle diffusivity ob-
served in a unbounded sheared blood flow [118]. Subtracting the 〈Drr〉 with 〈DRBCrr 〉
shows an overlap of the dataset 〈Drr〉-〈DRBCrr 〉 with the theoretical Brownian diffusivty,
confirming the RESID is linearly superimposed with the Browanian diffusivity [24]. More
interestingly, the increase of 〈DRBCrr 〉/DB shows a strong positive correlation with the in-
crease of CCFLn /〈Cn〉non−CFL, as shown in Fig 3.9b and 3.9d. This strong linkage between
the dispersion-to-margination transition and the particle-size relevant change of RESID-
to-Brownian diffusivity ratio is consistent with the margination characterization based on a
kinetic theory-based analysis [133], where the margination of microscale particles is shown
to be weakened as strong Brownian effect comes into play.
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3.4 Conclusions
Using a three-dimensional multiscale complex blood flow solver [3, 24, 120], we have
interrogated the long-time dispersive characteristics of rigid spherical particles with sizes
across nano-to-micrometers in blood flow through microvessels. The role of the confine-
ment ratio and the systemic hematocrit in altering the nanoparticle radial dispersion is quan-
titatively analyzed in terms of the radial distribution of particle concentration and particle
radial diffusion rate. The effect of changing particle size on the alteration of the particle
dispersive characteristics is highlighted.
It is found that nanoscale particles do not marginate under various confinement effects
or hematocrit levels, but rather show a non-uniform radial distribution across the vessel.
Increasing the confinement effect by decreasing the vessel diameter hinders the particle
radial diffusivity but also enhances the equilibrium concentration of nanoscale particles in
the cell free layer. Low hematocrit level (φ ∼ 5%) in the microvessel appears to be opti-
mal to the radial dispersion of nanoscale particles, leading to high radial diffusion rate and
near-wall concentrations being higher than the average concentration. High hematocrits
(φ=30%) slightly increases the near-wall concentration but meantime inhibits the disper-
sion of nanoscale particles in the RBC-laden region at the tube center.
Microscale particles exhibit pronounced margination behavior, where at equilibrium
the particles get concentrated in the cell-free layer at 4 to 17 times the average particle
concentration in the RBC-laden region. The margination propensity seems to be enhanced
with the particle size. For microscale particles, the RBC-enhanced shear-induced diffusiv-
ity is dominant over the Brownian diffusivity, where the RBC-laden area shows more than
10 times higher diffusivity compared to that in the RBC-free layer. These particle-size in-
duced changes of particle radial diffusivity in both distribution and magnitude collectively
give rise to margination of microscale particles in confined tubular blood flows.
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CHAPTER 4
PARTITIONING OF CELLULAR BLOOD-BORNE NANOPARTICLES
THROUGH MICROVASCULAR BIFURCATIONS
Blood flowing through microvascular bifurcations has been an active research topic for
many decades, while the partitioning pattern of nanoscale solutes in the blood remains rel-
atively unexplored. Here, we demonstrate a multiscale computational framework for direct
numerical simulation of the nanoparticle (NP) partitioning through physiologically-relevant
vascular bifurcations in the presence of red blood cells (RBCs). The computational frame-
work is established by embedding a newly-developed particulate suspension inflow/outflow
boundary condition into a multiscale blood flow solver. The computational framework is
verified by recovering a tubular blood flow without a bifurcation and validated against the
experimental measurement of an intravital bifurcation flow. The classic Zweifach-Fung
(ZF) effect is shown to be well captured by the method. Moreover, we observe that NPs
exhibit a ZF-like heterogeneous partition in response to the heterogeneous partition of the
RBC phase. The NP partitioning prioritizes the high-flow-rate daughter branch except for
extreme (large or small) suspension flow partition ratios under which the complete phase
separation tends to occur. By analyzing the flow field and the particle trajectories, we show
that the ZF-like heterogeneity in NP partition can be explained by the RBC-entrainment
effect caused by the deviation of the flow separatrix preceded by the tank-treading of RBCs
near the bifurcation junction. The recovery of homogeneity in the NP partition under ex-
treme flow partition ratios is due to the plasma skimming of NPs in the cell free layer.
These findings, based on the multiscale computational framework, provide biophysical in-




Blood is a biological fluid that conveys nutrients and wastes throughout the body. The pri-
mary constituents of blood are red blood cells (RBCs) that make up ∼45% of the systemic
blood volume and plasma that contains a variety of biomolecules including clotting fac-
tors and nutrients, etc. The exchange of materials between the blood and tissues primarily
occurs in the microvasculatures where blood vessels feature complex tree-like bifurcating
structures. Such microvascular bifurcations allow the blood flow to be partitioned and dis-
seminated to the bulk of tissues for efficient mass exchanges [134].
Given its significance in physiology and fluid mechanics, blood flowing through mi-
crovascular bifurcations has been a topic of research for many decades [135, 136, 137].
Among all the studies, substantial efforts have been dedicated to the understanding of
the pattern and biomechanistic mechanisms of RBC partitioning through single or multi-
generation bifurcations using in vivo [138, 139], in vitro [140, 141] and theoretical [142,
135, 126] approaches. It has been well accepted that the RBC volume concentration (i.e.,
hematocrit) in the two daughter branches are oftentimes not equally partitioned due to the
particulate nature of the blood cells. Rather, the hematocrit in the high-flow-rate daugh-
ter branch often gets elevated while the other daughter branch receives a diluted or even
depleted hematocrit level. This heterogeneous partition of RBCs, often referred to as the
Zweifach–Fung (ZF) effect [138, 141], is physiologically essential since it biomechanisti-
cally explains the reduction and heterogeneous distribution of the hematocrit in microvas-
culatures that has been observed physiologically [143, 144]. Utilizing the ZF effect, novel
microfluidic devices have also been developed for cell or bioprotein seperation and other
relevant biomedical applications [145, 146].
Besides the large body of research focusing on the RBC partition through microvas-
cular bifurcations, a few studies investigate the distribution and adhesion of other blood
species through bifurcating structures. The effect of size and shape of microscale particles,
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mimicking white blood cells, on their adhesion propensity at bifurcations has been studied
in vitro using synthetic microvascular networks [147, 148]. The model platelet distribution
in blood flow through idealized, vascular bifurcations or confluences has been simulated
directly, where the platelets shows anti-margination behaviors at the downstream of a con-
fluence [149]. The distribution and adhesion of nanoparticles (NPs) in vascular bifurcations
has been interrogated in silico without explicit consideration of RBCs [21, 150].
Notwithstanding current understanding of the RBC partitioning characteristics through
microvascular bifurcations, there is clearly a lack of knowledge regarding the partitioning
behaviors of nanoscale solutes through capillary beds subject to the influence of RBCs,
partly because of the difficulty imposed by the multiscale nature of the problem [24].
Nonetheless, studying the partition of nanoscale solutes through microvascular bifurca-
tions holds considerable significance biophysically and clinically. For example, the unde-
sired heterogeneous distribution of nanomedicine in tumor microvasculature remains to be
a major hurdle that limits the overall therapeutic efficiency [151]. Understanding the par-
titioning of solutes through microvascular bifurcations may provide possible mechanisms
that could be applied to regulate the heterogeneity of solute distribution in microcircula-
tion. Accordingly, novel design of NP-based drugs with improved drug delivery efficacy
could be inspired [152].
The goal of this paper is to develop a multiscale computational framework for direct
numerical simulation of NP partition through microvascular bifurcations, while quanti-
tatively elucidating the NP partitioning in the presence of RBCs. Towards that end, an
general index-based manipulation strategy for the particle inflow/outflow boundary condi-
tions embedded in a verified and validated multiscale blood flow solver [24, 120, 118] has
been developed and validated. Using the multiscale computational framework, the parti-
tion of the blood-borne NPs through microvascular bifurcations in response to the ZF effect
is found to be heterogeneous as well. The heterogeneity in the NP partition is conditional
depending on the ratio of the flow rates between the daughter branches. The physical mech-
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anisms responsible for the heterogeneity in the NP partition is found to be associated with
the flow separatrix deviation at the bifurcation junction caused by the RBC motion.
4.2 Materials and Methods
The computational framework proposed for this study is a 3D lattice-Boltzmann (LB) based
multiscale complex blood flow solver [64, 2, 3, 24, 120], augmented with a particulate
inflow and outflow boundary condition. The LB method is a well-established numerical
model for hydrodynamics and proves to be a highly scalable method for direct numerical
simulation (DNS) of dense particle suspensions [4, 2]. Modeling of the RBC dynamics and
deformation is via a coupled spectrin-link (SL)/LB method [3, 3, 7]. The NP suspension
dynamics are resolved via a two-way coupled lattice-Boltzmann Langevin-dynamics (LB-
LD) method with both particle Brownian motion and long-range hydrodynamic interactions
(HI) directly resolved and validated [24, 120]. The solver has been applied to a variety of
problems pertaining to particle and biomolecule transport in blood flow [7, 19, 111, 13, 24,
118, 153]. The newly developed open boundary conditions (BCs) are especially suitable
for complex geometries such as microvasculatures. All modules are two-way coupled and
embedded in a massively parallelized framework, as shown in Fig 4.1. To validate the
numerical methods, the blood flow through a microvascular bifurcation within the chicken
chorioallantoic membrane (CAM) in vivo model has been characterized through microscale
particle image velocimetry (µPIV).
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Figure 4.1: The multiscale computational framework for simulating blood-borne nanoparti-
cle partitioning through microvasculatures. The method directly and concurrently resolves
the dynamics of microscale cells and nanoscale particles and molecules suspended in blood
plasma through complex microvascular networks, where open boundary conditions (BCs)
are prescribed.
4.2.1 Open boundary strategies for particulate suspension inflow and outflow
Periodic boundary condition (P-BC), due to its computational efficiency, has been widely
used for simulations of blood flows through straight tubes/channels [17, 111, 24, 153] or ar-
tificial bifurcation structures [154, 126]. Physiologically, microvascular bifurcations often
involve one inlet but multiple outlets where flow conditions are non-periodic. To over-
come the methodological limitation, several open boundary strategies have been developed
for inflow and outflow of particle or cell suspensions in the context of dissipative particle
dynamics (DPD) [155, 156] or immersed-boundary (IB)/LB method [157]. Here we pro-
pose a general particulate suspension inflow and outflow boundary condition (PSIO-BC),
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which in principle is applicable to any index-based particle suspension methods. Applying
the PSIO-BC to both the LB-SL method [3] and the LB-LD method [120], we simulate
the RBC-NP suspension through a model microvascular bifurcation (Fig 4.2a) where the
number of particles initially increases and eventually plateaus when the system reaches
equilibrium (Fig 4.2b).
Figure 4.2: Demonstration of the particulate suspension inflow and outflow boundary con-
dition (PSIO-BC). The schematic illustration of the PSIO-BC applied to a NP-RBC bidis-
perse suspension flowing through a two-generation microvascular bifurcation (a). The time
course of the particle number simulated in the bifurcation (b), where at equilibrium the
particle number becomes quasi-conserved.
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Fluid phase
The Dirichlet BCs are applied to prescribe the velocity or pressure of the flow field at
the inlet and outlet. In the context of LB method, we employ the regularization BC proce-
dure [158, 159] to construct the incoming unknown PDFs based on prescribed macroscopic












where the tensor Qi is defined as Qi = eiei − csI and the stress tensor Π(1) is evaluated
based on the non-equilibrium components of the outward-pointing PDFs (in the opposite
directions of the unknown PDFs) [159]. Single phase regions are arranged to the upstream
of the particle introduction region as well as to the downstream of the particle removal
regions, as shown in Fig 4.2a. This way, the velocity or pressure can be prescribed within
the single phase region such that simple analytical solutions can be used. The aspect ratio
of the single phase regions is chosen to be roughly one to allow smooth transitions of the
properties from the single-phase to multi-phase regions or vice versa.
Particle phase
The introduction of particles at inlet is realized by inserting a particle introduction section
downstream proximal to the single phase region, as depicted in Fig 4.2a. Inside the seed-
ing section, the number of particles is conserved to control the particle concentration and
number flow rate introduced to the downstream. Similar to other approaches [157, 155,
156], particles in this section periodically leave and re-enter the domain, while at the exit
new particles are introduced to the downstream by duplicating the particle (and its proper-
ties such as mesh coordinates, velocity and mechanical properties, etc) that are wrapped to
the entrance (upstream end) of the particle introduction region. Besides, random motions
can be introduced to the particles within the introduction region to reduce the periodic pat-
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terning of the particle distribution. Through these operations, new particles at controlled
concentration and flow rate are introduced to the downstream with the surrounding flow
field being well-perturbed.
Figure 4.3: Schematics for the general particulate inflow and outflow boundary condition
(PSIO-BC). The particle array represents the array storing the particle information accord-
ing to the particle index, which increases from 1 to Nmax from left to right. Here for
example Nmax = 5 at time t
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Similarly, the particle removals are realized by embedding a particle removal region
upstream proximal to a single phase region where the outlet fluid BCs are imposed. At
the particle removal region, the particle information will be deleted at the local processor
(assuming multi-processor parallelization is employed). Meanwhile, the particle index and
the total number of removed particles at each time step will be recorded and communicated
to the processors in charge of the particle introduction. To minimize the memory allocation
for the particle array and perform minimal particle index manipulation, the indices of newly
introduced particles are assigned conditionally according to the number of inflow and out-
flow particles (Npin and N
p
out). The schematics for the PSIO-BC operations are shown in
Fig 4.3.
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Algorithm 1 The Particulate Suspension Inflow and Outflow (PSIO) Algorithm
Require: i, j, ip, jp, kp ∈ Z+ ∪ {0},
1: Count the number of inflow particles Npin
2: Store properties (location, velocity, etc) of inflow particles Ppin(i)|i∈{0,...,Npin−1}
3: Count the number of outflow particles, Npout
4: Store indices of outflow particles, Ipout(i)|i∈{0,...,Npout−1}







6: if Npin = N
p
out
7: for i← 0 to Npout − 1




10: else if Npin > N
p
out
11: for i← 0 to Npout − 1




14: Allocate memory for particles Npt−1, ..., N
p
t − 1
15: for i← Npt−1 to N
p
t − 1
16: ip ← i−Npt−1 +N
p
out
17: Assign Ppin(ip) to particle i
18: end for
19: else if Npin < N
p
out
20: jp ← 0
21: for i← 0 to Npin − 1
22: ip ← Ipout(i)
23: while ip ≥ Npt
24: jp ← jp + 1
25: ip ← Ipout(jp)
26: end while
27: jp ← jp + 1
28: Assign Ppin(i) to particle ip
29: end for
30: kp ← 0
31: for i← Npt to N
p
t−1 − 1
32: for j ← 0 to Npout − 1
33: if i 6= Ipout(j)
34: Ips(kp)← i




39: for i← jp to Npout − 1
40: kp ← i− jp
41: Assign Ppin(I
p
s(kp)) to particle I
p
out(i)
42: Free the memory of particle Ips(kp)
43: end for
44: end if
Specifically, if Npin = N
p
out, the inflow particle properties are assigned to the indices
71
corresponding to the outflow particles, as indicated in Fig 4.3a. IfNpin > N
p
out, in addition to
the same procedure as above, the data structure for storing all the particle information in the
computational domain (referred to as particle array) will be extended to accomodate for the
incremental particles, shown in Fig 4.3b. If Npin < N
p
out, the particle array will be truncated
to reflect the reduction of the total particle number. When the truncated particle indices
are all associated with outflow particles (denoted as Scenario I in Fig 4.3c), the outflow
particles and their memory allocation will be simply eliminated, and the inflow particles
will take the indices of the outflow particles starting from the lowest index. When the
truncated particle indices contain particles remaining in the computational domain (denoted
as Scenario II in Fig 4.3c), in addition to the operations in Scenario I, the remained particle
information will be assigned to the unoccupied outflow particle indices that are within the
range of the updated particle array. The detailed procedure for the PSIO-BC algorithm is
listed in the pseudo-code shown in Algorithm 1.
4.2.2 Reconstruction of physiologic microvascular bifurcations
Microvascular networks are comprised of many generations of single bifurcations connect-
ing all the way from arterioles or venules to capillaries [105]. Each single bifurcation
follows certain physiologic laws that constrain the geometric relation between parent and
daughter branches. The radii of parent and daughter branches have been found to obey the






where R0 is the radius of the parent branch; R1 and R2 are the radii of the daughter
branches. Complying to this simple geometric relationship leads to a more uniform distri-
bution of vessel wall shear stress and consequently minimizes the power consumption [161].
The bifurcating angles of two daughter branches also satisfy certain physiologic optimality
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where α1 and α2 are the bifurcating angles of the two daughter branches with respect to
the axial direction of the parent branch. Obeying Zamir’s law minimizes the lumen volume
of a single bifurcation [162]. In addition, we also assume the axes of three branches of a
single bifurcation are in-plane as suggested previously [163]. The vessel length is assumed
to be proportional to the vessel diameter with certain randomness [164]. The cross-section
shape of the branches are assumed to be circular.
Based on the above physiologic constraints, microvascular bifurcations of multiple gen-
erations of branches can be reconstructed as shown in Fig 4.4, provided the radius of the
parental branch, r0, and the size ratio of two daughter branches, ηD = R1R2 , being prescribed
randomly within the physiological range [163].
Figure 4.4: Demonstration of three reconstructed microvascular bifurcations of physiologic
relevance.
4.2.3 In vivo experiment
To validate the numerical methods, the blood flow through a microvascular bifurcation
within the chicken chorioallantoic membrane (CAM) in vivo model has been characterized
through microscale particle image velocimetry (µPIV). The CAM model is a highly vascu-
larized extraembryonic membrane that is readily accessible for intravital imaging. In-house
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synthesized mesoporous silica nanoparticles (MS-NP) were used as tracking particles.
The µPIV system is shown in Fig 4.5 (left), which mainly consists an upright micro-
scope (Zeiss Axio Examiner Z.1) modified with a heated stage operated at 63 magnification
to image the CAM model (10 days post fertilization). The microscope is fitted with a wa-
ter immersion lens (LDC-APO Chromat 63 1.15W) to facilitate imaging of deep vessels.
Imaging was performed using a high-speed camera (Hamamatsu Orca Flash 4.0) operated
at 142 frames/sec, enabling a resolution of 0.1 microns/pixel. A broadband light source
was used along with careful image and PIV processing methods through the LaVision PIV
software package DaVis v8.4 to mitigate image blur effects especially at peak velocities.
The CAM model is depicted in Fig 4.5 (middle). The ex-ovo avian embryos were
handled according to published methods [165] with all experiments conducted following
an institutional approval protocol (11-100652-T-HSC). Embryos were utilized for experi-
mentation 7 days post removal from shells (day 10 post fertilization). A dosage of 50 µg
MS-NPs with size ∼130 nm were injected into tertiary veins of the CAM. After injection,
embryos were placed in a customized avian embryo chamber for imaging.
Applying the preceding methodology, a greyscale image of a vascular bifurcation is
shown in Fig 4.5 (right). The image location was chosen such that the vessel branches
remain relatively flat over the entire field-of-view. To obtain the dynamic velocity field,
5000 images were acquired in total. A sliding sum-of-correlation method was used to cal-
culate vector fields [166]. In § 4.3.2, the mean velocity field obtained based on the NP flow
is compared with the computed counterparts through the current multiscale computational
framework.
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Figure 4.5: The benchtop microscale particle image velocimetry (µPIV) system (left), the
chick chorioallantoic membrane microvasculature model (middle) and the grey-scale visu-
alization of the flow field of a selected region of interest (right).
4.3 Results and Discussion
In this section, we first verify the PSIO-BC by recovering a tubular blood flow and com-
paring the results with that obtained from the typical periodic boundary condition. Fur-
thermore, the multiscale computational framework is further validated by reconstructing
the CAM bifurcation flow in silico and comparing simulation against the experimental
measurement. As follows, the NP partitioning pattern in the presence of RBCs is in-
terrogated quantitatively by simulating a bidisperse RBC-NP suspension through single
physiologically-relevant microvascular bifurcation under different flow partition ratios with
or without geometric asymmetry. Physical mechanisms leading to specific NP partitioning
characteristics are discussed in detail.
4.3.1 Recovering tubular flows
Flow through a straight tube with or without RBCs is simulated with both PSIO-BC and
P-BC. The tube has a diameter of 2R=20 µm and a length of L=80 µm. The fluid viscosity
is selected as µ=1.2 cP. A hematocrit of φ=30% is selected for the multiphase simula-
tions. The RBC has a shear modulus of G=0.0063 dynes/cm. For the P-BC simulations,
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a constant pressure gradient, −dp
dz
=240 Pa/mm, is applied to drive the flow (from left to
right according to Fig 4.6a) such that the wall shear rate is γ̇w=1000 s−1. For the sin-






prescribed at both the inlet and outlet. For RBC case through PSIO-BC, inlet and outlet
pressures are prescribed at the outmost ends of the single phase regions. The inlet pressure
is pi=p0+|dpdz |(L + LBC) and the outlet pressure is po=p0, where p0 is chosen as the atmo-
spheric pressure and LBC=60 µm that accounts for the extra tube sections for PSIO-BC.
Figure 4.6: Normalized axial flow velocity plotted against vessel radial locations for a
tubular flow with or without red blood cells, computed with the P-BC or the PSIO-BC.
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The velocity profiles for the tubular flow simulations using both PSIO-BC and P-BC
are plotted in Fig 4.6b. The velocity profiles for the cases with φ=30% are averaged over 10
different axial locations at one time point during equilibrium. It is shown that the results via
PSIO-BC agrees well with that via P-BC, showing the validity of the PSIO-BC algorithm.
4.3.2 Comparing with in vivo measurements
To further validate the current multiscale computational framework, we simulate a NP-RBC
suspension flow through a CAM microvascular bifurcation (see supplemental video 1) and
compared the results against experimental measurements through µPIV. An arterial branch
in the CAM model is selected for the study due to its relatively big size and flat orientation,
which are suitable for measurement. The parent branch has a radius of R0=20 µm and the
two daughter branches have radii of R1=7.5 µm and R2=17.5 µm respectively, shown in
Fig 4.7a. Slight pulsatility of the flow is observed with a frequency of f = 3 Hz. The
Womersley number for this problem can be estimated as α=
√
ρfR20/µ ≈ 0.03 1, which
suggests the pulsation effect is insignificant. Therefore, the study below concentrates on
comparing the mean velocity as a reasonable simplification.
Contour maps of the mean velocity field from the µPIV measurement are demonstrated
in Fig 4.7a on the left. The mean streamlines are overlaid, indicating the flow direction.
We simulate the NP-RBC suspension flow through the same reconstructed geometry using
the multiscale computational method, where Dirichlet velocity BCs based on the in vivo
measurements are applied at the inlet and outlet using the PSIO-BC. The hematocrit is
assumed to be 20% which is an average physiological value for CAM blood flows [167].
The NP number concentration is set to 107/ml for statistic purposes. The RBC size is
selected to be the same as human RBC size, while the rigidity (shear modulus) of the RBC
membrane is elevated by three folds to be consistence with low deformability observed
in avian RBCs [168]. As shown in Fig 4.7, the fluid velocity distribution reproduced by
simulation qualitatively matches well with the PIV results.
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Figure 4.7: (a) Comparisons of the mean velocity distribution between the experiment and
simulation through a CAM vascular bifurcation. The velocity contour for the simulation
is an snapshot after the system reaches equilibrium (i.e., the number of particles reach
plateau). (b) The radial distribution of the mean axial velocity at the A-A cross-section
annotated in (a). The asymmetry of the experimental curve may be related to the non-
circular shape of the actual cross-section area.
The velocity profiles across the diameter of the larger daughter branch at the A-A lo-
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cation (denoted) are further plotted in Fig 4.7b. The velocity profile in the simulation is
obtained by tracking the streamwise velocity of the NP flowing through the A-A cross-
section at equilibrium to mimic the µPIV process. The mean velocity near the wall has a
finite number for both the simulation and experiment as a result of the sliding nature of the
NP adjacent to the wall. The velocity profile in the RBC-laden region shows overall good
agreements between experiment and simulation.
4.3.3 NP partition through microvascular bifurcations
To understand how NPs partition at the junction of a microvascular bifurcation, a trade
study of NP-RBC suspension flow through single microvascular bifurcations is performed,
taking into account the asymmetry in both the flow partitioning and vascular geometry.
To control the partitioning of the bulk fluid, a flow partition ratio (FPR) is defined as
ηFQ,i = Qi/Q0 where Qi (i=1 or 2) denotes the suspension flow rate at one daughter branch
and Q0 is the suspension flow rate at the parental branch. Similarly, a particle partition
ratio (PPR) is defined as ηpQ,i = Ni/N0, where N denotes the number of particles entering
the corresponding branch. The PPR is used to quantitatively describe the partition pattern
of the particle phase (RBC and NP) under different FPR. For the following studies, the
parental branch has a size of 2R0=20 µm, a wall shear rate of γ̇=2000 s−1 and a hematocrit
of φ=20%, reflecting physiologic conditions of arterioles [136, 105]. The Dirichlet veloc-
ity boundaries are applied to both the inlet and outlet, where the Poiseuille flow velocity
profiles are imposed at the single phase region pertaining to specific ηFQ,i. The vascular
geometric effect is controlled by the daughter branch size ratio, ηD. Provided R0 and ηD,
the exact size and bifurcating angle of the two daugher branches are uniquely constrained
by the physiologic laws discussed in 4.2.2.
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Symmetric bifurcations
We first study the NP-RBC suspension flow partitioning through a geometrically symmetric
bifurcation by setting ηD = 1, as shown in Fig 4.8a. As a control, when there is no RBC in
the bifurcation, the ηpQ of NP changes linearly as the η
F
Q changing from 0.1 to 0.9, as shown
in the inset of Fig 4.8b. This partitioning pattern is termed homogeneous partition, as the
flow of the particle phase follows the fluid phase while branching towards the downstream.
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Figure 4.8: (a) Snapshots of RBC-NP suspension flow through symmetric bifurcations un-
der various suspension flow flux partition ratio, ηFQ. (b) Particle flow partition ratios, η
p
Q,
plotted against suspension flow partition ratio, ηFQ, for symmetric microvascular bifurca-
tions. The inset shows the results without the presence of RBCs.
When RBCs are introduced from the parental branch, the simulated ηpQ of the RBC
81
phase exhibits a sigmodal trend with respect to ηFQ, as shown in Fig 4.8b. This trend agrees
well with both the experimental measurement and theoretical correlation by [139], indi-
cating the classic ZF effect is well captured by the current computational methods. Such
heterogeneous partition of RBC is most prominent at ηFQ = 0.1 or 0.9, where complete
phase separation of RBC occurs in one of the daughter branches, as shown in Fig 4.8a.
Similar to the ZF effect in the RBC phase, the ηpQ for NP also deviates from the linear line,
suggesting the NP partitioning also becomes heterogeneous. However, such heterogeneity
in the NP partitioning seems to be conditional as the ηpQ falls back on the linear line at about
ηFQ=0.1 or 0.9 while complete phase separation of RBC occurs.
Asymmetric bifurcations
To introduce the effect of geometric asymmetry, we set ηD = 0.8 as a physiological ratio
of asymmetry reported in [163]. The resulting geometry of the asymmetric bifurcation is
shown in Fig 4.9a. Similar to the symmetric bifurcation case, NP shows mainly homoge-
neous partition when RBCs are not present, as shown in the inset of Fig 4.9b. However,
due to geometric asymmetry, the ηpQ of NP is deviated from the linear curve at η
F
Q = 0.5.
This can be explained by the slight deviation of the bifurcation junction towards the smaller
daughter branch which causes the uniformly dispersed NPs [153] prioritizing entering the
larger daughter branch (branch 1).
As further shown in Fig 4.9b, the asymmetric bifurcation exhibits a more pronounced
heterogeneity in the RBC partition, as predicted by both our simulations and the theory in
[139]. Different from the symmetric bifurcation, the heterogeneity of RBC partition even
occurs during equal flow partitioning (ηFQ = 0.5) as another manifestation of the effect
of the geometric asymmetry. The enhanced heterogeneity of the RBC partitioning further
elevates the heterogeneity in the NP partitioning compared to the symmetric bifurcation
case. Again, the partitioning of NP recovers homogeneity at extreme flow partition ratios
when severe phase separate occurs.
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Figure 4.9: (a) Snapshots of RBC-NP suspension flow through asymmetric bifurcations
under various suspension flow flux partition ratio, ηFQ. (b) Particle partition ratio, η
p
Q, plotted
against suspension flow partition ratio, ηFQ, for asymmetric microvascular bifurcations. The
inset shows the results without the presence of RBCs.
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4.3.4 Mechanisms for conditional heterogeneity in NP partition
Next, we take a detailed look at the particle trajectory and flow structure of the asymmetric
bifurcation case to understand the underlying mechanisms governing the conditional het-
erogeneity in the NP partition through microvascular bifurcations. Specifically, we look at
two flow partition ratios, ηFQ = 0.7 and 0.9, that gives rise to the high heterogeneity in NP
partition and the recovery of homogeneous partition, respectively.
At ηFQ = 0.7 , RBCs periodically collide onto the junction, linger for a while and ex-
hibit a higher frequency of entering the higher-velocity branch in consistence with the ZF
effect [141]. As an example shown in Fig 4.10a, the RBC (denoted in blue) is lingering
while performing a tank-treading motion and sliding into the upper branch where the flow
rate is higher. The upper sliding motion occurs more frequently than the lower sliding
motion, which consequently leads to ηpQ = 0.83 being higher than η
F
Q. The RBC tank-
treading motion at the bifurcation junction will further alter the local flow field. As shown
in Fig 4.10c, at the condition of ηFQ = 0.7, without RBCs the flow separatrix is well aligned
with the geometric dividing line at the junction; with RBCs lingering and tank-treading to-
wards the upper branch, the flow separatrix tends to locally shift towards the lower branch,
which locally leads to the recruitment of more NPs towards the upper branch. This RBC-
induced entrainment effect seems to be the mechanism that causes the heterogeneity in the
NP partition when RBCs are present.
When the recovery of homogeneous partitioning occurs at ηFQ = 0.9, a certain amount
of NPs can still flow into the RBC-free branch, as shown in Fig 4.10b. As indicated by the
trajectories of NP throughout the bifurcation, the majority of the NPs that enter the lower
branch come from the cell-free layer (CFL) of the parental branch. Unlike the deformable
RBCs that tend to concentrate to the center of the tube as a result of the lift force exerted
by the vessel wall [169], NPs tend to disperse throughout all the radial locations due to the
severe Brownian effect [24, 153]. In other words, the NP phase can always enter the cell-
free branch so long as the plasma skimming occurs, which will reasonably contribute to
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the homogeneity in the NP partitioning. As further shown in Fig 4.10b, the flow separatrix
at ηFQ = 0.9 does not seem to be drastically distorted when the RBC is present. Therefore,
given the incoming NPs are uniformed distributed in the parental tube [153], the ratio of
NP partitioning with RBCs is expected to be similar to the case without RBCs.
Taken together, the heterogeneity in the NP partition in the presence of RBCs seems
to be associated with an RBC-induced entrainment effect, that distorts the flow separatrix
to the low flow rate branch and thus entrains more NPs to the high flow rate branch. The
presence of NPs in the CFL accompanied by the normalization of flow separatrix at the ex-
treme flow partition ratios (when blood plasma skimming occurs) leads to the return of NP
partitioning from heterogeneity to homogeneity in the presence of RBCs. The competition
between th RBC-induced entrainment effect and the presence of NP in the CFL contributes
to the conditional heterogeneity of the NP partitioning as observed in 4.3.3.
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Figure 4.10: (a-b) The cell distribution, NP trajectories and a cross-section of interest
within an asymmetric microvascular bifurcation. (c) The contours of the Y velocity com-
ponent at the cross-section adjacent to the bifurcation junction. The left column shows the
case without the presence of RBCs. The other six columns corresponds to six time points
when a RBC sliding towards the upper branch. The black dashed line denotes the zero ve-
locity line for the cases without particles (RBCs and NPs), which shows the flow separatrix
that divides the flow entering two daughter branches.
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4.4 Summary
In this work, we have developed a multiscale computational framework to directly simulate
the NP distribution and partition through the microvascular bifurcations in the presence of
RBCs. A general particulate suspension inflow and outflow boundary condition has been
developed and embedded in the computational framework, and later applied to both the
RBC and NP suspension dynamics. To validate the model, in vivo measurements of the NP
flow through a CAM microvascular bifurcation have been performed. The current computa-
tional framework is able to quantitatively reconstruct the detailed physiological bifurcation
flow by directly simulating both the RBC and NP suspensions. The velocity distribution
for the NP phase through simulation matches well with the experimental measurement,
showing the accuracy and validity of the present multiscale computational framework.
Applying the multiscale computational framework, we further interrogate the RBC-NP
suspension flow through idealized single bifurcations under physiologically relevant geom-
etry and flow conditions. The classic Zweifach-Fung effect is found to be well captured by
the method. Moreover, we find the partition of the blood-borne NP through microvascular
bifurcations in response to the ZF effect also shows a substantial heterogeneity. The het-
erogeneity in the NP partition is however conditional depending on the level of dispropor-
tionality in the flow partitioning between the daughter branches. The physical mechanisms
responsible for the heterogeneity in the NP partition has been analyzed in terms of the flow
structure and the particle trajectories. It is found that the heterogeneity in the NP partition
in the presence of RBCs seems to be associated with the flow separatrix deviation at the bi-
furcation junction caused by the RBC tank-treading motion. The recovery of homogeneity
in the NP partitioning however has to do with the plasma skimming of the NPs in the CFL
accompanied with the normalization of flow separatrix at the extreme flow partition.
This study presents a numerical tool that can be used to directly analyze the blood-borne
NP distribution within microcirculation that often comprises complex branching structures
87
Figure 4.11: In silico reconstruction of cellular-blood-borne nanoparticles through a multi-
generation microvascular bifurcation using the developed PSIO-BC.
(see Fig 4.11). The results imply the importance of the presence of the RBC phase in
directing the blood solute distributions and provides possible physical mechanisms that
contribute to the heterogeneous distribution of blood solute in microvasculatures observed
clinically [151]. Such insights can provide valuable information for a upscaling to a net-
work model of the full vasculature [164] and may help the design of nanocarriers with
improved drug delivery efficacy [152]. It is also noteworthy that the proposed particulate
suspension inflow and outflow boundary condition is general and can be applied to other
applications such as modeling arterial thrombosis [170] or other reacting flows that often
involve consumption of particles or species.
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CHAPTER 5
SHEAR-INDUCED DIFFUSION OF NANOPARTICLES IN CELLULAR BLOOD
FLOW UNDERGOING UNBOUNDED SIMPLE SHEAR
Using a multiscale blood flow solver, the complete diffusion tensor of nanoparticle (NP)
in sheared cellular blood flow is calculated over a wide range of shear rate and hematocrit.
In the short-time regime, NPs exhibit anomalous dispersive behaviors under high shear
and high hematocrit due to the transient elongation and alignment of the red blood cells
(RBCs). In the long-time regime, the NP diffusion tensor features high anisotropy. Partic-
ularly, there exists a critical shear rate (∼100 s−1) around which the shear-rate dependence
of the diffusivity tensor changes from linear to nonlinear scale. Above the critical shear
rate, the cross-stream diffusivity terms vary sublinearly with shear rate, while the longitu-
dinal term varies superlinearly. The dependence on hematocrit is linear in general except
at high shear rates, where a sublinear scale is found for the vorticity term and a quadratic
scale for the longitudinal term. Through analysis of the suspension microstructure and nu-
merical experiments, the nonlinear hemorheological dependence of the NP diffusion tensor
is attributed to the streamwise elongation and cross-stream contraction of RBCs under high
shear, quantified by a Capillary number. The RBC size is shown to be the characteris-
tic length scale affecting the RBC-enhanced shear-induced diffusion (RESID), while the
NP size at submicron exhibits negligible influence on the RESID. Based on the observed
scaling behaviors, empirical correlations are proposed to bridge the NP diffusion tensor to
specific shear rate and hematocrit. The characterized NP diffusion tensor provides a con-




The rapid advancement of nanotechnology and nanomaterial manufacturing has led to
emerging exposure of human biological systems, such as cardiovascular systems, to nano-
sized particulate matters [115, 171], ranging from engineered nanocarriers functioning as
medicine/imaging agents [172, 173, 60] to aerosol pollutant particulates potentially caus-
ing fatal cardiovascular disease [174, 175, 176]. Both the design of optimal nanocarrier
systems and the prevention and control of nanoparticle (NP) toxicity rely heavily on the
knowledge of NP distribution in vascular systems [115]. Nevertheless, the biodistribution
of NP remains elusive to date and limits the bio-availability of NP systems to the human
bio-environment. One of the primary bottlenecks is the lack of understanding on the NP
dispersive mechanisms in blood flow with respect to specific hemorheological conditions.
Multi-scale computational models [23, 22, 24] have been developed and applied to
predict the NP distribution in micro-vessels by directly simulating NPs and red blood cells
(RBCs) suspended in blood plasma. Although these models, as particle-based approaches,
provide a straightforward means to predict the NP distribution in realistic, micro-scale
vessels, they are still computationally intractable when it comes to organ- and circulation-
level applications. Alternatively, continuum models [14, 25, 177, 15] have the ability to




+ u · ∇c+∇ · J = 0, (5.1)
where t is time, c is the NP concentration, u is the local fluid velocity and J is the flux of
NP concentration. Here, J is often estimated by the Fick’s law as J = −D∞ ·∇ c, where
the NP diffusion tensor, D∞, is so far treated as isotropic, Brownian diffusivity [177] or so-
lute diffusivity measured in a single principal direction [178]. Since the particle diffusion
tensor is anisotropic in nature even for monodisperse rigid sphere suspensions [40, 41], an
90
improved constitutive relation capturing the anisotropy of D∞ subject to local hemorheo-
logical properties is therefore necessary to form a better closure of this convection-diffusion
problem.
Using Couette-type flow devices, experiments have been conducted to characterize the
particle self-diffusivity [179, 180] and effective solute diffusivity [181, 178, 180] in non-
colloidal particle suspensions under linear shear flow for various shear rates and particle
volume fractions. However, due to the difficulties in particle tracking in the presence of
the affine flow effect, only the particle diffusivity in the cross-stream directions are re-
ported. Apart from the experimental efforts, particle-scale simulations have become an
important tool for characterizing the anisotropic particle diffusivity tensor in both colloidal
[40, 41, 93] and noncolloidal [42, 182, 74] suspensions under shear flow. Owing to the
success of those particle-scale simulation techniques, substantial progress have been made
in understanding the rheological and hydrodynamic response of the particle diffusion ten-
sor in sheared monodisperse suspensions. Nonetheless, the bidisperse RBC-NP suspension
system remains largely unexplored and entails unique transport phenomenology that is un-
available to the conventional monodisperse particle suspensions.
First, there is a large length-scale discrepancy between NPs ∼O(10 nm) and RBCs
∼O(10 µm). Consequently, NPs are subject to both molecular level thermal fluctuations
(Brownian motion) and cellular level interactions with RBCs. On macroscopic scales, the
two effects synergistically give rise to an apparent diffusivity contributed by both Brownian
diffusivity (BD) and the so-called RBC-enhanced shear-induced diffusivity (RESID) [15,
111, 24]. Second, the NP phase shows infinite dilution while the RBC phase exhibits a
range of physiological concentrations from ∼10% to ∼40%. Consequently, the BD shows
insignificant dependence on shear rate and hematocrit, while the RESID is highly depen-
dent on the hemorheological conditions [111]. Third, RBCs deform considerably under
shear, from biconcave shape in equilibrium to large elongation and tank treading of the
membrane under high shear [183]. Such geometric asymmetry and morphological changes
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of RBCs could alter RESID substantially.
Therefore, the objective of the present work is to characterize the bulk diffusivity ten-
sor of NP in sheared blood flow and interrogate the NP dispersive mechanism specific to
a broad range of hematocrit and shear rate. Given the large length-scale discrepancy (3∼4
orders of magnitude) between NP and RBC, resolving both particle phases using direct nu-
merical simulation (DNS) is computationally prohibitive. Therefore, a multiscale complex
blood flow solver [2, 3, 7, 24, 120] is employed to treat NP as effective Brownian particles
while directly resolving the RBC phase. Such multiscale treatment can substantially re-
duce the computational expense but still preserve the critical suspension physics at distinct
scales. As will be shown in the following section (§5.3.3), good comparison between the
simulation and experimental results can be obtained using this multiscale approach. Since
confinement (wall) effects in general lead to spatial heterogeneity of the blood flow [184]
that forbids the calculation of NP diffusivity related to specific hematocrit and shear rate,
the Lees-Edwards boundary condition (LEbc) [102] is implemented [8] to impose uncon-
fined simple shear flow to obtain the NP bulk diffusive properties.
Note that blood flow typically occurs under confinement (e.g., blood flow in arteries)
involving heterogeneous flow structures that could induce cell segregation [184, 13] and
margination [17, 18, 19, 15, 111]. Such phenomena are found to be a synergistic outcome
of the RBC-induced diffusion in the RBC-laden region and the formation of cell free layer
(CFL) near the wall [15, 111]. For NPs with negligible inertia and much smaller length
scale compared to the CFL thickness [18, 111], it is expected that the presence of wall has
insignificant direct influence on the NP diffusion in the RBC-laden region. Besides, large-
scale problems suitable for continuum modeling (such as blood flow through coronary
arteries) typically feature much larger length and time scales compared to those considered
in the current cellular-scale studies. It is therefore plausible to hypothesize the long-time
NP diffusion tensor evaluated in an unbounded simple shear flow should closely capture the
NP diffusive behavior subject to the same local hemorheological condition in a macroscale
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heterogeneous blood flow environment.
One unique contribution of this work is the development of a multiscale-simulation-
informed empirical expression that links the anisotropic NP diffusion tensor to the local
hemorheological conditions. Such 3D NP diffusive information in sheared blood is in-
tractable to measure through either experiment or DNS simulation. On the application
side, the developed NP diffusion tensor provides a constitutive relation that can lead to
more effective continuum-level models to tackle large-scale NP biotransport problems. On
the suspension rheology side, the diffusive phenomenology observed in such a biophysi-
cal, bidisperse RBC-NP suspension system could entail novel suspension physics that is
unavailable to conventional suspension flows.
The remainder of this chapter is organized as follows. In §5.2.1, the details of the com-
putational methodology are presented. In §5.3, we present results and perform numerical
experiments. In §5.3.1, the numerical problem is formulated with careful consideration of
numerical resolution as well as physiological significance. In §5.3.2, the transient disper-
sive behaviors of NP are presented. As follows in §5.3.3, the long-time diffusive behaviors
of NP subject to a wide range of shear rate and hematocrit are validated with available
experimental data and interrogated with various hemorheological scaling behaviors. In
§5.3.4, the NP-RBC suspension microstructure is analyzed to give mechanistic insights to
the hemorheological scaling observations. In §5.3.5 and §5.3.6, numerical experiments are
conducted to shed light on the physical mechanisms governing the nonlinear shear-rate de-
pendence of the NP diffusion tensor. In §5.3.7, empirical correlations are proposed based
on the hemorheological scalings observed in previous sections. In §5.4, we conclude this
work with some remarks.
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5.2 Methodology
5.2.1 Multiscale whole blood flow solver
The numerical method for this study is through a 3D lattice-Boltzmann based multiscale
complex blood flow solver that efficiently resolves both the dynamics and interactions of
nanoscale particles and microscale capsules [185, 3, 24, 120], as demonstrated in figure
5.1. The LB method is a well-established numerical model for hydrodynamics and proves
to be a highly scalable method for direct numerical simulation (DNS) of dense particulate
suspensions [4]. Modeling of the RBC dynamics and deformation is via a coarse-grained
spectrin-link membrane method [6, 121] coupled to the LB method[3], which has been
validated against experimental results[3, 7]. The NP suspension dynamics are resolved
via a two-way coupled lattice-Boltzmann Langevin-dynamics (LB-LD) method with both
particle Brownian motion and long-range hydrodynamic interactions (HI) directly resolved
and validated [24, 120]. The solver has been successfully applied to several studies of
particle and biopolymer transport in cellular blood flow [7, 19, 111, 13, 24, 60].
5.2.2 Lees-Edwards boundary condition
Since the primary focus of this study is on the particle bulk diffusive behavior subject
to no wall effect, simulations are performed in an unbounded, triply periodic cubic do-
main where a constant shear rate is imposed through the Lees-Edwards boundary condition
(LEbc) [102]. This method, originally developed for molecular dynamics simulations, was
extended to the LB method by [186] and later applied to deformable suspensions on paral-
lel computing architectures by [74, 7]. In addition to the operations associated with regular
periodic boundary conditions, both the particle (NP and RBC) phase and the fluid phase
undergo a shift in position and velocity according to the LEbc scheme as they cross the top
(+y) or bottom (−y) boundary.
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Figure 5.1: (a) The RBC-NP bidisperse suspension in a triply periodic domain at shear rate
γ̇ = 1 000 s−1 and hematocrit, φ = 40%. (b) The RBC membrane immersed in the LB
lattice domain. The RBC membrane dynamics and deformation is captured by the course-
grained spectrin-link method [6, 121, 3]. (c) The NP suspension dynamics is captured by
the LB-LD method [24, 120], which captures the NP Brownian motion and long-ranged HI
in an off-lattice fashion.
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5.2.3 Characterization of the particle diffusion tensor
The presence of shearing flow imposes a convective effect on the particle suspension and
complicates the characterization of particle diffusion tensor. The major difficulty lies in de-
termination of the longitudinal diffusivity (D∞xx) and off-diagonal diffusivity (D
∞
xy), which
require careful subtraction of the affine particle displacement. The diffusion tensor in
sheared monodisperse colloidal suspensions have been successfully quantified by sampling
the non-affine particle mean square displacements (MSDs) [187, 40, 41, 188]. Therefore,



































[〈z (t)z (t)〉 − 〈z (t)〉〈z (t)〉], (5.3d)
as t → ∞. Here, and hereinafter, the angle brackets denote an ensemble average over all
NPs in the system; x, y and z denote the absolute displacement of NP in three principal
flow directions, i.e., longitudinal, velocity-gradient, and vorticity direction, respectively.
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The diffusivity tensor is symmetric, thus D∞xy and D
∞





transpose) are insignificant [189], which is also confirmed in our simulation. The non-
affine displacement, xna, is calculated by subtracting the absolute displacement with its
affine component, xa, i.e. xna(t) = x(t) − xa(t), where xa(t) =
∫ t
0
γ̇y(τ)dτ and γ̇ is
the imposed shear rate through LEbc. When calculating the absolute displacement of NPs
that undergo a shift of position due to the LEbc, the particle reference position is shifted
accordingly to subtract the shift effect. Particle displacements are followed every ∼0.06 γ̇t
to ensure the growth of MSDs captured with adequate accuracy. For clarity, the superscript
of the affine displacement and the expectation terms are both dropped in the MSD notations
as follows.
5.2.4 Sensitivity to NP-RBC contact model
The NP-RBC short-distance interaction is through Morse potential that forbids NP from
penetrating the RBC membrane. The potential parameters are adjusted to match the mea-
sured inter-cell potential energy, as discussed in [10]. The Morse potential function is given
as
UM(r) = De[e
−2β(r−r0) − 2e−β(r−r0)], (r ≤ r0) (5.4)
where r is the normal distance between the particle center to the RBC surface, r0 is a cut-off
distance in which no interaction forces are present, De is the potential well depth and β is a
scaling factor. The surface energy is set to De = 1× 107kBT and the equilibrium distance
is set to r0 = a1 + 10 nm. In figure 5.2, we explore the sensitivity of the NP diffusivity
calculation to the adjustment of the Morse model parameters. Figure 5.2 (a) and (b) show
the D∞yy and D
∞
zz calculation exhibits less than 5% variation when changing the magnitude
of the energy and equilibrium distance, respectively, by up to±60%. This indicates the NP
diffusion is largely driven by the hydrodynamic interaction rather than the direct contact
between NP and RBC membrane.
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Figure 5.2: (a) NP long-time diffusivities in the cross-stream directions plotted against the
relative variation of the Morse potential (a) well depth and (b) equilibrium distance.
5.2.5 Calculation of the partial pair distribution function
In the bidisperse RBC-NP suspension system, the NP-RBC partial pair distribution func-
tion (PPDF), g21(r), quantifies the conditional probability of finding a NP (species 1) at a
position of r with respect to the geometric center of a single RBC (species 2). This quantity
















where Lb defines the cubic box size for PPDF sampling around one RBC, index j goes
through all NPs within the local sampling box, and i goes through all RBCs in the compu-
tational LB domain. ri2 and r
j
1 denotes the position of RBC and NP, respectively. n
i
1 shows
the number concentration of NP within the sampling box, while n2 denotes the number con-
centration of RBC in the entire domain. The angle bracket represents the ensemble average
among independent realizations, which in the current case is through time averaging given
the ergodic hypothesis. Similar techniques have recently been used in calculating PPDFs
in bidisperse and polydisperse rigid particle suspensions [190, 191]. Projection of g21(r)
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to principal planes follows the integration procedure discussed in [192] but with a smaller
integration interval, [−a2/4, a2/4], to better capture the RBC morphological change.
The PPDF sampling box size for all cases is selected to be three times of the RBC
maximum diameter at equalibrium in biconcave shape, i.e., Lb=24 µm. To capture the
PPDF in the long-time regime (tγ̇>100) with detailed suspension microstructure, a total
number of 300 strain units are employed for time averaging. In the short-regime (tγ̇∼1),
owing to limited time steps associated with specific suspension configuration (e.g. the
string ordered configuration), about 3 strain units are adopted for averaging.
5.3 Results and Discussion
In this section, we first formulate the simulations based on both physiological and numer-
ical rationales. As follows, the transient growth of the NP mobility is discussed to under-
stand the short-time response of the NP dispersive behavior at various hematocrit and shear
rate. Then, focus will be shifted to understanding the NP long-time diffusive behavior under
different hemorheological conditions with appropriate scaling, where the simulation results
are also compared with available experimental data. To gain insight into the mechanisms
governing the nonlinear hematocrit and shear-rate dependence of the NP diffusion tensor,
we visualize the NP-RBC microstructure and carry out numerical experiments. Eventually,
we construct empirical correlations for the complete NP diffusion tensor.
5.3.1 Problem formulation
The apparent diffusivity of NPs in unbounded blood flow under simple shear is determined
by NP radius, a1, shear rate, γ̇, and hematocrit, φ, with NP concentration in the dilute







Table 5.1: Simulation data. Each case is simulated independently in a LB domain of size
128×128×80 at specified Pe, CaG and φ. NP long-time diffusivities, D∞xx, D∞yy , D∞zz and
D∞xy , normalized by the theoretical Brownian diffusivity, D
B, are listed for all cases. The
unlisted off-diagonal diffusivities, D∞xz and D
∞
yz , are found to be negligible. RBC has an
effective radius of a2 = 2.9 µm, yielding a particle size ratio of a1/a2 = 0.017. Brownian
diffusivity is calculated by DB = kBT/6µπa1 at temperature T = 310 K.





10 0.0 0 5 000 0.0066 0.0055 1.0 1.0 1.0 0.0
10 0.1 52 5 000 0.0066 0.0055 1.4 1.1 1.1 0.05
10 0.2 104 5 000 0.0066 0.0055 2.5 1.1 1.2 0.03
10 0.3 156 5 000 0.0066 0.0055 2.6 1.1 1.3 0.05
10 0.4 208 5 000 0.0066 0.0055 3.2 1.2 1.4 0.03
30 0.0 0 5 000 0.020 0.017 1.0 1.0 1.0 0.0
30 0.1 52 5 000 0.020 0.017 2.6 1.3 1.2 -0.1
30 0.2 104 5 000 0.020 0.017 4.8 1.6 1.3 -0.2
30 0.3 156 5 000 0.020 0.017 6.7 1.9 1.5 -0.2
30 0.4 208 5 000 0.020 0.017 7.2 2.0 1.8 -0.4
100 0.0 0 5 000 0.066 0.055 1.1 1.0 1.1 0.0
100 0.1 52 5 000 0.066 0.055 7.3 1.9 1.6 -0.6
100 0.2 104 5 000 0.066 0.055 14.5 2.9 2.0 -1.0
100 0.3 156 5 000 0.066 0.055 18.9 3.7 3.1 -1.3
100 0.4 208 5 000 0.066 0.055 29.2 4.1 3.8 -2.0
300 0.0 0 5 000 0.198 0.165 1.0 1.0 1.0 0.0
300 0.1 52 5 000 0.198 0.165 28.0 3.3 2.9 -2.2
300 0.2 104 5 000 0.198 0.165 67.9 5.7 3.7 -4.3
300 0.3 156 5 000 0.198 0.165 133.0 8.8 6.3 -7.6
300 0.4 208 5 000 0.198 0.165 216.4 10.8 8.0 -9.1
1 000 0.0 0 5 000 0.66 0.55 1.0 1.0 1.0 0.0
1 000 0.1 52 5 000 0.66 0.55 73.8 7.0 8.1 -10.1
1 000 0.2 104 5 000 0.66 0.55 211.1 12.5 10.5 -14.9
1 000 0.3 156 5 000 0.66 0.55 674.2 19.1 16.1 -26.9
1 000 0.4 208 5 000 0.66 0.55 2095.9 23.2 18.8 -38.1
2 000 0.0 0 5 000 1.32 1.10 0.9 1.0 1.0 0.0
2 000 0.1 52 5 000 1.32 1.10 122.8 12.5 15.6 -19.9
2 000 0.2 104 5 000 1.32 1.10 350.0 20.7 21.5 -25.7
2 000 0.3 156 5 000 1.32 1.10 1379.3 29.6 26.3 -50.0
2 000 0.4 208 5 000 1.32 1.10 4150.3 36.6 29.4 -82.8
10 000 0.0 0 5 000 6.60 5.52 1.1 1.0 1.0 0.0
10 000 0.1 52 5 000 6.60 5.52 606.7 40.9 77.3 -73.1
10 000 0.2 104 5 000 6.60 5.52 1363.7 44.9 86.4 -81.8
10 000 0.3 156 5 000 6.60 5.52 2788.5 64.0 110.8 -138.0
10 000 0.4 208 5 000 6.60 5.52 7575.6 80.4 120.3 -220.9
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quantifying the competition between the fluid viscous stress and the membrane elastic
stress. Here, µ is the dynamic viscosity of suspending plasma, a2 is the effective radius
of RBC and G is the elastic shear modulus of the RBC membrane; DB is the Brownian dif-
fusivity, which is determined by the Stokes-Einstein relation, DB=kBT/6πµa1, where kB
is Boltzmann’s constant and T is the absolute temperature. The NP Péclet number quan-
tifies the severity of the NP Brownian effect, while the RBC capillary number determines
the deformability of the RBC capsule.
To obtain appropriate scaling relations, we performed a large number of independent
3D simulations. Table 5.1 lists all the simulation parameters and the measured NP diffusiv-
ities. A wide range of shear rate (10≤γ̇≤10 000 s−1) and hematocrit (0≤φ≤0.4) with phys-
iological relevance [124, 193] is covered. Cases with γ̇=10 000 s−1 are to match certain
vascular pathological conditions, e.g., the high shear induced thrombosis [11]. For discus-
sions in this section, NP size is set to 2a1=100 nm. RBCs are assumed to be in healthy state
with an effective radius a2=2.9 µm and a membrane shear modulus G=0.0063 dynes/cm.
The absolute temperature is set to T=37 ◦C, at which the plasma has a viscosity µ=1.2 cP
and a density ρ=1.0 g/cm3. The viscosity ratio of RBC cytoplasm to plasma is set to the
physiological value λ=5.0. The density of cytoplasm is set to that of the plasma. The cor-
responding Pe and CaG lie in the range of 0.0066 ≤Pe≤ 6.60 and 0.0055 ≤CaG≤ 5.52,
respectively. All simulations are formulated by matching the dimensionless group, i.e., φ,
Pe and CaG.
Simulations are initiated by imposing steady shear flow on the uniformly, randomly
mixed NPs and RBCs at specific shear rate in a LEbc computational domain, as shown in
figure 5.3 (a). The domain has a dimension of 128 × 128 × 80 (42.7 × 42.7 × 26.7 µm3)
in longitudinal (x), velocity-gradient (y) and vorticity (z) directions, respectively. This LB
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domain size matches the highest resolution applied for the rheological characterization of
cellular blood flow under shear by [7]. The selected LB grid resolution (300 nm per lattice
unit) and the equilibrium RBC mesh size (1.5 lattice units per link length), has previously
proven to be fine enough to capture both the single RBC dynamics [8, 3] and the rheological
properties of concentrated cellular blood flow [8, 7].
To obtain converged long-time diffusivity, sufficient strains (tγ̇∼1 000) and a large
number of particles (5 000 NPs and up to 208 RBCs) are employed for each simulation.
The resolution of these simulations in terms of strain units and number of particles is on
the higher end compared to other numerical studies on particle diffusion in colloidal/non-
colloidal suspensions [40, 41, 42, 182, 74, 183, 194]. As will be discussed in §5.3.3,
the selected resolution produces good agreement between the simulation results and the
available experimental data.
Simulations are performed on the Intel Xeon Skylake nodes of the TACC (Texas Ad-
vanced Computing Center) Stampede-2 system where each node features 48 cores and a
2.1 GHz clock rate. For the case at φ = 0.4 with 208 RBCs and 5 000 NPs, each run takes
∼168 hours on 32 cores (∼5 376 core hours) to accomplish 1 000 strains (tγ̇). The total
computational cost for the 35 independent cases listed in table 5.1 is approximately 140
000 core hours.
5.3.2 Temporal growth of NP transient mobility
To understand the short-time dispersive characteristics of the NP phase, we examine the
transient behavior of NP mobility by tracking the temporal growth of NP MSDs. Cross-
stream MSDs, 〈y(t)y(t)〉/a21 and 〈z(t)z(t)〉/a21, are sampled from the initial configuration
(tγ̇=0) where NPs and RBCs are randomly and uniformly mixed, as shown in figure 5.3
(a). Longitudinal and off-diagonal MSDs, 〈x(t)x(t)〉/a21 and 〈x(t)y(t)〉/a21, are sampled
starting from a long-time configuration (tγ̇=400) to avoid extra convective effect caused
by the transient elongation and reorientation of RBCs. Such transient effects are found to
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Figure 5.3: (a) The RBC-NP complex configuration at tγ̇=0. NPs and RBCs are randomly
and uniformly mixed in an unbounded shear flow. RBCs are shown partially in the domain
to visualize the NP phase. The athermal system is determined by shear rate, γ̇, hematocrit,
φ and NP radius, a1. (b-f) The RBC-NP complex configuration in the long-time scale
regime under a shear rate of γ̇ = (b) 10, (c) 100, (d) 1 000, (e) 2 000 and (f) 10 000 s−1
with φ = 0.4.
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introduce extra affine displacement leading to ∼t3 growth of MSDs and hence jeopardize
the measurement of the long-time diffusivity in the x-relevant directions. The necessity of
eliminating affine effect for calculating streamwise diffusivities is elaborated by [41] in the
context of sheared colloidal suspensions.
Figure 5.4 plots the particle normalized MSDs growth with respect to the relative strains
sampled. At φ=0, all diagonal MSDs grow according to the Stokes-Einstein (SE) predic-
tion with no dependence on shear rate, while off-diagonal MSD produces zero value (not
shown). This is consistent with the isotropic nature of NP Brownian motion in a dilute and
unbounded solution, and also serves as a verification of the MSD calculations. At φ>0, a
deviation from SE relation occurs in all diagonal MSDs as a result of NP-RBC interactions.
At the γ̇=10 s−1, only slight deviation from SE relation is observed given the dominance
of Brownian diffusion; see figure 5.4 (a).
The transient deviation of NP mobility from the SE relation can be further interrogated
through the evolution of cross-stream MSDs, as depicted in figure 5.4 (a-d, g-h). In the
short-time regime (tγ̇1), a linear growth of MSD (∼t) is observed particularly under
low shear rate (e.g. γ̇≤100 s−1) or high shear rate and high hematocrit (e.g. γ̇≥2000
s−1 and φ=0.4) condition, as shown in figure 5.4 (b) and (c), respectively. The short-time
linear growth of MSD suggests a short-time diffusive mechanism. Since the short-time
linear growth of MSD always occurs before the ballistic regime (∼t2) where RBC-NP
collisions start to occur, such short-time diffusive driver should logically be the Brown-
ian effect. Therefore, the initial linear MSD growth at low shear rates (with φ=0∼0.4) or
high shear rates (with φ=0.4) can be explained by the Brownian diffusive time scale being
much shorter than the RBC-NP collision time scale under such hemorheological condi-
tions. However, under high shear rate (e.g. γ̇≥2000 s−1), the diffusive behavior (∼t) turns
to ballistic (∼t2) as φ increase to 0.4; see figure 5.4 (c,d,g,h). This is likely due to the
high convective (high shear rate) and low inertial (low hematocrit) effects that reduce the
RBC-NP collision time scale to be comparable to the Brownian diffusion time scale. As
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Figure 5.4: Normalized MSDs plotted against relative shear strains in logarithm scale at
various hematocrits for different shear rate. (a), (b), (c) and (d) are concerned with evolu-
tions of 〈y(t)y(t)〉/a21; (e) and (f) depict evolutions of 〈x(t)x(t)〉/a21 and |〈x(t)y(t)〉|/a21,
respectively; (g) and (h) depict evolutions of 〈z(t)z(t)〉/a21. The imposed shear rate is de-
noted on each plot. Inset of (b) shows the RBC-NP distribution at tγ̇∼1 under γ̇ = 100s−1.
Insets of (c) shows the RBC-NP distribution at tγ̇∼1 (upper) and tγ̇∼100 (lower) under
γ̇ = 2000s−1 and φ = 0.4. A NP radius of a1=50 nm is used for normalization. Cross-
stream MSDs (a-d) and (g,h) are sampled starting from tγ̇=0 to capture the transient NP
dispersive behavior; stream-wise and off-diagonal MSDs are sampled starting from tγ̇=400
to avoid the initial extra affine displacement induced by RBC elongation and orientation.
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a result, the Brownian diffusion of NP is overwhelmed by the ballistic behavior caused by
insufficient RBC-NP collisions.
In the intermediate-time regime, tγ̇=O(1)∼O(10), anomalous dispersive behavior is
observed as RBCs start to elongate and rotate to be aligned with the streamwise direction
due to shear. For cases at high shear rates (γ̇≥2 000 s−1) and high hematocrit (φ = 0.4), we
observe a sublinear growth of MSD, representing a temporary hindrance of the NP mobil-
ity. This hindrance effect is caused by a string-ordered microstructure of NP in the shearing
plane accompanied by the elongation and alignment of RBCs; see the contrast between up-
per inset of figure 5.4 (c) and inset of figure 5.4 (b). Such string-ordered NP distribution
can be better visualized by plotting the RBC-NP partial pair distribution function (PPDF),
g21(r), projected on the xy plane (the computing procedure of PPDF in the short-time
regime is discussed in §5.2.5). As shown in figure 5.5, g21(r) in xy plane exhibits streaks
showing intensified distribution particularly near the RBC surface under high shear rate and
high hematocrit, while in contrast no significant string structure is found in low shear rate
(γ̇≤100 s−1) or/and low hematocrit (φ = 0.1) cases, as shown in figure 5.5 (a-c). Note that
suspension string-like structure often occurs in sheared monodisperse colloidal suspensions
at equilibrium as a consequence of the absence of interparticle lubrication interactions at
high concentration [195, 41] or the presence of long-range repulsive forces at low con-
centration [196]. However, in the current case, ordering of NP occurs at a non-equilibrium
state that involves the change of the RBC suspension structure from a uniformly distributed
and randomly oriented configuration to a streamwise-aligned and elongated configuration
under high shear and high hematocrit. The sublinear growth of MSD is followed by a
super-ballistic behavior (∼t3) at high shear rate (γ̇=10 000 s−1), which might be associated
with the large jump of NP between strings when the NP phase gradually evolves from the
string-like structure towards the more uniform structure featuring in the long-time diffusive
regime.
In the long-time regime (tγ̇>100), MSD reaches the second linear-growth stage (∼t),
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(a) γ̇=100 s−1 , φ=0.1 (b) γ̇=100 s−1 , φ=0.4
(c) γ̇=2000 s−1 , φ=0.1 (d) γ̇=2000 s−1 , φ=0.4
Figure 5.5: RBC-NP partial pair distribution function, g21(r), projected on the xy plane
under various hemorheological conditions. The results are sampled through temporal aver-
aging in the strain range of tγ̇=1∼3.
where RESID becomes the dominate diffusive mechanism leading to an uniform distribu-
tion of NP (see lower inset of figure 5.4 (c)). Such three-stage (diffusive/super-ballistic/diffusive)
anomalous dispersion behavior has previously been reported in the dispersion of Brownian
particles subjected to external forces [197]. Here, we show that such dispersive anomalies
also occur in a sheared NP-RBC bidisperse suspension, where the anomalous NP disper-
sion is, however, driven by an internal shear-induced mechanism, i.e., the elongation and
the alignment of the concentrated RBCs along streamwise direction under high shear. Such
transient shear-induced morphological adaptation of RBCs contributes to extra mobility of
the NP phase, seemingly playing a role of external forces exerted on the NP phase.
Figures 5.4 (e, f) depict the longitudinal and off-diagonal MSD evolution at γ̇=10 000 s−1.
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Results for lower shear rate show similar MSD behaviors and are not presented for discus-
sion. Because the initial transient regime is neglected, the longitudinal and off-diagonal
MSDs yield classical ballistic-diffusive transitions similar to the dispersive behavior of
rigid particle suspensions under shear [40, 74]. The off-diagonal MSD under high shear
starts with positive values during the ballistic regime, exhibits a crossover transition in-
volving a change of sign, and eventually maintains negative values in the diffusive regime.
Absolute values are shown for the off-diagonal MSDs with the sign at certain temporal
stage denoted in figure 5.4 (f). The change of sign from positive (+) to negative (-) is a
hallmark of the dominant NP migration direction shifted from along the extensional axes
(1st and 3rd quadrants) to along the compressive axes (2nd and 4th quadrants) of the flow,
as also observed in sheared colloidal suspensions [40].
5.3.3 Hemorheological dependence of NP long-time diffusivity
In this section, we focus on examining the NP long-time diffusive behavior. The NP long-
time diffusivities are evaluated in the long time regime (after 100 strain units) and listed
in table 5.1. Experimental statistics from various sources [12, 198, 116, 181] are selected
for comparison to gain credibility of the simulation results. Given the distinct time scales
associated with the Brownian (τB∼10−4 s) and the long-time RBC-enhanced diffusion




Bδij , as confirmed in previous studies, e.g., [24], where DRij denotes the
RESID. Since DB at infinite dilution follows SE relation with negligible dependence on




Figure 5.6 plots the normalized RESID, D̂Rij = D
∞
ij /D
B − δij against normalized shear
rate, Pe (or CaG). To first validate the simulation results, experimental results of solute or
cell velocity-gradient (yy) diffusivity in sheared human or animal blood are selected for
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comparison; see figure 5.6 (b). [181] measured the augmentation of ferricyanide solute dif-
fusivity in both bovine and human RBC suspensions using a rotating Couette flow device.
[116] measured the enhanced radial diffusivity of oxygen solute in human blood using a
tube oxygenator device. [12] calculated the platelet velocity-gradient diffusivity in cavine
blood flowing through a channel by measuring the platelet rate of adhesion/deposition to
a foreign surface attached to the flow chamber. Similar experiment was later conducted
by [198] to measure the platelet radial diffusivity in human blood. These measured dif-
fusivity in 40% hematocrit normalized based on our notation compares favorably with the
calculated D̂Ryy at φ=0.4 based on the simulation, as shown in figure 5.6 (b).
Depending on the level of shear rate imposed at various hematocrit, the diffusion tensor
of NP in sheared blood shows different shear-rate dependence. At low shear rates (γ̇≤100),
all RESID terms exhibit linear dependence on shear rate (∼γ̇), matching the linear γ̇ scaling
of shear-induced diffusivity in rigid particle suspensions [40, 42]. This is also consistent
with the insignificant RBC morphological changes at γ̇≤100 s−1, as shown in figures 5.3
(a-c).
At intermediate shear rates (100≤γ̇≤2 000), significant streamwise elongation of RBCs
occurs with increasing shear rate; see figure 5.3 (c-e). As a result, nonlinear γ̇ scaling is
observed in all diagonal RESID terms. Specifically, cross-stream diffusivities, D̂Ryy and
D̂Rzz, show sublinear scales (∼γ̇m, m=0.7∼0.8), while streamwise diffusivity, D̂Rxx, exhibits
superlinear scales (∼γ̇n, n=1∼1.8). In contrast to the nonlinear scaling in diagonal diffu-
sivities, D̂Rxy maintains largely a linear scale at the intermediate shear-rate regime, as shown
in figure 5.6 (d). It is also noted that such nonlinear shear-rate scaling in diagonal RESID
terms is most prominent at intermediate to high hematocrit (φ>0.1), which implies the
RBC deformability plays less important role in altering the RESID shear-dependence at low
hematocrits. This observation is consistent with the results of shear-augmented solute dif-
fusivity in model-RBC suspensions at various RBC deformability reported by [181], where
they found changing RBC deformability barely affects the augmentation at particle volume
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Figure 5.6: Normalized particle long-time RESID in (a) xx, (b) yy, (c) zz and (d) xy
directions against normalized shear rate (Pe or CaG) in a log-log scale. Each curve at
specific φ forms by connecting D̂Rij data at shear rate, γ̇ =10, 30, 100, 300, 1000, 2000 and
10 000 s−1, from left to right; D̂Rxy at γ̇=10 s
−1 is not shown for scaling purpose due to its
small magnitude. Experimental results for RBC enhanced solute [116, 181] and platelet
[12, 198] diffusivity in the velocity gradient (yy) direction are plotted for comparison. NPs
of size 2a1=100 nm yield DB=3.78 µm2/s.
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concentration of 0.1 or less. [181] also find a sublinear scaling of ∼γ̇β (0.67≤β≤0.89)
for the solute diffusivity in velocity-gradient directions, while our simulations observe a
exponent of β=0.7.
At high shear rates (γ̇≥2 000) and intermediate to high hematocrit (φ>0.1), all RESID
terms except D̂Rzz exhibit reduced shear-rate dependence compared to the intermediate
shear-rate regime. In the velocity-gradient (y) direction, the hindrance of diffusion is due
to the fact that the concentrated RBCs become more aligned and elongated with flow such
that RBCs act as obstacles against the NP cross-stream diffusion in y-direction; see figure
5.3 (f). Such effect however shows less hindrance on D̂Rzz, as it does not forbid the NP
migration in the vorticity (z) direction. In the streamwise (x) direction, the reduction of the
shear dependence of D̂Rxx is likely to be associated with the saturation of the RBC elonga-
tion. Owing to the compound effects in both x and y directions, the off-diagonal diffusivty,
D̂Rxy, also exhibit certain reduction of the shear-rate dependence.
hematocrit dependence
Figure 5.7 display the same data as figure 5.6 but plotted against φ to show the hematocrit
dependence of RESID at different shear rate. At low shear rates (γ̇≤100), all diffusion
terms manifest a linear φ scaling. Note that linear concentration dependence of particle
self-diffusivity has been observed in sheared monodisperse suspensions in the presence of
surface roughness [199] or residual Brownian motion [189], which causes the two-body
interaction being irreversible and hence giving rise to a diffusive behavior. Since the shear-
induced diffusion of NP is driven by NP-RBC interaction, it is likely that the φ scaling
of NP diffusion tensor results from the irreversible two-body interaction between NP and
RBC induced by the RBC membrane roughness/flexibility and the NP Brownian effect. The
off-diagonal diffusivity D̂Rxy is found to be positive (+) at very low shear rate (γ̇≤10 s−1)
and otherwise negative (-). The change-of-sign behavior of the off-diagonal diffusivity
designate the dominant displacement direction of NP changing from along the extensional
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Figure 5.7: Normalized particle long-time RESID in (a) xx, (b) yy, (c) zz and (d) xy
directions against hematocrit under different shear rate in logarithm scale. Lines are the
best power-law fits to the data points at specific γ̇. D̂Rxy at γ̇=10 s
−1 (not shown) is positive
with negligible magnitude compared to other diffusion terms. NPs of size 2a1=100 nm
yield DB=3.78 µm2/s.
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axes to along the compressive axes of the flow as shear rate increases. Similar observation
has been reported in sheared monodisperse colloidal suspensions [40].
As shear rate grows above 100 s−1, various φ scaling arises in different RESID com-
ponents. D̂Rxx exhibits a quadratic φ scaling (∼φ2), which suggests that in the x-direction
additional effects exist to drive the NP diffusive motion besides the irreversible pairwise
interactions. D̂Ryy and D̂
R
xy scale linearly with φ, suggesting the irreversible pairwise in-
teraction remains to be the dominant diffusive mechanism. D̂Rzz exhibits a transition from
linear to sublinear φ scale (∼φ0.6). The mostly linear φ scale in D̂Ryy observed in the current
numerical study is consistent with the experimental observation in [181], where they show
that the solute diffusivity in the velocity-gradient (y) direction is augmented by about three
folds when the particle concentration increases from 0.1 to 0.31. Since suspension viscos-
ity typically increases with the particle concentration [41], the enhancement of solute (e.g.
NP) diffusivity at increased φ indicates the RESID is due to the RBC-NP interaction rather
than the secondary flow effect [181].
5.3.4 Microstructure
The rheological properties of particle suspensions are often determined by the mechanistic
phenomenon occurred on the particle length scales. To elucidate the physical mechanisms
that govern the hemorheological scaling behaviors of the NP diffusion tensor observed in
§5.3.3, the RBC-NP PPDF, g21(r), in the long-time regime are plotted to visualize the con-
figurational microstructure of the RBC-NP bidisperse suspension under various hematocrit
and shear rate. The techniques used to compute and project g21(r) are discussed in detail
in §5.2.5.
Figure 5.8 presents a matrix of g21(r) projections onto the velocity-velocity gradient
(xy) plane, the velocity-vorticity (xz) plane and the velocity gradient-vorticity (yz) plane
under two shear rates (γ̇=100 or 2000 s−1) and two hematocrits (φ=0.1 or 0.4). In general,
all PPDFs feature a large-scale rhombus shape as opposed to typical circular shape com-
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Figure 5.8: RBC-NP partial pair distribution function, g21(r), projected onto the xy, xz
and yz planes in the long-time regime under various hemorheological conditions, where
the PPDF contour has the horizontal edge aligned with the first axis (e.g., xy PPDF contour
has the horizontal edge aligned with x axis.). The edge length of the sampling box for
computing g21(r) is three times of the maximum diameter of the undeformed RBC.
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monly observed in rigid-sphere-particle suspensions [93, 190, 191]. This can be attributed
to the disk-shape of RBC that causes geometry-specific anisotropy of the microstructure.
The average RBC shapes under various hemorheological conditions, as shown in the central
low-intensity region of the PPDF contours, are nicely captured through the PPDF sampling
procedure. All PPDFs considered in the xy plane show more intensified distribution (i.e.,
higher probability of RBC-NP interaction) near the RBC disk surfaces, of which the surface
normal directions are more aligned with the compressive axes (in 2nd and 4th quadrants) in
accordance with the negative values of D̂Rxy. In the xz and yz plane, the PPDF distribution
tends to be symmetric about the principal axes (x, y or z), which explains the zero values
of the xz and yz diffusivities.
As the hemorheological condition changes, the detailed configuration of the PPDF
within the rhombus structure also varies. At low hematocrit (φ=0.1), the xy PPDF shows
fore-aft low intensity similar to rigid particle suspensions [192]. However, the break of the
fore-aft symmetry, being different from the rigid particle suspensions, seems to be related
to the RBC orientation algned with the extensional flow axes that is further caused by the
tank-treading motion of the RBC membrane [7]. As the hematocrit increases to φ=0.4, the
overall PPDF around the RBC becomes more intensified, meaning the local NP concentra-
tion near RBC surface increases. More interestingly, the fore-aft low PPDF region observed
under low hematocrit gets intensified substantially. The change of the NP microstructure
with increased hematocrit can be explained by smaller inter-cell separation and hence NP
getting squeezed in a smaller inter-cell region. At low shear rate (γ̇=100 s−1), RBC shows
a close-to-equilibrium biconcave shape. Increasing shear rate to γ̇=2 000 s−1 results in a
significant elongation of the average RBC shape in the flow (x) direction accompanied by
certain contraction in the velocity-gradient (y) and vorticity (z) directions.
The above configurational changes of g21(r) under various shear rates and hematocrits
provide possible mechanistic explanations for the nonlinear φ dependence observed at high
shear rates, as discussed in §5.3.3. The quadradic dependence of D̂Rxx (∼φ2), shown in
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figure 5.7 (a), is likely due to the occurrance of three-body RBC-NP interactions in the
longitudinal (x) direction caused by the compound effect of the elevated NP concentration
at the RBC fore-aft surface and the elongation of the RBC in the x direction. The reduced
φ dependence in D̂Rzz at high shear rate, as shown in figure 5.7 (c), can be attributed to
the relatively large contraction of the RBC in the vorticity direction, which reduces the
effective φ in the z direction. The less reduction of the φ dependence in the y direction, as
shown in figure 5.7 (c), is owing to the y direction contraction of RBC under shear being
less significant than that in the z direction, as clearly indicated in the PPDF contours.
5.3.5 Role of RBC deformability
The above PPDF analysis shows prominent RBC morphological change with elevated shear
rate, which suggests the RBC deformability may play an important role in causing the non-
linear γ̇ dependence of the NP diffusion tensor. In this section, we perform numerical
experiments to further quantitatively explain the nonlinear γ̇ scaling of RESID in the inter-
mediate shear-rate regime (100≤γ̇≤2 000 s−1), as observed in §5.3.3. Changing shear rate
alters both the fluid inertia and RBC deformability, quantified by Pe and CaG, respectively.
To interrogate the isolated effect of RBC deformability (CaG), we fix CaG by scaling up
G while increasing Pe (through increasing γ̇). Two Capillary numbers, CaG=0.055 and
0.55, are considered corresponding to the CaG regime where the nonlinear shear-rate de-
pendence of RESID occurs. For these simulations, we select a fixed hematocrit of φ=0.4
and a NP size of 2a1=100 nm. Table 5.2 lists all parameters and the NP diffusivity values
for the cases tested.
As presented in figure 5.9 (a, b), instead of exhibiting nonlinear Pe scaling as observed
in 5.3.3, all RESID components show linear dependence on Pe at fixed RBC capilary num-
ber of CaG=0.55 or 0.055 across the wide range of shear rates. This recovers the linear
Pe dependence of solute/self-diffusivity in sheared rigid particle suspensions [178, 40, 42]
since we intentionally fix the RBC deformation (CaG) while adjusting Pe.
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Table 5.2: Simulation data for numerical experiments concerning the isolated RBC defor-
mation effect in NP-RBC suspensions. The RBC membrane shear modulus, G, is re-scaled
to numerically match specific CaG while changing shear rate. Here, the NP size is fixed to
2a1=100 nm RBC has an effective radius of a2=2.9 µm. Brownian diffusivity is calculated
by DB=kBT/6µπa1 at a temperature of T=310 K.





10 0.4 208 5 000 0.0066 0.055 3.4 1.2 1.2 0.06
100 0.4 208 5 000 0.066 0.055 29.2 4.1 3.8 -2.0
1 000 0.4 208 5 000 0.66 0.055 317.6 31.6 23.8 -36.1
10 000 0.4 208 5 000 6.60 0.055 2999.8 286.9 248.6 -416.0
10 0.4 208 5 000 0.0066 0.55 14.6 1.1 1.1 0.35
100 0.4 208 5 000 0.066 0.55 247.6 3.3 2.6 -1.66
1 000 0.4 208 5 000 0.66 0.55 2095.9 23.2 18.8 -38.1
10 000 0.4 208 5 000 6.60 0.55 31698.3 209.0 158.3 -499.3
Figure 5.9: The Pe dependence of the (a) diagonal and (b) off-diagonal RESID terms
at fixed capillary number (by rescaling G) with φ=0.4. Two RBC capillary numbers,
CaG=0.55 and 0.055, are considered to see the isolated effect of changing RBC deforma-
bility (CaG) or adjusting the inertial effect (Pe).
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Table 5.3: Simulation data for numerical experiments concerning the relevant length scale
in NP-RBC suspensions. NP size is varied in the range of 2a1=50∼800 nm. RBC has an
effective radius of a2=2.9 µm. Brownian diffusivity is calculated by DB=kBT/6µπa1 at
temperature T=310 K. For the 800 nm case, the number of NP is set to 500 to satisfy
the dilute condition for the NP volume fraction. The last three cases are performed with
adjusted G to fix CaG. The hematocrit of φ = 0.2 corresponds to 104 RBCs in the LB
domain.
γ̇ [s−1] φ a1/a2 N





1 000 0.2 0.017 5 000 0.66 0.55 211.1 12.5 10.5 -14.9
1 000 0.2 0.034 5 000 5.28 0.55 801.1 26.3 21.9 -34.1
1 000 0.2 0.069 5 000 42.28 0.55 1491.9 53.3 38.1 -64.7
1 000 0.2 0.14 500 338.23 0.55 3309.1 106.9 84.9 -186.8
10 0.2 0.017 5 000 0.0066 0.55 3.1 1.0 1.1 0.2
100 0.2 0.017 5 000 0.066 0.55 40.9 2.3 1.8 -1.3
10 000 0.2 0.017 5 000 6.60 0.55 6109.4 113.0 102.2 -270.5
Moreover, an increase of CaG (from 0.055 to 0.55) leads to an increase of D̂Rxx but a
decrease of D̂Ryy and D̂
R
zz, as shown in figure 5.9 (a). These results are direct evidence indi-
cating that the nonlinear shear-rate scaling of the diagonal RESID terms observed in §5.3.3
is due to the variation of RBC deformability (CaG) induced by changing shear rate at fixed
G. More specifically, the increase of CaG with increasing shear rate at 100<γ̇<2 000 s−1
under fixed G leads to the superlinear shear-rate dependence of longitudinal diffusivity and
meanwhile the sublinear dependence of cross-stream diffusivities. In figure 5.9 (b), the
off-diagonal diffusivity shows insignificant change at different CaG, in consistency with its
mostly linear shear-rate dependence shown in figure 5.6 (d).
5.3.6 Relevant length scales
Although the shear-adaption of the RBC deformability is shown to be responsible for the
nonlinear shear-rate dependence of the RESID, it is still unclear in what way it alters the
RESID. In this section, we further identify the characteristic length scale relevant to the
RESID to gain more in-depth understanding of this nonlinear phenomenon.
In a series of experiments measuring the particle diffusivity in a concentrated non-
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colloidal suspension, [180] show that the ratio of the diffusivity of fluid tracers to the self-
diffusivity of non-colloidal particles is close to unity. Through DNS of the cellular blood
flow in a micro-channel, [18] show that the cross-stream diffusivity of platelets (∼2 µm)
in blood exhibits similar magnitude to that of passive tracers. These findings imply that
the shear-induced diffusivity is insensitive to the size of the scarce (in terms of volume
fraction), small particles. Following these results, we hypothesize that RESID is insensitive
to the size of NP. Moreover, the characteristic length scale associated with the RESID
should be the size of RBC. To confirm this hypothesis, we evaluate the RESID at fixed
hemorheological condition with various NP size. The NP size is kept in submicron-scale
such that the NP-RBC size ratio satisfies a1/a21. The volume fraction of the NP phase
are kept below 0.32% to satify the dilute condition. The set up and measured diffusivities
are listed in table 5.3.
In Figure 5.10 (a), we plot the RESID versus Pe at γ̇=1 000 s−1 and φ=0.2. Here, Pe is
adjusted by NP size in the range of 50≤2a1≤800 nm. A sublinear D̂Rij -Pe relationship is
observed for all diffusion coefficients. Figure 5.10 (b) further plots the same data as figure









This simple rescaling leads to a strong linear relationship between all RESID terms and
the rescaled Péclet number,
∼




Pe), can be deduced to show that DRij∼O(γ̇a22), which indicates that the dimen-
sional RESID is indeed insensitive to the NP size within the range of NP sizes considered
in the current study. This also suggests NP size at submicron plays a secondary role in
affecting the NP apparent diffusivity primarily through altering BD.
To further justify the universality of the rescaled Péclet number,
∼
Pe, i.e., whether the
RBC size is the reasonable length scale associated with RBC-enhanced diffusion or not,
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Figure 5.10: RESID plotted against (a) Péclet number Pe and (b) the rescaled Péclet num-
ber,
∼
Pe, at γ̇=1 000 s−1 and φ=0.2 in logarithm scales. Both Pe and
∼
Pe are adjusted with
NP size in the ranges of 2a1=50∼800 nm. (c) Linear dependence of RESID on
∼
Pe at fixed
CaG = 0.55 and φ=0.2;
∼
Pe is adjusted by shear rate (with 2a1=100 nm) or NP size (with
γ̇=1 000 s−1). The diffusion tensor in monodisperse colloidal suspensions [40] are also
plotted for comparison, where
∼
Pe degrades to Pe.
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Figure 5.11: RBC and NP distributions and morphology in the cross-stream plane (y-z)
with (a) CaG=0.055, (b) CaG=0.55 and (c) CaG=1.1 at Pe=0.066 and φ=0.4. Large non-
circular disks are RBC cross-sectional contours. Small circles are NP cross-sectional con-
tours. ā2,yz can be estimated from the PPDF analysis.
we plot RESID against
∼
Pe at CaG=0.55 and φ=0.2, with
∼
Pe adjusted by either shear rate or
NP size. As shown in figure 5.10 (c), the data points for particular RESID coefficient are
found to be well aligned on the same linear
∼
Pe scaling line. This directly confirms that the
RBC size is the characteristic length scale governing the RBC-enhanced diffusion, and
∼
Pe
is a more general nondimensional term quantifying the RESID.
Identifying RBC size being the RESID length scale helps further understanding the
nonlinear shear-rate dependence of the RESID. In figure 5.11, we present snapshots of
RBC and NP distribution and morphology in the mid cross-stream cross-sectional plane.
As shown in figure 5.11, the x-direction elongation of RBCs under high shear causes a
contraction of RBCs in the yz plane, which causes a reduction of the average effective
RBC size (i.e., the length scale ā2,yz) and hence a decrease of the effective
∼
Pe in cross-
stream directions. This explains the sublinear shear-rate scaling of the cross-stream RESID
when increasing CaG. Likewise, the super-linear shear-rate scaling of the longitudinal
RESID can be attributed to the elongation of RBC in the streamwise direction, i.e. the
increase of the RESID length scale in the longitudinal direction. The change of the RESID
length scales in different principal directions due to shear is the root cause of the nonlinear
shear-rate dependence of the NP diffusion tensor.
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5.3.7 Theory for RESID
In this section, we construct empirical correlations for the long-time NP diffusion tensor in
sheared blood based on the scaling observations in the previous sections. Since all RESID
coefficients scales linearly with
∼
Pe at fixed CaG, and the nonlinear shear-rate dependence
of RESID is primarily due to the variation of CaG, as demonstrated in §5.3.5 and §5.3.6;
there hence exists a scaling relation, D̂Rij∼O(φp1
∼
Pe Cap2G ), such that the exponents p1
and p2 can be estimated through matching the nonlinear φ and γ̇ scalings, respectively, as
observed in §5.3.3. Therefore, empirical correlations of NP long-time diffusivities can be
constructed as functions of φ,
∼
Pe and CaG in the hemorheological range of 10≤γ̇≤2 000







Pe, 0.0055 ≤ CaG ≤ 0.055
1 + ChxxφCaG+0.945
∼








Pe, 0.0055 ≤ CaG ≤ 0.055
1 + Chyyφ
∼








Pe, 0.0055 ≤ CaG ≤ 0.055
1 + Chzzφ1.022−0.4CaG
∼









Clxy, 0.0055 ≤ CaG ≤ 0.055
Chxyφ
∼
Pe, 0.055 < CaG ≤ 1.10
(5.9d)
where Cqij with q∈{l, h} are constants fitting the correlation values with the simulation
measurements at low or high shear rates. The dimensional NP diffusion tensor can then be
122
written in terms of the conventional shear-induced diffusion scaling, O(γ̇a22), as
D∞ = DBI + φγ̇a22M
q, (5.10)
where the anisotropic tensor, Mq, according to the severity of the RBC deformability













100 < γ̇ ≤ 2 000 s−1
(5.11b)
where Mq quantifies the anisotropic behavior of the NP diffusion tensor and characterizes
its departure from the conventional shear-induced diffusion scaling, O(γ̇a22), due to the
presence of the deformable RBC phase. Table 5.4 lists all the constants, Cqij . Each constant





for specific i, j and q at various γ̇ and φ. Here, D(R,m)ij =D
∞
ij −DBδij denotes the measured







denotes the theoretical diffusivity based on the proposed empirical correlations. Clxy is set to
zero given its small magnitude. Chxy is negative, suggesting the predominant direction of NP
migration in the long-time regime is along the contractile flow direction under high shear
flow [40]. For cases at γ̇<10 s−1 and φ<0.1, D∞ can be approximated by the isotropic
Brownian diffusivity provided the small magnitude of the RESID.
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Table 5.4: Correlation constants for the empirical correlations of NP diffusion tensor in
sheared cellular blood flow.
Clxx Chxx Clyy Chyy Clzz Chzz Clxy Chxy
0.281 2.86 0.0432 0.0181 0.0241 0.0135 0 -0.0332
Figure 5.12 plots the measured NP diffusivities (subtracted by BD) versus the theoret-
ical estimation based on the empirical correlations. The good collapse of the diffusivity
measurements on the D(R,m)ij =D
(R,th)
ij line demonstrates the empirical correlations can well
reproduce the numerically measured diffusivity tensor of NP in sheared blood.
5.4 Conclusions
The dispersion of NP in cellular blood flow under unbounded, homogeneous shear has been
investigated over a wide range of shear rate and hematocrit using a LB-LD-SL multiscale
complex blood flow solver. In the short-time regimes, NP dispersive anomalies are ob-
served and attributed to the transient morphology and orientation change of RBCs under
high shear and high hematocrit. In the long-time regimes, results for the long-time dif-
fusivity in the velocity gradient direction agree well with existing experimental data. The
long-time NP diffusion tensor has been described as a function of shear-rate and hematocrit
with various power-law scalings.
By plotting the RBC-NP PPDF, the NP microstructure in sheared blood has been visual-
ized for the first time that features a rhombus configuration with the detailed inner structure
changes according to specific hemorheological conditions. The RBC-NP PPDF analysis
also suggests a novel approach to visualizing the average RBC morphology in concen-
trated RBC suspensions subject to different hemorheological conditions. Under high shear
rate, the φ2 dependence in D̂Rxx is proposed to be related to the x-elongation of RBC and
elevated RBC-NP PPDF near the fore-aft region, which together suggests possible more-
than-two-body interaction occurred particularly in the streamwise direction. The sublinear
φ dependence is suggested to be related to the reduced effective φ owing to the substantial
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Figure 5.12: Measured NP RESID, D(R,m)ij = D
∞
ij − DBδij , as a function of the theoretical




ij , based on the empirical correlations presented in equations
5.11a and 5.11b. For cases with γ̇≤100 s−1 (filled symbols), M lij is applied to calculate
D
(R,th)
ij . For cases with γ̇>100 s




contraction of RBC in the vorticity direction subject to high shear. The RBC-NP bidisperse
suspension presents an example of highly anisotropic microstructure of particle suspen-
sions caused by the compound effect of particle-shape/orientation anisotropy and shear-
flow anisotropy.
It is also found that there exists a critical shear rate (∼100 s−1) around which the RESID
shear-rate dependence changes from linear to nonlinear scale. Through numerical experi-
ments, the transition to nonlinear shear-rate scaling of RESID has been related to the promi-
nent change of average RBC morphological state between different shear rate. Specifically,
the superlinear scalings (γ̇1∼1.8) of D̂Rxx are due to the streamwise elongation of RBC, while
the sublinar scalings (γ̇0.7∼0.8) of D̂Ryy and D̂
R
zz are associated with the cross-stream con-
traction of RBC (in response to the streamwise elongation). The morphological changes
under shear alter the RESID length scale in different principal directions, which has been
demonstrated to be the fundamental cause of the nonlinear shear-rate dependence of the
RESID. This mechanism is also worth to be distinguished from the causes of the nonlinear
shear-rate scaling of the self-diffusivity of RBCs [183, 194] or deformable capsules [74],
where latter has been attributed to the heterogeneous interparticle ‘collision’ due to the
cell deformability [184]. However, the nonlinear shear-rate dependence of NP diffusion
in sheared blood, based on our interrogation, is more associated with a ‘one-way’ mech-
anism, i.e., the RBC morphological adaptation to shear flow changes the RESID length
scale which further alters the NP diffusion rate.
The determination of the rescaled Pélect number being a more general nondimensional
term to describe the severity of RESID enables the comparison between the bidisperse
NP-RBC suspension and the monodisperse colloidal suspensions. In the latter scenario
where the particle size ratio is one,
∼
Pe drops to Pe and ‘RESID’ drops to the particle
self-diffusivity. The self-diffusion tensor reported by [40] in a sheared monodisperse col-
loidal suspensions are plotted in figure 5.10 (c) for comparison. In both monodisperse and




slightly greater than D̂Rzz. In general, D̂
R
ij in RBC-NP suspension shows higher anisotropy
than the monodisperse case owing to the geometric asymmetry of RBCs (x being greater
than y and z dimensions). Such geometric asymmetry effect can be further increased with
CaG, leading to higher anisotropy of the diffusivity tensor. In the monodisperse scenario,
D̂Rxy is the smallest; while in the NP-RBC bidisperse scenario, D̂
R
xy is greater than D̂
R
yy and
D̂Rzz due to the severe diffusive effect in x direction.
This work, to the authors’ knowledge, offers the first detailed study of the complete 3D
NP diffusion tensor in cellular blood flow over a wide range of shear rate and hematocrit.
The proposed empirical correlations for the NP diffusion tensor offers a constitutive relation
that can be adopted by effective continuum models to pursue large-scale NP biotransport
applications (e.g. in vivo NP drug delivery) with better accuracy.
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CHAPTER 6
SHEAR-INDUCED PLATELET AGGREGATION THROUGH VON
WILLEBRAND FACTOR ENTANGLEMENT UNDER ELEVATED HIGH SHEAR
Occlusive arterial thrombosis can lead to acute life-threatening events such as heart at-
tacks and strokes. The rapid growth of thrombi against elevated high shear relies on shear-
induced platelet aggregation (SIPA) through the entanglement of von Willebrand factor
(VWF) multimers. The biophysical mechanism for SIPA remains unclear and hinders the
better understanding of the pathology for occlusive arterial thrombosis. In this work, we
develop a multiscale and multiphysics computational method informed by the status quo
single-molecule-level measurements to directly simulate the SIPA process. It is found that
SIPA is a two-stage process involving agglomeration of platelets in the flow and capture of
agglomerates to the thrombotic surface. Under elevated high shear (∼10,000 s−1), SIPA
occurs in milliseconds as fast as the platelet transit time through the stenosis apex. In par-
ticular, the transition from the lag time (LT) regime to rapid platelet accumulation (RPA)
is found to be attributable to the enhancement of agglomerate capture rate through elevat-
ing the local VWF concentration and/or the VWF size (length). Excessively shortening
VWF size and/or lowering VWF concentration prevents SIPA, consistent with von Wille-
brand disease (VWD) conditions. Ultra-long VWF can form loose aggregate at normal or
subnormal VWF concentration, consistent with pathological conditions such as thrombotic
thrombocytopenic purpura (TTP). Besides, our work also reconciles some contradictory
experimental observations in the field of high-shear thrombosis.
This work, for the first time, bridges the single-molecule bond force measurements
to the microthrombi formation, and provides possible bio-physico-chemical explanations
to thrombotic or bleeding complications. The multiscale in silico approach provides a
cross-scale tool for exploring novel biophysical mechanisms for SIPA that are typically
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inaccessible to only single-molecule measurements and micro-/marcro-fluidic assays. Such
new perspectives may lead to the discovery of novel anti-thrombotic therapies.
6.1 Introduction
Occlusive arterial thrombosis is an acute pathological condition under which a blood clot
rapidly forms and occludes an artery, which are the direct cause of ischemic stroke or
myocardial infarction as two of the leading causes of death globally [200]. The onset
of arterial thrombosis typically stems from a chronic atherosclerotic plaque (over many
decades) that narrows the artery and creates high, oscillating shear stresses (OSS) on the
plaque surface [201]. Overtime the plaque cap becomes ruptured (owing to the OSS) and
the sub-endothelial collagen gets exposed, which subsequently triggers the acute occlusive
thrombosis process [11].
The arterial thrombosis specific to high shear is different from the low shear venous
thrombosis governed by the Virchow’s Triad [202]. Rather, it can be explained by a high-
shear thrombosis triad, which includes (1) a pro-thrombotic surface, (2) pathologically
high shear rates, and (3) necessary blood constituents mainly including platelets and von
Willebrand factor (VWF) [29, 11, 170]. Based on this alternative triad, occlusive arterial
thrombosis has been successfully modeled in vitro [203] and ex vivo [204] using blood
flow-through systems. The time to occluding the vessel is found to be ∼20 minutes, which
is consistent with the time related to sudden cardiac ischemic death [205]. Moreover, the
high-shear occlusive thrombosis is characterized by three growing phases [204, 203, 11].
Phase I is the lag time (LT) phase which typically lasts for 1∼5 minutes and shows mostly
platelet adhesion with a limited thrombi accumulation. Phase II is the rapid platelet accu-
mulation (RPA) phase, which features prominent shear-induced platelet aggregation (SIPA)
with the thrombi accumulation rate being 4−6 times that of Phase I [30, 33]. Following
RPA, the vessel becomes occluded at Phase III. Despite RPA being the direct cause of
thrombotic occlusion in arteries, the mechanism for the explosive thrombi growth during
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RPA has remained unexplained.
VWF has now been recognized as a primary determinant for high-shear thrombosis.
Under pathological high shear (>3000 s−1), platelet mural adhesion exclusively depends
on VWF as opposed to other ligands such as fibrinogen that normally play a role under
low shear (∼100 s−1) [206]. This is supported by the ultra-fast platelet-VWF binding via
GP1b-A1 bonds [207, 208]. The GP1b-A1 kinetic on rate has been estimated theoreti-
cally [207] and recently measured in vitro [208] with a rate from 106 to 109 M−1s−1,
which is 2−5 orders of magnitude faster than the platelet GPIIbIIIa-fibrinogen formation
rate (∼104 M−1s−1) [209]. In addition, under high shear VWF molecule changes its ter-
tiary structure from a globular state to elongated state, which enhances its bind affinity
(per molecule) by both exposing more A1 domains for multi-valency [87, 85] and ele-
vating the A1 activity through local conformation unfolding [208]. These factors allow
for platelet capture through VWF under ultra-high drag forces independent of platelet ac-
tivation [207]. Moreover, SIPA specific to elevated high shear (>10000 s−1) has been
demonstrated in vitro and in vivo to be platelet activation-independent while exclusively
dependent on VWF [210, 26].
Furthermore, the VWF size and concentration varies under various pathophysiologi-
cal conditions. For example, patients with von Willebrand disease (VWD) type 2A/2B
or acquired von Willebrand syndrome (aVWS) systematically have a below-average size
of VWF multimer [211, 212] and are accompanied with bleeding complications. Patients
with thrombotic microangiopathies (TMA) or thrombotic thrombocytopenic purpura (TTP)
are found to have an excessive amount of ultra-long VWF (ULVWF) in the microvascula-
tures which tend to form micro-aggregates and block small vessels [213]. VWF multimers
formed in endothelial cells and platelet α-granules are rich in ULVWF at high concen-
trations [214]. Such pool of ULVWF can be released during the thrombotic events and
enhance the local thrombogenicity [11]. Therefore, elucidating how the change of VWF
conditions (size and concentration) affect the high-shear thrombosis through SIPA may
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shed light on the RPA mechanism and meanwhile give physics-based interpretations to the
pathology of various VWF-related diseases.
There are several research questions and controversies remaining to be addressed in the
field of high-shear thrombosis. First, what is the timescale for SIPA to occur? Previous the-
oretical study by Wellings and Ku [207], based on force balance analysis, suggest a single
platelet can be captured in microseconds, faster than the platelet transit time (millisecond-
scale). It is however unclear how fast SIPA could occur, provided the millesecond-scale
transit time. Second, where does the thrombi stem from, at the stenotic apex where the
shear peaks or distal to the stenosis where the shear-gradient is highest? Using in vivo
and in vitro stenoses that feature an apex narrower than 100 µm, Netsbitt et al. [215,
216] observed the thrombi accumulates primarily downstream to the stenosis apex. In con-
trast, our group has consistently obserse the growth of thrombi primarily at the stenosis
apex/throat using different scales of in vitro [203, 30, 217, 29, 60] and ex/in vivo [204,
218] stenosis models. Third, the GP1b-A1 bond lifetime measured by various researchers
using single-molecule measurements [219, 220, 221] shows different degradation behavior
with respect to bond force. How the molecular-level difference relates to or affects the
high-shear thrombosis has not been interrogated.
In silico biophysical models are powerful tools that can be efficiently and economi-
cally used to study the sensitivity of a particular parameter across a large parametric space.
Previous in silicomethods [222, 223, 170] for high-shear thrombosis either completely ne-
glect the presence of VWF or implicitly incorporate effect of VWF based on empirical data,
lacking the ability to study the effect of VWF on high-shear thrombosis. Multiscale compu-
tational methods [224, 225] that directly model the suspension dynamics and interactions of
molecule and cell/colloid can be further developed to model high-shear thrombosis based
on first principles. A systematic study that bridges endpoints across molecular and cellu-
lar scales may shed light on the mechanism of RPA and help addressing the controversies
primarily caused by limiting to single-scale perspectives.
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The goal of this study is twofold. First, we will develop a multiscale and multiphysics
computational method that incorporates the VWF polymer hydrodynamics, platelet particle
suspension dynamics and the stochastic binding kinetics between VWFs and platelets for
direct numerical simulation of the SIPA process. A experiment-informed GP1b-A1 binding
model will be developed by combining the status quo single-molecule-level measurements
with the classical equilibrium kinetic theory to obtain cross-scale consistent results. The
platelet and VWF polymer hydrodynamics are based on the multiscale particulate suspen-
sion dynamics developed and validated in previous chapters [24, 225, 104, 153]. Second,
we will apply this bottom-up in silico approach to explore a large parameter space to un-
derstand SIPA dependence on various VWF size, concentrations and kinetics rates so as
to elucidate the mechanism for RPA and address some existing controversies in the field
of high-shear thrombosis. This work appears to be the first attempt to bridge information
across molecule-level, cellular-level and microthrombi-level based on first principles.
The remaining sections of the chapter are organized as follows. In § 6.2, we present
the multiscale computational method for high-shear microthrombi formation. Particularly,
a single-molecule-measurement informed kinetic model for platelet-VWF GP1b-A1 bond
formation and rupture will be developed. In § 6.3, the dynamics of SIPA delineated in
terms of the effect of VWF size, concentration and bond characteristics. In § 6.4, we will
address several controversies in the field of high-shear thrombosis based on our computa-
tional results. The clinical relevance of the study is presented. In § 6.5, we summarize the
new findings related to SIPA and occlusive arterial thrombosis.
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6.2 Methodology
The computational method is developed to simulate mural thrombi formation at a growing
arterial thrombus surface where the local shear rate is ultra-high (> 10 000 s−1), as shown
in Fig. 6.1a. The three necessary ingredients for arterial thrombosis, including high shear,
pro-thrombotic surface and necessary blood components (VWF and platelets), are included
in the model system, as shown in Fig. 6.1b. The red blood cells (RBCs) are neglected for
simplification, provided they are not necessary for the onset of SIPA [226] and the region
of interest mainly locate within the RBC-free layer [111, 153]. The thrombus-blood inter-
face region is simplified as a three-dimensional Couette flow domain, where the interaction
and motion of each individual platelet and VWF strand at physiologically-relevant con-
centrations are computed over time. The thrombus surface is simplified as flat surface as
the relatively low curvature compared to the size of the selected region. The surface is as-
sumed to be coated with immobilized VWFs to be pro-thrombotic. The schematics of the
entire model system are shown in Fig. 6.1c, where the suspension dynamics of platelets and
VWF polymers, the GP1b-A1 binding and volume exclusion between VWF and platelets,
the inter-/intra-association of VWF, and the fluid-structure interactions are all computed
over time.
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Figure 6.1: Schematics for the model system. (a) Blood flow through an arterial stenosis
where an occlusive thrombi is forming and locally creating an elevated-high-shear envi-
ronment. Further growth requires platelet aggregation under ultra-high shear stress. (b)
The triad illustrates the necessary conditions for arterial thrombosis [11]. (c) The in silico
model system represents a zoom-in view of the thrombi-blood interface subjected to ele-
vated high shear. Shear-induced platelet aggregation (SIPA) occurs onto a VWF-rich pro-
thrombotic surface. The SIPA process is supported by forming platelet-VWF GP1b-A1
bonds and the VWF inter-/intra-association bonds.
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6.2.1 Langevin-dynamics for the VWF polymer dynamics
The VWF suspended in the blood plasma is modeled as a chain of beads connected with
hyperelastic springs using the LB-LD method developed by Liu et al. [225], as previously
presented in §2. Each bead represents a VWF dimer that has a hydrodynamic radius of 80
nm. The VWF intra-association is realized through the LJ potential with a well-depth of
εintra = 2kBT [85] to match the critical shear rate for VWF unfolding.
The VWF inter-association has been reported to be controlled by complex multi-domain
interactions [227]. The type of bond supporting the VWF inter-association possibly ranges
from weak hydrogen bond to strong covalent bond, where former supports the observation
that reversible VWF self-association can form under high shear [228] and latter has been
reported in the context of forming disulfide bonds [229, 230]. The energy well-depth for
hydrogen bonds typically ranges from O(kBT ) to O(10kBT ), while the covalent bond
ranges from O(10kBT ) to O(102kBT ) [231]. To reflect the hybrid mode of the VWF
inter-association, we model the VWF inter-association through LJ potential with an energy
well-depth εinter = 20kBT .
6.2.2 Rigid-body dynamics for platelets
The translational and rotational dynamics of suspended platelets are modeled through New-
tonian rigid-body dynamics coupled with the LB fluid [64]. Different from previous stud-
ies [19, 111] assuming disc shape platelets (Figure 6.2a), the current study focused on
elevated shear conditions assumes the platelets adopting a spherical shape. This is to be
consistent with the experimental observation by Maxwell et al. [232], where the authors
show nonactivated platelets under elevated shear rates (10000 to 20000 s−1) tend to develop
a smooth ball-like morphology as shown in Figure 6.2b.
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Figure 6.2: The differential interference contrast (DIC) image of nonactivated platelets
under different shear rate conditions. Low shear rates (<1000s−1) show disc shape platelets
(a), while elevated high shear rates (>10000s−1) give rise to spherical shape platelets (b).
The scale bar is 1 µm. Images are adopted from Maxwell et al. [232].
6.2.3 Single-molecule-measurement-informed stochastic GP1b-A1 binding model
To model the VWF-platelet adhesion through GP1b-A1 bond, We have developed a binding
model particularly suitable for direct numerical simulation of ligand-receptor binding activ-
ity under hydrodynamic influence. Our theoretical approach combines the classic equilib-
rium binding kinetic theory [233, 234] with the recent single-molecule level kinetics mea-
surements [208, 219, 220], enabling us to obtain the intrinsic GP1b-A1 kinetic rates that
is decoupled from the transport effect.Such theoretical approach can be extended to model
other ligand-receptor bindings subjected to hydrodynamic perturbation, given the apparent
kinetic rates can be measured using fluidics approaches such as that in Fu et al. [208].
GP1b-A1 on rate
Fu et al. [208] applied a single-molecule microfluidic system to quantify the temporal bind-
ing percentage of the GP1b molecules onto a tethered VWF under various shear stresses.
The apparent GP1b-A1 on rate, Kon, was found to be VWF tension force dependent, which
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can be estimated as
Kon =
Kmon
1 + exp[(∆G− Ft∆x)/kBT ]
, (6.1)
where Ft is the VWF internal tension force, Kmon is the maximum on rate under sufficiently
high VWF tension (Ft ∼ 100 pN ), ∆G is the energy barrier between the no-tension state
and the maximum-tension state, and ∆x is the displacement between the two states along
the tension axis. The model constants are given as Kmon = (50.8 ± 4.2) × 106 M−1s−1,
∆G ≈ 6.2kBT and ∆x = 1 nm by fitting the experimental data.
It should be noted that the apparent kinetic on rate is controlled by both transport (con-
vection and diffusion) and intrinsic association (on) rate [233]. As a result, the apparent
on rate is not generic and depends on the experimental setup. To obtain the GP1b-A1
intrinsic on rate that is transport-independent, the encounter and escape rates through con-
vection/diffusion need to be estimated and decoupled from the apparent on rate.
Figure 6.3: Schematic illustration of the ligand-receptor binding kinetics. (a) The appar-
ent kinetic process can be decomposed into the transport portion and the intrinsic kinetics
portion. The macroscopic association (dissociation) involves first the encounter (unbound)
of the ligand and receptor, and then the bound (escape) of the two molecules. (b) The two
reactive molecules (e.g., GP1b and A1) need to locate adjacent to each other within certain
encounter distance, RAb, in order to proceed with the subsequent intrinsic kinetic process.
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Noting that the molecule encounter and escape through transport (convection/diffusion
induced translation and rotation) in the experimental system by Fu et al. [208] is diffusion-
limited, the transport-induced GP1b-A1 encounter rate, e+, and escape rate, e−, can there-
fore be estimated according to the statistical mechanics [235] as
e+ = 4π(DGP1b +DA1)RAB, (6.2)
e− = 3(DGP1b +DA1)R
−2
AB, (6.3)
whereDGP1b andDA1 are the Brownian diffusion rate of GP1b molecules and A1 molecules,
respectively, RAB is the encounter distance, which can be estimated as twice the hydro-
dynamic radius of GP1b molecule, RAB ≈ 2RGP1b. In the microfluidic system of Fu
et al. [208], the VWF strings (contains A1) were tethered onto the wall whereas the
GP1b molecules were suspended in the liquid. Thus, the two diffusivities should satisfy
DGP1b  DA1. The diffusion rate of GP1b can be quantified by its Brownian diffusivity,
i.e., DGP1b = kBT/6πµRGP1b. Therefore, the encounter and escape rates between GP1b
and A1 can be approximated as








Quantitatively, the above expressions yield an encounter rate of e+ = 3.5 × 109 M−1s−1
and an escape rate of e− = 7× 106 s−1.
Based on the measured apparent on rate Kon and the encounter and escape rates esti-
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1 + exp[(∆G− Ft∆x)/kBT ]
, (6.6)
where the maximum intrinsic on rate is km+ = K
m
one−/e+ ≈ 1 × 105 s−1. Our derived
km+ quantitatively describes the minimal time required for the GP1bA1 bond formation is
1/km+ ∼ 10 µs, which has not been directly measured before due to its ultra-short timescale.
The k+ value depends on the VWF tension force, Ft, which is explicitly tracked by the LB-
LD method [225]. Note that the GP1b-A1 formation takes much shorter time (∼10 µs)
compared to the bond lifetime (0.01∼1 s), which supports rapid accumulation of GP1b-A1
bonds needed for capturing platelets under elevated high shear (>10000 s−1) [207].
GP1b-A1 off rate
The GP1b-A1 intrinsic off rate quantifies the rupture dynamics of the GP1b-A1 bond,
which is also equivalent to the reciprocal of the bond lifetime. The general functional form




− exp[Fbσ/kBT ], (6.7)
where k0− is the zero-force intrinsic off rate,and σ is the reactive compliance that determines
the degradation rate of the bond stability subjected to the GP1b-A1 bond force, Fb.
The intrinsic GP1b-A1 off rate, k−, has been measured by several groups using single-
molecule force-measurement assays [219, 220, 221]. Fitting the measurements of wild-
type GP1b-A1 bond lifetime by Kim et al. [219], the rate constants can be obtained as
k0− ≈ 0.001 − 0.01 s−1 and σ = 2.0 nm. Fitting the measurements by Zhang et al. [220]
and Chen et al. [221] yields the rate constants k0− ≈ 0.1− 1.0 s−1 and σ = 0.2 nm.
Fig. 6.4 depicts the measured GP1b-A1 bond lifetime and the corresponding Bell equa-
tions of GP1b-A1 bond lifetime and off rate with specific rate constants. Noticeably, the
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major distinction among the different measurements lies in the difference in the bond degra-
dation rate determined by the reactive compliance, σ, while k0− only leads to minor differ-
ence. To address the discrepancy in the measured k− primarily caused by the difference
in the reactive compliance of GP1b-A1 bond, following studies in § 6.3.3 will access the
effectiveness of various k− data in causing platelet aggregation and capture.
Figure 6.4: GP1b-A1 bond off rate (a) and bond life time (b) as functions of GP1b-A1
bond force. The curves are the best fit to the existing measurement based on the Bell-type
functional form. The symbols are experimental single-molecule measurements of the bond
lifetime from various groups. The off rate is obtained as the reciprocal of the bond lifetime.
Calculation of the bound/unbound probability
With the obtained GPIb-A1 intrinsic rates, k+ and k−, the probabilities for GP1b-A1 bond




ki(1 − Pi); i ∈ +,− [234], the bound probability for two reactants (GPIb and A1) upon
encounter (through transport), P+, and the unbound probability of the existing GP1b-A1
bond, P−, can be calculated by
P+ = 1− exp[−k+∆t], (6.8)
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P− = 1− exp[−k−∆t], (6.9)
respectively, where ∆t is the time interval used to update the binding state. Because of the
high temporal resolution in our computational method, ∆t is set to 100 LB timesteps, mean-
ing the bound or rupture attempts between each VWF-A1 and platelet-GP1b are performed
every 100 timesteps. The P+ and P− are used to quantitatively regulate the likelihood of
forming a new GP1b-A1 bond or rupturing an existing GP1b-A1 bond, respectively.
6.2.4 WLC model for the GP1b-A1 bond force
The GP1b-A1 bond is modeled as a worm-like chain (WLC) spring to capture its hypere-








− 0.25 + l
L0
], (6.10)
where Lp is the bond persistence length, L0 is the bond contour length and l is the bond
extension. To account for the effective bond extension caused by the unfolding of the
juxtamembrane mechanosensitive domain (jMSD) within the GP1b complex [220], the
bond contour length is assumed to be L0 = 100 nm, longer than the actual GP1b-A1 bond;
while the bond persistence length is set to Lp = 0.08 nm. The bond force is cut off at




VWF length varies under different pathphysiological conditions. As demonstrated by the
western blot data in Fig. 6.5(c,d) [236, 237], VWF multimers formed in endothelial cells
and platelet α-granules are typically rich in high-molecular-weight multimers (HMWMs)
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that are up to 40 000 kDa, which corresponds to 80 dimers or 12.8 µm in VWF length [214].
After release to blood and subject to the cleavage of protease ADAMTS13, VWF multi-
mers are regulated to containing about 1 to 40 dimers, featuring a VWF contour length
of 0.16−6.4 µm [238, 239]. Moreover, the size distribution of the plasma VWF exhibits
an exponential distribution with the high-molar fraction highly polarizing the short-VWF
side [240]. As a result, the average size (defined as the molar-fraction-weighted mean) of
VWF in normal plasma is about 4 dimers or 0.64 µm in length.
von Willebrand disease (VWD) type 2A/2B shows a lack of intermediate (4−10 dimers
or 0.64−1.6 µm in length) and/or large (10−40 dimers or 1.6−6.4 µm in length) size
VWF [211, 212], as shown in Fig. 6.5(b). Clinically, VWD type 2A/2B is oftentimes
associated with prolonged bleeding times [241, 213]. Besides, patients regularly under-
going extracorporeal membrane oxygenation (ECMO) or ventricular assist device (VAD)
treatment often develop acquired von Willebrand syndrome (aVWS), which also features a
shortening of VWF length and consequently bleeding disorders [242, 243]. These scenar-
ios shift the average size of the plasma VWF towards 1−2 dimers, i.e., 0.16−0.32 µm in
length [239].
Under pathological conditions such as thrombotic microangiopathies (TMA) or throm-
botic thrombocytopenic purpura (TTP), excessive presence of ultra-long VWF (ULVWF)
(>60 dimers or >10 µm in length) would occur in the plasma or/and on the surface
of endothelial cells (shown in Fig. 6.5e), as a result of the deficiency or abnormality in
ADAMTS13 [213]. Such elevated level of ULVWF often leads to excessive microthrombi
formation in microvasculatures, causing extravagant recruitment of platelets and conse-
quently also leading to bleeding disorders.
To understand how the difference in VWF length alters the SIPA process and causes
VWF-length dependent thrombotic/hemostatic complications, we simulate SIPA with a
wide range of VWF multimer sizes ranging from 2−100 dimers or 0.32−16.0 µm in VWF
length, as indicated by the VWF length spectrum in Fig. 6.5a. This spectrum covers the
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short VWF (0.32 µm) observed in both inherited VWD as well as aVWS, intermediate-size
VWF (0.64−1.6 µm) in normal plasma, long VWF (1.6−6.4 µm) as a minority in normal
plasma, and ULVWFs (16 µm) secreted from endothelial cells or platelet α-granules that
excessively exist in TMA or TTP.
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Figure 6.5: VWF length and concentration associated with pathophysiological events. (a)
The VWF length spectrum (plotted in log scale) interrogated in the current study. Different
VWF length corresponds to different pathophysiologic conditions as denoted. (b-e) The
western blot data showing the difference in VWF size (length) distribution between nor-
mal plasma (NP) and VWD blood (b) [244], between NP and platelet-derived VWF (PLT-
VWF) (c) [236], between NP and endothelial cell-derived VWF (EC-VWF) (d) [245], and
between NP and TTP condition (e) [237].
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VWF concentration
VWF concentration could also be altered through pathophysiological processes. The α-
granule release upon platelet activation locally supplies VWFs that are not only long and
ultra-long in length (Fig. 6.5c) but also up to 50× elevated in concentration [246]. Recent
experiments using genetically modified mice that lack of α-granule showed α-granule re-
lease is necessary for occlusive thrombosis, suggesting the local elevation in VWF level
may play an essential role in driving the rapid platelet accumulation and subsequently the
thrombotic occlusion. In a separate pathological scenario, VWD type 1 is often associ-
ated with a partial quantitative deficiency of plasma VWF (Fig. 6.5b), while the structure
and size distribution of VWF remains indistinguishable from normal [213]. In an more
extreme scenario, VWD type 3 shows a complete deficiency of VWF [239] (Fig. 6.5b) and
consequently results in excessive bleeding disorders in patients.
To reflect the role of VWF concentration in SIPA, a wide range of soluble VWF (sVWF)
concentrations from 0.1× to 18× normal concentration are considered for each VWF
length, where the normal VWF concentration is defined as 0.5% in terms of volume fraction
as suggested in Chen et al. [224]. Understanding the SIPA dependence on VWF concen-
tration can provide biophysical insights to the pathology of VWD type 1 and 3 and help
identifying the role of platelet-derived VWF in driving the occlusive thrombosis.
Other parameters
The shear rates selected for the following studies are γ̇ ≥10 000 s−1, which represent
typical shear levels for occlusive arterial thrombosis [247, 248, 27] and was also reported
to be critical shear levels that give rise to activation-independent platelet aggregation [210,
249]. The platelet concentration is set to 3× normal platelet concentration to reflect the
margination effect [19], which corresponds to a volume fraction of φPLT = 3.0% [224].
The mural surface density of immobilized VWF (iVWF) is set to SVWF=0.1 ng/mm2,
consistent with the existing in vitro measurements of VWF surface absorption level [250,
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251].
Three computational domains (10×20×10, 20×20×10 and 40×20×10 µm3) are con-
sidered to ensure the results being independent of the periodic boundary condition in the
streamwise direction, along which the VWF elongates. ULVWF is selected for the analy-
sis, corresponding to a ratio of the streamwise domain size to the VWF length varying from
Lx/LVWF=0.6 to 2.5. The results suggest that the Lx/LVWF=1.5 is the most cost-effective
resolution (results are shown in the Appendix). Therefore, the intermediate-size domain
20×20×10 µm3 is used for the subsequent studies.
All simulations are initiated by seeding the platelets and VWF uniformly distributed
in the lower half of the domain to mitigate the confinement effect of the upper moving
boundary. The VWF conformation is set to be a globular state initially to reflect the stress-
free initial condition. The prescribed shear rate is imposed from time zero.
For the specifications of the GP1b-A1 intrinsic off-rate, the zero-bond-force off rate is
fixed at k0− = 1 s
−1 and the reactive compliance is set to σ = 0.2 nm hereafter, except in
§ 6.3.3 where the influence of different σ from single-molecule measurements on SIPA will
be discussed. Table 6.1 summarizes all 40 simulation cases, spanning the entire parameter
space of interest to the current study.
6.2.6 SIPA metrics
To quantitatively describe the SIPA process in terms platelet agglomeration and capture,
two dimensionless metrics are introduced. Following the concept of average coordination
number that is typically used in chemistry or geology to describe the average number of
neighbors surrounding a central atom/granule [252, 253], we define a platelet agglomera-





where Ncnt denotes the number of pairs of platelets that are in close contact and Nplt is the
total number of platelets existed in the system. The criterion for platelet contact is defined
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such that the platelet-platelet separation is smaller than 10 nm.
To describe the level and rate of platelets being captured onto the thrombotic surface, a





where 〈Vplt〉 is the ensemble average of the platelet velocity in the system and 〈Vfld〉 denotes
the volume-averaged fluid velocity within the control volume that initially suspended with
platelets and VWFs.
Agglomeration is the ability of the platelets to come together to form a larger mass then
may travel in the flow or stick to the wall. As the density of the mass increases, the PAI
will increase. We use agglomerate to refer to the several platelets that may or may not be
adherent to the wall. The PMI is 1 when the mass travels downstream in the flow, but goes
to zero when the mass is captured by the wall and no longer moves. When an agglomerate
is firmly captured to the wall and no longer moves (PAI>0 and PMI=0), then it is called an
“aggregate” similar to common usage in platelet adhesion and aggregation studies.
6.3 Results
6.3.1 Dynamics of SIPA: platelet agglomeration and capture
Previous experiments [210, 249] observed platelet aggregates forming and adhering onto
the wall under elevated shear. Such process is found to be independent of platelet activation
and exclusively supported by VWF through GP1b-A1 bond formation.
More quantitative understanding of the SIPA process could be achieved by compar-
ing the relevant timescales specific to the elevated high-shear environment, as shown in
Fig. 6.6a. Considering a typical stenotic section that is 1000 µm long in the flow direc-
tion [254], the platelet transit time (defined as the time for the near-wall platelet to flow
through the stenotic section) can be estimated as 100 to 1 ms as the wall shear rate chang-
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ing from 104 to 106 s−1. Hellums et al. [255] experimentally quantified the minimal time
required for the shear-induced platelet activation under various shear rates. The reported
shear-induced platelet activation time, as plotted in Fig. 6.6a, is found to be much greater
than the platelet transit time, when shear rate is  106 s−1. Although platelet activation
may be possible within the platelet transit time when shear rate exceeds 106 s−1, this high
shear rate tends to be less relevant to the occlusive thrombosis since the net thrombotic
growth approaches zero under that shear level [11]. As previously mentioned in Eqn 6.6,
the formation of GP1b-A1 bond limited by its maximum intrinsic on-rate requires at least
10 µs, which acts as a lower bound for the time required for the capture of platelets and
platelet aggregates.
Consistent with the experimental observations [210], our analysis suggests the SIPA un-
der elevated shear should occur independent of the shear-induced platelet activation given
the relatively short transit time. Moreover, in order for the mural capture of platelet ag-
gregates as needed for thrombi growth, the timescale for SIPA under the shear rates of
104 − 106 s−1 can be estimated to be within the range of 0.01−10 ms, as denoted in the
dark blue area of Fig. 6.6.
To verify the estimated timescales as well as the validity of the in silico computational
method, we conduct simulations (cases NO. 33-35 in Table 6.1) with parameters matching
the in vitro experiment by Ruggeri et al. [210]. The VWF is 2× the normal concentration
to be consistent with the experiments. Three cases are conducted with different VWF
length changing from 1.6∼6.4 µm to introduce possible variability. The shear rate is set to
20 000 −1, which also matches with the elevated shear imposed in Ruggeri et al. [210].
Fig. 6.6b plots the time course of the SIPA in terms of platelet agglomeration and cap-
ture, quantified by PAI and PMI as defined in § 6.2.6. The two concepts of agglomera-
tion and mobility in general feature different characteristics. Platelet agglomeration (PAI)
forms quickly between 0-6 ms, and then plateaus when all the platelets in the domain are
connected by sVWF. Platelet mobility (PMI), however, has a different time course. PMI
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Figure 6.6: The dynamic process of SIPA specific to occlusive arterial thrombosis. (a)
SIPA under elevated shear needs to be activation-independent and rapid (< 10−2 s), given
the relatively short platelet transit time and long platelet activation time. (b) SIPA under
elevated shear involves platelet agglomeration and capture processes. (c) The platelet cap-
ture distance for SIPA under a shear rate of 20000 s−1: a comparison between existing
in vitro results and current in silico results. (d) The time sequence of the SIPA process
under shear rate of 20000 s−1. Green beads are regular VWF dimers; red beads are adhered
VWF dimers (by forming GP1b-A1 bonds).
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remains relatively constant between 0-4 ms, decreases after 4 ms, and then falls to zero at
8 ms as the agglomerate is firmly captured as an aggregate stuck on the wall. The different
times for agglomeration and mobility processes suggests that platelets agglomerate in the
flow before being captured at the wall. In other words, platelet agglomeration can gather
platelets away from the wall before being captured at the wall.
Our model predicts that platelet aggregates would not form at the entrance of a high
shear zone until the agglomerates are captured. By integrating the average velocity of




240±50µm. This streamwise travel length of 240 µm compares favorably with the obser-
vation of no aggregates at the beginning of the high shear zone for 280± 100µm observed
in vitro by Ruggeri et al. [222], as demonstrated in Fig. 6.6c. Another way to interpret the
lack of mural aggregates is to calculate a capture time, or the time to observe aggregates
at the wall. The model estimates the capture time at about 8 ms (tcap ≈ 8 ms) under the
specific shear rate (γ̇ = 20 000). We mark this point on the Hellums-type plot that falls in
the region of capture without activation as previously defined (Fig. 6.6a, diamond symbol).
The analysis and simulation results collectively match the experimental observations that
SIPA under elevated shear occurs in millisecond-scales, thus add credibility to the in silico
model developed in the current study.
6.3.2 Roles of soluble VWF and immobilized VWF
To further identify the specific roles of soluble VWF (sVWF) and immoblized VWF (iVWF)
in SIPA, we selectively remove sVWF and/or iVWF in the system to study its effect on
platelet agglomeration, aggregate capture and bond formation. For the cases simulated in
this section, the shear rate is set to 10 000 s−1 and VWF length is 1.6 µm (normal whole
blood). The sVWF concentration is set to 6×physiologic concentration (3%) to shortening
the computational time needed for observing phenomenological endpoint differences (such
as whether capturing aggregates or not) between cases.
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Fig. 6.7a and 6.7b shows the dynamics of platelet agglomeration and capture, respec-
tively. In the presence of both sVWF and iVWF, the platelet agglomerates rapidly with
PAI increasing from 0 to 5 in the first ∼3 ms. At about t=3 ms, the formed agglomerate in
the system gets firmly captured and becomes an aggregate, as the PMI drops to ∼0. The
small, finite fluctuation in PMI near zero is a result of the unsteadiness in flow caused by
the fluid-structure interaction.
Removing all VWF (no VWF) serves as a control: the platelets do not agglomerate
(PAI∼0.9) and mobility stays at 1. Attached iVWF only has a small effect: PAI∼0.9 and
mobility is slightly less than 1 from a few individual platelets being captured at the wall;
No platelet aggregation is observed. Plasma sVWF with no iVWF (sVWF only) causes
the platelets to agglomerate with PAI increasing in a similar manner to the normal case.
However, mobility in the sVWF only case actually increases dramatically. This rise in the
platelet mobility is caused by the agglomerate migrating away from the wall and traveling
in the higher velocity fluid away from the wall. The larger, deformable agglomerates are
subject to cross-stream migration by the lift force caused by the hydrodynamic interactions
with the wall, which has been experimentally observed previously [169].
The bond formation for the SIPA process is shown in Fig. 6.7c and 6.7d. For the normal
case, more than 6000 GPIb-A1 bonds form to agglomerate and capture the aggregates.
When sVWF only is present in the system, the formation of 6000 GP1b-A1 bonds is about
the same as the normal case in the first 3 ms as agglomeration occurs. When iVWF only
is present, only about 500 GP1b-A1 bonds can form as opposed to more than 6000 bonds
formed when sVWF is present, as a result of lacking in-flow GP1b-A1 formation (i.e.,
platelet agglomeration). When iVWF is present, the VWF-association bonds generally
starts at a level of around ∼2000 bonds from the fast formation of mural VWF nets upon
VWF elongation in less than 2 ms upon exposure to elevated shear rates (e.g., see Fig. 6.6d).
In the presence of both sVWF and iVWF, further increase of the VWF-association bonds
(from ∼2000 to ∼4000 bonds after 2 ms) predominantly comes from the inter-association
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among sVWF. The number of VWF-association bonds in general shows a high-frequeny
fluctuation over time when sVWF is present. Through power spectrum analysis, a peak
frequency of fp = 15 000 s−1 for the fluctuating VWF-association curves is obtained,
which is close to the imposed shear rate (γ̇=10 000 s−1). This indicates that the rotational
and elongational effect of the shear periodically rupture the VWF-association bonds.
Figure 6.7: The time course of platelet agglomeration index (a), mobility index (b), number
of GP1b-A1 bonds (c) and number of VWF-association bonds for selective VWF condi-
tions. For the set of simulations, the shear rate is 10000 s−1 and the VWF length is set to
1.6 µm.
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It should be noted that previous experiments by Ruggeri et al. [210] demonstrated
that sVWF is necessary for activation-independent platelet aggregation under elevated high
shear. Here we describe the sub-second events that cause the platelet agglomerate to form
in the flow and be captured as an aggregate onto the wall. Our computational work based
on first principles explicitly show that the platelet micro-agglomerates can be assembled in
the flow through the shear-induced entanglement of sVWF without the presence of iVWF.
iVWF is then necessary for the mural capture of the flowing platelet agglomerate.
Our results directly demonstrate that SIPA is driven by in-flow platelet agglomeration
that precedes the mural capture of the platelet agglomerate (if that occurs), as a two-step
process. Note that this is different from the existing understanding of platelet aggregation
under high shear, which generally presents a picture of single platelet capture on a sur-
face with subsequent platelet aggregates forming on top of this captured platelet through
various mechanisms [256, 215]. Our finding describes a new paradigm for high shear in-
duced platelet aggregation forms from platelet agglomerates formed in the flow that are
then captured as opposed to single platelet accumulation. This mechanism would allow the
aggregate to grow much faster and could account for the rapid platelet accumulation (RPA)
phase II as distinct from the an initial iVWF formation phase I (lag time) [204].
6.3.3 Effect of the GP1b-A1 bond reactive compliance
In this section, we aim to understanding how the difference in GP1b-A1 bond reactive
compliance would impact the SIPA process so as to evaluate the actual prothrombotic ef-
fect of various existing GP1b-A1 bond lifetime measurements [220, 221, 219]. Two levels
of GP1b-A1 bond reactive compliance, σ=0.2 versus 2.0 nm, are selected for the analy-
sis, representing the reports of single-molecule assays by the Li group [220] and the Zhu
group [221] versus that by the Springer group [219], respectively. The GP1b-A1 bond
off-rate (lifetime) is much more sensitive to the change of σ compared to k0−, as previ-
ously shown in Fig. 6.4. Therefore, a fixed zero-bond-force off rate k0−=1 s
−1 is selected
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for this example. An intermediate-size (LVWF=1.6 µm) VWF at normal and 6×normal
concentrations are selected to bring in variation of the available A1 ligands.
As shown in Fig. 6.8, For a low reactive compliance (σ = 0.2 nm) of the GP1b-A1
bond, platelet agglomeration occurs between 0 and 6 ms (blue trace on Fig. 6.8(a)) and the
agglomerate is captured as a platelet aggregate around 7ms, as shown in Fig. 6.9(b). Adding
more VWF to the system further elevates the agglomeration level and shortens the capture
time to 3 ms. The rapid SIPA process occurred with σ = 0.2 nm is accompanied and driven
by the rapid formation of 4000−9000 GP1b-A1 bonds and 3000−7000 VWF-association
bonds in milliseconds. Moreover, elevating VWF concentration by 6× increases the rate
of GP1b-A1 and VWF-association bond formation by more than 2 folds. The platelet
aggregates formed with the low reactive compliance GP1b-A1 bonds can be visualized in
Fig. 6.9(a,c).
In contrast, a large reactive compliance (σ = 2.0 nm) prevents SIPA even with 6×
elevated VWV concentration. Specifically, platelets located away from the wall largely
remain translating with the flow, while the platelets adjacent to the wall show a capture-
and-release pattern, as manifested by the large fluctuations in the PMI values((pink and
light blue traces in Fig. 6.8(b)). Neither platelet agglomeration nor firm platelet adhesion
are observed with σ = 2.0 nm, as shown by the simulation snapshots in Fig. 6.9(b,d). This
can be explained by the fast degradation of the GP1b-A1 bond stability at elevated shear
stresses, such that the bond lifetime becomes comparable to or shorter than the minimal
bond formation time (tb ≤ 1/km+ ≈ 10−5 s). As a result, the net accumulation of GP1b-A1
bonds remains very low and insufficient to give rise to SIPA. Intriguingly, the number of
VWF-association bond at σ = 2.0 nm is much smaller than that at σ = 0.2 nm, despite
the characteristics of the VWF-association bond remaining identical. This implies that
the VWF-association bond formation depends on the GP1b-A1 bond formation; in other
words, the VWF association seems to be an outcome of the platelet agglomeration primarily
supported by GP1b-A1 bond formation.
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Figure 6.8: The time course of (a) platelet agglomeration index (PAI), (b) platelet mobility
index (PMI), (c) number of GP1b-A1 bonds and (d) number of VWF-association bonds
based on different GP1b-A1 bond reactive compliance, σ, for normal VWF concentration
and elevated (6×normal) VWF concentration. For this set of simulations, the shear rate is
10,000 s−1 and the VWF length is set to 1.6 µm.
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Figure 6.9: The platelet and VWF distribution during the SIPA process for two GP1b-A1
reactive compliance (σ = 0.2 and 2.0 nm) reported from single-molecule measurements at
normal and elevated (6×normal) VWF concentrations. The time-point for each snapshot is
indicated accordingly. (a, c) For small reactive compliance, aggregates form within 7ms.
(b,d) For VWF with large reactive compliance, agglomeration does not occur.
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6.3.4 Dependence of SIPA on VWF characteristics
The bioactivity of VWF heavily depends on its biological characteristics primarily includ-
ing the VWF concentration (level) and VWF length (size). As already discussed in § 6.2.5,
altering the VWF characteristics could lead to severe thrombotic and hemostatic diseases.
Understanding how the alteration of VWF characteristics leads to the change of high-shear
clot formation through SIPA may shed light on the pathology and potential treatment of
relevant pathological complications.
Dependence on VWF concentration
To demonstrate the effect of changing VWF concentration on the microthrombi formation
at the thrombi-blood interface, we simulate SIPA with the a wide range of sVWF con-
centrations changing from 0.1 to 18× normal concentrations at each specific VWF length.
Here, we select the cases (Case NO. 3, 8, 13, 23 and 30) with intermediate-long VWFs
(LVWF=1.6 µm) for discussion.
As shown in Fig. 6.10 (a), increasing the sVWF concentration leads to a greater slope
of the PAI curve, indicating the platelets agglomerates more rapidly. As a result, the
time to capture the agglomerate deceases as indicated in Fig. 6.10b. For this particu-
lar intermediate-length VWF (LVWF=1.6 µm), normal and elevated VWF concentrations
(1∼18× normal concentration) lead to a firm capture of the agglomerate (PMI∼0). Quan-
titatively, elevating the normal sVWF concentration by 6× shortens the capture time by
about 2.7 fold; elevating concentration by 18× shortens the capture time by about 4 fold.
Diluting VWF concentrations by 10% and 40% (0.1× and 0.4×) reduces agglomeration as
well as preventing platelet aggregation, as the PMI maintains around 1 (Fig. 6.10(b)).
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Figure 6.10: The time course of (a) platelet agglomeration index (PAI), (b) platelet mobility
index (PMI), (c) the number of GP1b-A1 bonds and (d) the number of VWF-association
bonds for different VWF concentrations. For this set of simulations, the shear rate is 10,000
s−1. The platelets are set to 3×normal concentration to account for the margination effect.
The VWF length is set at 1.6 µm.
The temporal change of bond numbers provides further insights to the SIPA process.
As shown in Fig. 6.10c, the formation rate of GP1b-A1 bonds increases considerably with
the elevation of sVWF concentration despite the platelet concentration remaining constant.
This suggests the finite number of platelets can provide abundant binding sites to support an
elevated level of GP1b-A1 binding events and platelet number is generally not the critical
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limiting factor [226]. This is consistent with the experimental observation that each platelet
on average contains more than 15000 GP1b receptors that is sufficiently high to support
excessive binding events [257, 258]. The formation of VWF-association bonds in general
follows the same trend as the GP1b-A1 bonds, which is aligned with the hypothesis that
VWF-association depends on the GP1b-A1 bond formation during SIPA as speculated in
§ 6.3.3.
Fig. 6.11 depicts the platelet-VWF distributions in the long-time asymptotic limit. The
dilute VWF concentration (0.4×) clearly manifests a cell-free layer between the adhered
platelet mono-layer and the platelet aggregate suspended in the flow. In contrast, normal or
elevated VWF concentrations show firmly captured platelet aggregates.
The captured aggregates also features a non-monotonic dependence on the VWF con-
centration, as the normal and severely elevated (18×normal) VWF concentration has a
more elongated morphology (with PAI ranging from 3∼4) compared to the moderately el-
evated (6×normal) VWF concentration (with PAI around 5). Such non-monotonic change
in the aggregate compactness can be explained by the synergy between GP1b-A1 bonds
and VWF-association bonds. While moderate elevation in VWF concentration leads to
more compact aggregates due to more GP1b-A1 bonds ((Fig. 6.10c) agglomerating the
platelets, further elevation in VWF concentration could lead to excessive VWF association
(Fig. 6.10d) between platelets which separates platelets through volume exclusion effect
and through an increase in effective VWF from attached VWF strands.
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Figure 6.11: Platelet agglomeration and capture at (a) dilute (0.4×), (b) normal, (c)
moderately elevated (6×) and (d) severely elevated (18×) sVWF concentrations. An
intermediate-length (1.6 µm) VWF is selected for all the cases here. For this specific VWF
length, diluting sVWF to 40% prevents the aggregate from being captured (a). Normal and
elevated sVWF concentration can lead to firm capture (b−d).
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Dependence on VWF length
To understand how VWF length alters the microthrombi formation, we simulated SIPA with
various VWF length changing from 0.32 to 16 µm for each specific VWF concentration.
Note that two dimers is 0.32 µm and ULVWF can be >16 µm (100 dimers). Here, we
select the cases with normal VWF concentration (Case NO. 11−15) and shear rates of
10,000 s−1 for this section.
The platelet agglomeration proceeds with various VWF lengths and are plotted as
platelet agglomeration index (PAI) in Fig. 6.12(a). All PAI curves plateau after about 8
ms, indicating the agglomeration forms quickly and the system reaches equilibrium. As
the VWF length increases, the platelet agglomeration rate (slope of the PAI curves before
plateau) changes less than with concentration. Specifically, increasing VWF length from
short (2 dimers or 0.32 µm) to long (40 dimers or 6.4 µm) enhances the agglomeration
rate. In contrast, further increasing the VWF length to ultra-long (100 dimers or 16 µm)
lowers the agglomeration rate.
The platelet capture processes are depicted in Fig. 6.12b as the platelet mobility in-
dex (PMI). With short VWF length (0.32 µm), the PMI oscillates around 1 even after the
system reaching equilibrium. Correspondingly, the platelet aggregate remains suspended
without being captured. Similar to the dilute VWF concentration case shown in previous
section, a cell-free layer persists between the flowing aggregate and the surface of platelet
monolayer (formed by platelet adhesion) as shown in Fig. 6.13(a). As the length of VWF
increases to an intermediate regime (0.64 µm), the PMI at equilibrium decreases to 0.5.
Such reduced level of PMI corresponds to a marginal capture of the aggregate onto the
thrombotic surface, which exhibits a periodic ”catch and release” adhesion between the
aggregate and the adhered platelet monolayer, as shown in Fig. 6.13b. Further increasing
VWF length to above 1 µm leads to the firm capture of the platelet aggregates. The capture
time for 1.6−6.4 µm VWF is about 8 ms, while it can be shorten to 6 ms with ULVWF (16
µm).
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Figure 6.12: The time course of (a) platelet agglomeration index (PAI), (b) platelet mobility
index (PMI), (c) the number of GP1b-A1 bonds and (d) the number of VWF-association
bonds at different VWF length. For the VWF length, 0.32 µm corresponds to 2 dimers and
16 µm corresponds to 100 dimers. The symbols in (a) denotes the point when the aggregate
becomes captured. For the set of simulations, the shear rate is set to 10,000 s−1. Platelets
is 3×normal concentration and VWF has a normal plasma concentration.
Since the agglomeration rate with ULVWF is significantly lower than that with long
VWFs, the shorter capture time in ULVWF suggests ULVWF is capable of arresting a
rather loose aggregate, as demonstrated in Fig. 6.13(d). The PAI for the captured aggregates
is denoted by symbols in Fig. 6.12, where the PAI upon Capture for ULVWF is about 2.5
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and the PAI for longer VWFs is greater than 3.5.
Decreasing VWF length (with the same volume fraction) increases the level of VWF
association (more VWF-association bonds) but reduces the rate of GP1b-A1 bond forma-
tion, as indicated in Fig. 6.13(c) and Fig. 6.13(d), respectively. The VWF length induced
change in the number of VWF-association bond is more prominent compared to that of the
GP1b-A1 bond. In particular, short VWF (0.32 µm) yields ∼6× more VWF-association
bonds compared to ULVWFs; while its number of GP1b-A1 bond is reduced by 50 %. This
implies the platelet agglomeration occurred with short VWFs may be more supported by
the VWF-association bonds, where with ULVWF the agglomeration is more driven by the
GP1b-A1 bond.
Referring back to Fig. 6.12(a), the orange 16 µm ULVWF case features a persistent
increase of PAI even after the capture event, while with green normal 1.6 µm case, the
agglomeration level typically remains unchanged after the capture event. This behavior
in PAI with ULVWF is associated with a post-capture compaction of the loose aggregate.
During the aggregate compaction process (6−7 ms), the increase of VWF-association bond
shows a rapid increase by 50% (orange curve Fig. 6.12(d)), while the GP1b-A1 bond curve
roughly maintains the same slope (accumulation rate) (orange curve Fig. 6.12(c)). This sug-
gests the post-capture compaction of the aggregate observed with ULVWF may be caused
by the VWF association.
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Figure 6.13: Platelet agglomeration and capture at normal VWF concentration with various
VWF length. (a) Short VWF forms loose aggregate in the flow. The aggregate remains to
be suspended without being captured onto the wall. (b) Average plasma VWF length leads
to marginal capture of the aggregate. Marginal capture refers to a periodic ”catch and
release” adhesion between the in-flow agglomerate and the adhered platelet monolayer. (c)
Long VWF firmly captures the aggregate. (d) ULVWF can firmly capture the aggregate at
a loose morphology.
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Morphology and structure of captured platelet aggregate
The captured platelet aggregates that form under different VWF conditions show different
morphological and structural characteristics. To understand how VWF length and con-
centration alters the aggregate morphology and structure, we summarize the PAIs of all
14 captured platelet aggregates and categorize the aggregate morphology observed in our
simulations under different VWF conditions.
As shown in Fig. 6.14a, three aggregate morphological states can be classified based
on the PAI levels. For PAI'4.5, the aggregates feature a compact morphology where
the platelets are densely packed into a spherical shape. Such compact aggregates mostly
occur under moderately elevated (6×) VWF concentration with intermediate VWFs that
are typically available in normal plasma (NP). For 3/PAI/4.5, the aggregates exhibit
an elongated morphology with platelets packed primarily along the streamwise direction.
Such elongated aggregates are commonly observable with NP-VWF under either normal
VWF concentration or severely elevated VWF concentration. For PAI/3, the aggregates
feature a loose morphology, where platelets are entangled by VWF nets without contacting
each other. These loose aggregates mainly occurs with ULVWF or sometimes with long
VWF under severely elevated concentrations. For visual demonstration purpose, the snap-
shots of aggregates for representative cases (A−F) are selected and depicted in Fig. 6.14a,
which cover all three aggregate morphological states.
The PAI (average coordination number) can be experimentally related to its correspond-
ing porosity and permeability in the context of a packed bed of spherical particles. Specif-
ically, the porosity of the platelet aggregate can be estimated based on an empirical corre-





With the calculated porosity, the permeability of the aggregate can be further calculated
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where aPLT is the radius of platelets with a value of 1 micron. The KC model is generally
applicable to the porosity range of 0.26 < ΩPLT < 0.8. The calculated aggregate porosity
and permeability is also annotated in Fig. 6.14a. The compact aggregate has a porosity
between 40−55%, corresponding to a permeability between 0.005−0.01 µm2. Elongated
aggregate show a porosity between 55−75%, which corresponds to a permeability between
0.04−0.2 µm2. Loose aggregate in general has a porosity above 80%, where the perme-
ability is much greater than 0.2 µm2. In general, the platelet aggregates are at least 40%
porous, which can affect the hydrodynamic drag it experiences and allow firm capture of
such aggregates even under elevated shear.
Blood has a range of VWF size and concentrations. Processes such as cell release as
discussed in § 6.2.5 could further alter the local concentration and size of VWFs in blood.
It is expected that the three representative states of the platelet aggregate morphology being
present in the vascular environment. In fact, previous in vitro experiments have also ob-
served the three states of mural aggregate morphology with NP-VWF [210] or EC-VWF
(rich in ULVWF) [261], as demonstrated in Fig. 6.14(b). The aggregate morphology pre-
dicted by our in silico approach compares qualitatively well with the in vitro counterparts.
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Figure 6.14: (a) Platelet agglomeration index of captured platelet aggregates as a function
of VWF length and VWF concentration. The aggregate porosity (ΩPLT ) and permeability
(kPLT ) are estimated and denoted based on the PAI values. The aggregate morphology for
selective VWF conditions is denoted in alphabetical order and depicted on the right. (b)
Top views of the morphology of captured platelet aggregates observed in vitro [210, 261]
versus in silico. For all three cases, the flow direction is from left to right. The platelet
color in the simulation is rendered similar to the experiment.
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Phase diagrams of SIPA
SIPA can occur from several factors intersecting in complex ways. It is illustrative to cre-
ate a phase diagram between VWF concentration and VWF length to show the boundaries
between different behaviors of agglomeration and capture. To describe the rate of platelet
agglomeration in the flow through VWF entanglement, we define an agglomeration rate
as the slope of the best-linear fit to the PAI curve before reaching the long-time equilib-






where the braket denotes the linear fit of the PAI curve when t ≤ teq. Note that the platelet
agglomeration rate does not necessarily determine how fast the platelet aggregates become
captured onto the wall. To further describe the rate for aggregate capture, we define a
capture rate based on the reciprocal of the aggregate capture time (tcap) as follows,
Capture rate = 1/tcap, (6.16)
where the capture time is defined as the time needed for PMI to reach the long-time equi-
librium plateau, provided PMI is less than 0.2 indicating a firm capture. The capture rate
is set to zero (i.e., tcap →∞) when marginal or no capture (PMI>0.2) is observed. Based
on the above definitions, we calculate the platelet agglomeration and capture rate specific
to various VWF lengths and concentrations.
Fig. 6.15 plots the contour of agglomeration rate as a function of VWF length and
concentration. Short VWF (<0.32 µm) and ULVWF (>10 µm) show relatively lower
agglomeration rates compared to NP-level VWF length (0.64−6.4 µm). Diluting the VWF
concentration to 10% eliminates the VWF-entanglement induced agglomeration, yielding
an agglomeration rate below 0.1 ms−1 similar to the case without VWF. In other words,
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we would expect that a large thrombus would NOT occur for these conditions.
Agglomeration rate shows a strong dependence on VWF concentration while only sec-
ondarily depends on the VWF length. Specifically, elevating the concentration of normal
plasma (NP) VWF (0.64−6.4 µm) by 6× increase the agglomeration rate by 3 fold. With
the intermediate VWF length (0.64−1.6 µm), increasing the VWF concentration to 18×
increases the agglomeration rate by 5 fold, the fastest rate in the diagram. The primacy
of the agglomeration dependence on VWF concentrations stresses the importance of local
high concentration of VWF for effective hemostasis.
Overall, the platelet agglomeration under elevated shear is fast (>0.4 ms−1) in major-
ity of the parameter space. As an example, based on the 0.4 ms−1 agglomeration rate,
an elongated aggregate (PAI=4) may form in less than 10 ms, provided the local VWF
concentration remaining at least 40% the NP level. The agglomeration rate can be further
enhanced by up to 5 fold with elevated VWF concentrations. Patho-physiologically, the
quick formation of in-flow (mobile) agglomerates through SIPA may be a defensive mech-
anism in case of hemorrhagic injury. Such mobile agglomerate may act as building blocks
ready to be captured onto hyper-thrombotic surfaces to stop bleeding.
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Figure 6.15: The rate of platelet agglomeration as a function of VWF length and VWF con-
centration. The filled symbols indicate an agglomeration rate that is above 0.1 ms−1 with
the size of the symbol scales as the agglomeration rate. The empty symbols corresponds to
an agglomeration rate below 0.1 ms−1, which is comparable to the level of agglomeration
in the absence of sVWF. The figure is plotted in log-log scale.
Fig. 6.16 plots the contour of capture rate with respect to VWF length and concentra-
tion. Three phases in terms of the aggregate capture characteristics can be observed. Short
VWFs with diluted concentrations tend to cause no capture of the aggregate, which is in-
dicated as the ”No Capture” phase. Increasing the VWF concentration and/or with long
VWFs, a transitional phase featuring ”Marginal Capture” of platelet aggregates can be ar-
rived. Further increasing the VWF concentration and length, the system transitions to the
”Firm Capture” phase.
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Overall, the enhancement of the agglomerate capture is a strong function of concentra-
tion and secondarily by length. Increasing the VWF concentration from normal to ∼20×
with long VWF can leads to 5× enhancement of capture rate. Increasing VWF length while
maintaining VWF normal or slightly higher concentration (3×) does not affect the capture
as much. Alternatively, lowering the VWF concentration to sub-normal (∼40%) can lead
to no capture of agglomerate. Increasing VWF length does not alter the capture diagram
as much. Nonetheless, ultra-long VWF lowers the VWF concentration (to∼40%) required
for capture.
Note that the normal blood condition with an average of 4 dimers of VWF will yield
only marginal capture which is the balance that normal blood will want to maintain since
blood should not clot in the normal vasculature. Some larger lengths of VWF in the blood
can be on “reserve” to quickly stop blood loss when shear rates become elevated as in
hemorrhage.
The corresponding long-time configurations of platelet-VWF complexes specific to dif-
ferent VWF conditions are summarized in Fig. 6.17, which schematically shows the transi-
tion from the no capture to the firm capture regime. Within the no capture regime, platelets
are either uniformly dispersed or loose agglomerate in the flow, although near-wall platelet
adhesion can still occur. Within the marginal capture regime, the aggregate loosely inter-
acts with the surface through VWF tethers without being firmly captured. Within the firm
capture regime, either loosely or compactly packed aggregates are firmly captured on the
thrombotic surface.
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Figure 6.16: The rate of forming murally captured aggregate as a function of VWF length
and VWF concentration. The filled, partially filled and empty symbols indicate the firm
capture, marginal capture and no capture regime, respectively. The dashed lines qualita-
tively seperates the different regimes. The capture rate for the no capture and marginal
capture regime is set to zero, as no firm capture of aggregates can be observed in the long-
time asymptotic regime (when PAI reaches plateau). The figure is plotted in log-log scale.
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Figure 6.17: The long-time distribution of platelet and VWF under elevated shear with
specific VWF lengths and concentrations. Elevating the VWF concentration or increasing
the VWF at normal concentration leads the transition from no capture, to marginal capture
and to firm capture of platelet aggregates.
6.4 Discussion
6.4.1 In-flow aggregate formation
Our results demonstrate the physics of platelet agglomerates in the flow through entangle-
ment of VWF under elevated shear precedent to the mural capture of the platelet aggregate
(if which occurs). Note that this is different from the existing viewpoint of platelet ag-
gregation in the field of thrombosis and hemostasis, which generally regards the platelet
aggregation as a surface phenomenon of discrete platelets attaching to pre-adhered mural
platelets [256, 215].
Our findings define a new paradigm that the mural thrombi formation under elevated
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shear is a two-stage process, where flowing platelets first agglomerate into micro-aggregates
in the flow through entanglement by sVWF and then the preformed agglomerates are cap-
tured onto the thrombotic surface by iVWF (forming so-called platelet aggregates). Such
in-flow pre-agglomeration through VWF entanglement facilitates the capture of platelets
that are further away from the wall to increase the efficiency of thrombus formation.
6.4.2 Lag capture distance
Our in silico approach quantitatively show that there should exist a lag capture distance
(defined in 6.3.1) that is a few hundred microns (∼200 µm) along the stream-wise direction,
within which few platelet agglomerates can be captured on the thrombotic surface. Studies
performed by our group using stenosis with wider throat (500−1000 µm) [30, 32, 262]
show thrombi accumulation primarily occurs at the stenotic throat region where the shear
rate peaks.
This capture distance may have relevance to studies with stenosis geometries that typ-
ically features a narrow throat (10−100 µm). Nesbitt et al. [215, 216] observed thrombi
accumulation primarily distal to the stenosis. Based on that, they proposed the thrombi
formation is triggered by the large shear-gradient at the channel expansion region. The in-
significant thrombus growth at the stenotic throat observed by Nesbitt et al.may stem from
their throat being much narrower than the lag capture distance such that few agglomerates
could be captured at the peak of the stenosis. The platelet aggregates seen distal to the
stenoses in their systems may have formed as agglomerates under high shear at the throat
and then captured just downstream of the throat. We would predict that the agglomerates
would then continually be captured and grow in the area>100 µm downstream as observed
in their videos. Atherosclerotic stenoses typically have streamwise dimensions greater than
1 mm [263, 204, 264], so occlusive thrombosis would be expected to accumulate within
the throat [263]. However, aortic valves that are stenotic but not thickened (∼100 µm) may
exhibit platelet aggregates downstream of the valve tips instead of on the leaflet edge as
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seen clinically [265, 266].
Overall, the finding of lag capture distance using our computational approach aids in
clarifying the controversy in terms of where the micro-thrombi initiates and grows. Be-
sides, this lag capture distance could be an important geometric lower-bound constraint
when designing thrombotic fluidic assays that are clinically relevant.
6.4.3 Microthrombi formation in milliseconds
Our study discovers that the microthrombi formation through VWF entanglement occurs
on the millisecond timescale (∼10−3 s). This is much shorter than the minimal time for
shear-induced platelet activation (1−104 s) [255] and the typical GP1b-A1 bond lifetime
(0.1−10 s) [219, 220, 221]. Such rapid process is made possible through both the ultra-fast
intrinsic on rate of GP1b-A1 (∼105 s−1) and the elevated high shear rate (>10 000 s−1),
as an effective synergy of both kinetics and transport that drives SIPA. Moreover, such
millisecond-timescale SIPA process is fast enough to form mural aggregates within the
short platelet transit time through high-shear stenosis (also in millisecond timescale), en-
abling the rapid platelet accumulation and the subsequent occlusion.
6.4.4 Controversies in GP1b-A1 off-rate measurements
Our results show that SIPA under elevated shear requires a relatively low GP1b-A1 bond re-
active compliance (σ = 0.2 nm) in order to withstand the high shear stresses, which support
the single-molecule measurements of GP1b-A1 bond lifetime reported by Li Group [220]
and Zhu Group [221]. The bond reactive compliance (σ = 2.0 nm) reported by Springer
Group [219] seems too high and would prevent occlusive SIPA from occurring based on
our bottom-up computational approach. This is, however, contradictory to the in vitro and
in vivo observations that SIPA occurs with normal blood under elevated high shear [30,
217, 262].
The difference in the measurement of GP1b-A1 bond lifetime may be attributed to
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the different single-molecule force measurement technique used in these studies. As re-
cently demonstrated by Chen et al. [221], the force-ramp technique primarily used in Kim
et al. [219] tends to disrupt the bond stability. In contrast, the force-clamp technique
adopted in Chen et al. [221] is shown to better retain the bond stability. The laser optical
tweezers used in Zhang et al. [220] generally has higher force and temporal resolution
compared to the other two techniques.
6.4.5 ULVWF enhances SIPA efficiency
Our study shows ULVWF can capture platelet agglomerates in a loose morphology even
with a moderately diluted VWF concentration, while maintaining the capture time still
around millisecond-scale. Such high efficiency of ULVWF in causing SIPA can be demon-





which describes how fast the capture event could occur at the corresponding agglomera-
tion rate of the phase diagram. Based on this definition, the resulting heat map shown in
Fig. 6.18 shows a peak efficiency at the ULVWF regime around the NP-level concentration.
Thus, SIPA efficiency (Fig. 6.18) points to VWF length as primary over concentration, in
contrast to just agglomeration (Fig. 6.15). Such high SIPA efficiency with ULVWF may
explain the clinical thrombotic complications such as TTP and TMA, where an extrava-
gant number of platelets can be sequestered by ULVWF through forming micro-aggregates
throughout the microvasculatures where shear rates are elevated [213].
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Figure 6.18: The SIPA efficiency as a function of VWF length and VWF concentration.
The ULVWF at normal plasma concentration shows the peak efficiency.
6.4.6 Quantitative or qualitative deficiency in VWF prevents SIPA
Our results show short VWF (<0.64 µm) does not form captured aggregates even with
mildly elevated VWF concentration (∼3×normal). This is consistent with the experimental
observation by Ruggeri et al. [210] that dimeric VWF-A1 always led to rolling aggregates
while normal length VWF could sometimes form adhered aggregates. Clinically, this is
also consistent with the bleeding complications observed in patients with VWD type 2A/2B
and aVWS, where their blood plasma shows a substantial deficiency in intermediate and
long VWF [211, 212, 242, 243].
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Casa et al. [226] show that healthy human blood after 90% dilution and restoration
of normal platelet concentration leads to no occlusion (3 out of 5 cases), indicating the
necessity of sufficient VWF concentration for thrombi formation. Our results show that
lowering the VWF concentration to 40% NP-level with normal length should prevent cap-
ture, which can explain why no occlusion was observed by Casa et al. [226]. Clinically,
this also explains the excessive bleeding disorders observed in patients with VWD type
1/3, who systematically carry a lower-level or no plasma VWF compared to healthy popu-
lation [213, 239].
6.4.7 Elevation in VWF concentration and length causes transition from LT to RPA
Previous studies using ex vivo [204] and in vitro [203] flow-through systems demonstrate
the high-shear occlusive thrombus forms by three phases. Phase I is the lag time (LT)
phase, which features mainly platelet adhesion with limited thrombus growth. Phase II
is the rapid platelet accumulation (RPA) phase, which shows an explosive growth of the
thrombus. Phase III is the occlusion phase which causes the cessation of blood flow. Para
et al. [30] have shown the thrombi growth rate during RPA phase is 4−6 times the rate
within the LT phase. Before this study, the mechanism that governs this elevation of growth
rate from LT to RPA remains unexplained.
As shown by our phase diagram of capture rate (Fig. 6.16), normal plasma (NP)-VWF
at normal concentration primarily leads platelet adhesion with only marginal capture of
aggregates, which is consistent with the LT phenomenon observed experimentally [226,
11]. Quantitatively, the aggregate capture rate with NP-VWF at normal concentration is
about 0.1 ms−1 based on our rate metric (Eqn. 6.16). Elevating the VWF concentration
by 18× while shifting the VWF average size to the high-end (10−40 dimers), the capture
rate can be enhanced by∼5 times (∼0.5 ms−1), which agrees well with the experimentally
measured enhancement of thrombi growth rate from LT to RPA [30]. Furthermore, platelet
upon activation can locally supply long VWFs at up to 50× NP concentration [246]. Such
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local supplement of long VWF through platelet α-granule release should be sufficient to
support the 5× elevation in thrombus growth rate. Therefore, our results suggest the driving
mechanism for the LT-to-RPA transition during occlusive high-shear thrombosis may be the
α-granule release through platelet activation that locally supports elevated VWF concen-
tration at large multimer sizes. Using knock-out mice that genetically lack α-granule, Kim
et al. [218] recently show α-granule release is required for occlusive high-shear thrombo-
sis. This supports our hypothesis for the LT-RPA transition mechanism.
Based on our capture rate diagram, the theoretical microthrombi accumulation rate dur-
ing RPA can be calculated to be about 2.5× 103 um3/s in terms of platelet volume, which
is 2−3 orders of magnitude greater than the macroscale RPA rates (50−80 um3/s) [30, 33,
11]. The rate discrepancy between the microthrombi formation and macrothrombi forma-
tion is likely due to a rate-limiting effect imposed by the shear-induced platelet activation,
which generally operates at second-scale and can take up to minutes under elevated shear
(i.e, at least 3 orders of magnitude slower compared to the millisecond-scale microthrombi
formation) [255].
The down-regulation of SIPA growth by platelet activation could be through two path-
ways. On one hand, platelet activation supplies long VWF at a high local concentration
through α-granule release to support the (millisecond-scale) microthrombi formation [246].
One the other hand, platelet activation activates the GPIIb/IIIa-associated bonds to rein-
force the pre-formed thrombi avoiding large embolization [11]. Nevertheless, ultra-fast
aggregate capture in milliseconds is required for the macroscale RPA rate.
Major thrombotic events or complications related to the alteration of VWF length and
concentration can be summarized and denoted in our SIPA capture-rate phase diagram,
as shown in Fig. 6.19. VWD type 2A/B and aVWS occurs with excessive short VWFs,
which features no capture of agglomerates. Normal plasma (NP) primarily leads to platelet
adhesion with marginal capture of agglomerates, which is LT phenomenon. VWD type 1/3
has low concentration of VWF, which can be characterized by the no capture phenomenon.
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TTP and TMA features excessive capture of platelet aggregates with ULVWF. Elevation
in VWF concentrations at intermediate length leads to substantial increase of agglomerate
capture rate, which causes the transition from LT to RPA. Similarly, hemostasis can be
explained by the local release of long VWF in the neighborhood of an arterial wound to
move from NP to the top right corner to stop bleeding as soon as possible. The consistency
between the agglomerate capture behavior and the pathological symptoms/observations
illustrates the reach of our theory to clinical relevance by our SIPA capture rate diagram.
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Figure 6.19: The clinical relevance of the SIPA capture diagram. VWD type 2A/B and
aVWS occurs with excessive short VWFs, which features no capture of platelet agglom-
erates. Normal plasma (NP) primarily leads to platelet adhesion with marginal capture of
agglomerates, which is LT phenomenon. VWD type 1/3 has low concentration of VWF,
which can be characterized by the no capture phenomenon. TTP and TMA features ex-
cessive capture of platelet agglomerates with ULVWF. Elevation in VWF concentrations
at intermediate length leads to substantial increase of the capture rate, which causes the
transition from LT to RPA.
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6.4.8 Multiscale hierarchy of occlusive thrombosis
As we have identified the plausible spatio-temporal scales associated with critical biolog-
ical events for building up a high-shear thrombus, a multiscale hierarchy scaling up from
molecular-level to cellular-level to tissue-level can be mapped out to better delineate the
RPA process of acute arterial thrombosis leading to thrombotic occlusion, as shown in
Fig. 6.20.
At the molecular-level, the GP1b-A1 formation features ultra-fast intrinsic on-rates
(∼ 105 s−1), which can occur as fast as a few micro-seconds. Depending on the bond
force, the GP1b-A1 bond lifetime varies from seconds to milliseconds, which is generally
much longer than the time for bond formation. Such rate disparity between GP1b-A1 bond
formation and rupture allows for the rapid accumulation of sufficient GP1b-A1 bonds in
the elevated shear-rate environment.
As both the length- and time-scale move to the cellular-level, micro-thrombi start to
appear in milliseconds, which is made possible through the microsecond-scale GP1b-A1
formation. The microthrombi is formed by SIPA, which is through VWF entanglement
only and does not require platelet activation. Such pure physical mechanism make it just
fast enough to form and capture the platelet aggregates within the short platelet transit
time through stenosis (also in millisecond-scale depending on the shear rate). Note with
normal plasma VWF, micro-thrombi would occur infrequently (as the platelet aggregates
marginally captured) and only with platelet adhesion near the wall, which would not be
sufficient to form occlusive thrombi at tissue-level. This should be the case with normal
physiology.
To transition from the cellular-level to the tissue-level quickly, more sustained micro-
thrombi formation is needed. This can be created by the shear-induced activation of pre-
adhered platelets that occurs in second-scale. During this process, platelet activation plays
at least two crucial roles. On one hand, it releases α-granule contents which contain
HMWMs at high concentrations (up to 50× NP concentration) [246], thus supplying nec-
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essary VWF levels for firm capture of aggregates. On the other hand, it activates the slower
but stronger GPIIb/IIIa-VWF/fibrinogen bonds [209] to reinforce the microthrombi attach-
ment so that the thrombi can grow against the elevating shear stresses. Thus, platelet acti-
vation is indeed necessary for thrombus formation, but not prior to platelet aggregation.
Such meticulous arrangement of multi-level bioactivities macroscopically gives rise to
the RPA phase that is responsible for the arterial thrombotic occlusion with subsequent
clinically strokes or heart-attacks. On the other hand, this elaborate mechanism could be
life saving for hemostasis. The findings based on our bottom-up computational approach
provide us a multiscale understanding of the occlusive arterial thrombosis.
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Figure 6.20: Occlusive arterial thrombosis is the outcome of a spatiotemporally multi-
scale hierarchay of bio-chem-phyiscal processes. The ultra-fast GP1b-A1 bond formation
within micro-seconds allows the rapid micro-thrombi formation through SIPA that occurs
in milliseconds. The activation of captured platelets locally supplies elevated concentra-
tion of VWF through α-granule release, which provides necessary environment for rapid
microthrombi formation and further bridges micro-thrombi formation to macro-thrombi




In this chapter, we have developed a multiscale computational model that incorporates the
necessary molecular and cellular ingredients for SIPA under elevated shear that is relevant
to occlusive arterial thrombosis. By theoretically decomposing the macroscopic kinetics
into the transport component and the intrinsic-kinetics component, an experiment-informed
platelet-VWF GP1b-A1 binding kinetic model has been developed to specify the intrinsic
role of GP1b-A1 bond formation and rupture. The intricate VWF polymer suspension
dynamics are directly resolved through a well-validated LB-LD nanocale pariculate sus-
pension flow method [225, 104].
Using this multiscale and multiphysics computational approach, the mechanobiology
of SIPA has been interrogated in silico by directly incorporating cellular and molecular
biophysical information. The in silico results show relevance and consistency with clinical
and experimental observations. Multiple biophysical mechanisms regarding the high-shear
occlusive thrombosis from spatio-temporally multiscale perspectives has been discovered,
as listed below:
• SIPA under elevated shear is a two-stage process involving platelet agglomeration
and agglomerate capture, where the agglomeration occurs in flow and agglomerate
capture to the wall occurs subsequent to the agglomeration.
• The time-scale for micro-thrombi formation through SIPA is in milliseconds, which
is comparable to the platelet transit time through high-shear stenosis.
• A lag capture distance of a few hundred micrometers (200∼400 µm) is required
before the platelet aggregate forms and becomes murally attached.
• The reactive compliance of GP1b-A1 bond needs to be in the order of ∼O(0.1) nm
in order to give rise to macroscopic SIPA.
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• The captured platelet aggregates typically show three morphological states, including
compact state, elongated state and loose state.
• ULVWF can efficiently form mural microthrombi by forming loose aggregates with
a porosity above ∼80%.
• Shortening VWF average size to below 4 dimers or lowering the VWF concentration
to <40% prevents SIPA.
• Elevating the VWF concentration by ∼20× and/or extending the average multimer
size (10−40 dimers) accelerates SIPA by ∼5 times, and can be the mechanism tran-
sitioning LT (lag time) regime to RPA (rapid platelet accumulation) regime.
This work, for the first time, bridges the single-molecule bond force measurements to
the microthrombi formation, and provides possible bio-physico-chemical explanations to
clinical thrombosis or bleeding complications. The developed in silico multiscale high-
shear thrombosis simulator provides a cross-scale tool for exploring novel biophysical
mechanisms that are typically inaccessible to only single-molecule measurements and micro-




Figure 6.21: The numerical sensitivity of the platelet mobility index to the variation of the
streamwise domain size. The results indicate the ratio Lx/LVWF = 1.25 is a cost-effective
resolution for simulating microthrombi formation in the current setting.
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Table 6.1: Table of parameters simulated in the current study. Parameters are varied selec-
tively to study the effect of VWF length, VWF concentration and GP1b-A1 off-rate, etc.
Three domain sizes are considered to minimize the numeric artifacts of the periodic bound-
ary conditions in the streamwise direction. The platelet volume fraction is set to φPLT=3%
to match the physiologic level in the presence of platelet margination. The zero-bond-force
intrinsic rate for GP1b-A1 is set to k0−=1 s
−1.
Case NO. γ̇ φsV WF SiV WF LVWF Ndimer σ Domain size
- [s−1] [%] [ng/mm2] [µm] - [nm] [µm3]
1 10 000 0.05 0.1 0.32 2 0.2 20×20×10
2 10 000 0.05 0.1 0.64 4 0.2 20×20×10
3 10 000 0.05 0.1 1.6 10 0.2 20×20×10
4 10 000 0.05 0.1 6.4 40 0.2 20×20×10
5 10 000 0.05 0.1 16.0 100 0.2 20×20×10
6 10 000 0.2 0.1 0.32 2 0.2 20×20×10
7 10 000 0.2 0.1 0.64 4 0.2 20×20×10
8 10 000 0.2 0.1 1.6 10 0.2 20×20×10
9 10 000 0.2 0.1 6.4 40 0.2 20×20×10
10 10 000 0.2 0.1 16.0 100 0.2 20×20×10
11 10 000 0.5 0.1 0.32 2 0.2 20×20×10
12 10 000 0.5 0.1 0.64 4 0.2 20×20×10
13 10 000 0.5 0.1 1.6 10 0.2 20×20×10
14 10 000 0.5 0.1 6.4 40 0.2 20×20×10
15 10 000 0.5 0.1 16.0 100 0.2 20×20×10
16 10 000 1.5 0.1 0.32 2 0.2 20×20×10
17 10 000 1.5 0.1 0.64 4 0.2 20×20×10
18 10 000 1.5 0.1 1.6 10 0.2 20×20×10
19 10 000 1.5 0.1 6.4 40 0.2 20×20×10
20 10 000 1.5 0.1 16.0 100 0.2 20×20×10
21 10 000 3.0 0.1 0.32 2 0.2 20×20×10
22 10 000 3.0 0.1 0.64 4 0.2 20×20×10
23 10 000 3.0 0.1 1.6 10 0.2 20×20×10
24 10 000 3.0 0.1 6.4 40 0.2 20×20×10
25 10 000 3.0 0.1 16.0 100 0.2 10×20×10
26 10 000 3.0 0.1 16.0 100 0.2 20×20×10
27 10 000 3.0 0.1 16.0 100 0.2 40×20×10
28 10 000 9.0 0.1 0.32 2 0.2 20×20×10
29 10 000 9.0 0.1 0.64 4 0.2 20×20×10
30 10 000 9.0 0.1 1.6 10 0.2 20×20×10
31 10 000 9.0 0.1 6.4 40 0.2 20×20×10
32 10 000 9.0 0.1 16.0 100 0.2 20×20×10
33 20 000 1.0 0.1 1.6 10 0.2 20×20×10
34 20 000 1.0 0.1 3.2 20 0.2 20×20×10
35 20 000 1.0 0.1 6.4 40 0.2 20×20×10
36 10 000 0 0 1.6 10 0.2 20×20×10
37 10 000 0.5 0 1.6 10 0.2 20×20×10
38 10 000 0 0.1 1.6 10 0.2 20×20×10
39 10 000 0.5 0.1 1.6 10 2.0 20×20×10




The research described in this thesis is focused on multiscale modeling of blood flow and
clotting by incorporating both molecular- and cellular-level particle/polymer suspension
dynamics and biological details. This work is to address the urgency for better under-
standing blood biorheology across both molecular level and cellular level, so as to provide
biophysical insights and understanding of vascular patho-physiological processes such as
nanoscale solutes transport in blood and occlusive arterial thrombosis.
7.1 Original contributions
A number of original scientific contributions have been made from the thesis, as listed in
the following:
1. We developed a coupled lattice-Boltzmann/Langevin-dynamics (LB-LD) method for
simulating nanoscale particle/polymer suspensions [24, 225]. By coupling the non-
fluctuating LB method with the LD method through momentum exchange, this method
can effectively capture Brownian motion and long-distance hydrodynamics interac-
tions without empirical renormalization. The coupling operation is local, therefore
convenient for parallelization. This method can be used to study various polymeric
fluids and soft matter physics.
2. The LB-LD method was further coupled with a course-grained spectrin-link (SL)
based cellular blood flow solver [225]. The opens up a new area of studying blood
flow and vascular diseases by incorporating both molecular- and cellular-level bio-
physical details, allowing for studying .
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3. We developed of a general particulate suspension inflow and outflow boundary con-
dition (PSIO-BC) [267]. This PSIO-BC can be applied to particulate flows where
particle number is not conserved and/or periodic boundary condition is not applica-
ble. Areas can be used including branching flows, cross-channel flows, flows with
arbitrary inlet/outlet geometries and reactive flows, etc.
4. A single-molecule-measurement-informed binding kinetic model was developed for
modeling GP1b-A1 bond formation and rupture in the presence of hydrodynamic
influences. This binding kinetic model combines the classic equilibrium binding
kinetic theory with the single-molecule level force/kinetics measurements, enabling
us to obtain the intrinsic kinetic rates that is decoupled from the transport effect.
5. The abrupt transition from nanoparticle dispersion to platelet marginationin in mi-
crovesels was captured and found to be attributed to the RBC-enhanced diffusion
overcoming the Brownian diffusion [24, 153].
6. We discovered a heterogeneous partitioning pattern of cellular-blood borne nanopar-
ticles through microvascular bifurcations in response to the well-know Zweifach-
Fung (ZF) effect [267]. This new phenomenon can be used for manipulating or
separating nano-solute/molecule from blood.
7. The complete diffusion tensor of nano-solute in sheared cellular blood was fully char-
acterized based on an in silico rheometer [104]. This provides a major update of
the shear-augmented diffusivity theories since 1980s’ (by Zydney and Colton [178],
etc.). The multiscale-simulation informed theory extends the scalar diffusivity to
a diffusion tensorial form to account for the anisotropy of blood microstructure.
It provides a more accurate constitutive law for solute transport in blood flows at
continuum-scale.
8. We delineated the sub-second dynamic process of shear-induced platelet aggregation
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(SIPA) as a two-stage process. The flowing platelets first agglomerate into micro-
agglomerates in the flow through soluble VWF, and then the pre-formed agglomer-
ates are captured onto the thrombotic surface by immobilized VWF. This provides
a new perspective for the understanding of SIPA that is different from the existing
paradigm regarding SIPA as a surface accumulation of platelets.
9. We discovered a lag capture distance of a few hundred microns is needed in order
for the agglomerate to form and be captured on the thrombotic surface. This aids in
clarifying the controversy in terms of where the micro-thrombi initiates and grows,
and quantitatively provides a geometric constraint for designing fluidic thrombotic
assays with better clinical relevance.
10. We demonstrated a relatively low GP1b-A1 bond reactive compliance (σ = 0.2 nm)
is required in order to yield SIPA. This aids in addressing the variations in measure-
ments of GP1b-A1 bond lifetime performed by various researcher using different
single-molecule measurements, recommending force-clamp and optical-tweezer as-
says over force-ramp assay.
11. The transitioning from lag time to rapid platelet accumulation (LT-to-RPA) during
occlusive arterial thrombosis was attributed to the local elevation of VWF concentra-
tion at intermediate VWF sizes. This local elevation in VWF bioactivity can lead to
the formation and firm capture of platelet agglomerates in milliseconds.
12. Biophysical explanation of the pathology regarding various thrombotic or hemostatic
complications, such as von Willebrand disease (VWD) type 1/2B/2A/3, thrombotic
microangiopathies (TMA) or thrombotic thrombocytopenic purpura (TTP), were pro-
vided with regard to various VWF length and concentration.
13. Three characteristic morphological states for the mural captured platelet micro-aggregates,
including compact aggregate, elongated aggregate and loose aggregate, were ob-
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served and summarized in terms of different VWF lengths and concentrations.
7.2 Publications in peer-reviewed articles
The above original contributions have so far led/contributed to the following articles pub-
lished or to appear in peer-reviewed journals:
1. Z. Liu, C. K. Aidun, D. N. Ku, “Controlling shear-induced platelet aggregation
(SIPA) through altering von Willebrand factor characteristics under elevated shear”,
Annals of Biomedical Engineering (in submission)
2. Z. Liu, C. K. Aidun, D. N. Ku, “Shear-induced platelet aggregation (SIPA) under
elevated shear depends on low reactive compliance of GP1b-A1 bonds”, Biophysical
Journal (in submission)
3. Z. Liu, C. K. Aidun, D. N. Ku, “Mechanobiology of shear-induced platelet aggrega-
tion (SIPA): an in silico perspective”, Journal of Biomechanics (invited perspectives,
in submission)
4. Z. Liu, J. R. Clausen, J. Wagner, K. S. Butler, D. S. Bolintineanu, J. B. Lechman, R.
R. Rao, and C. K. Aidun, “Heterogeneous partition of cellular blood-borne nanopar-
ticles through microvascular bifurcations”, Physical Review E, 102 (1), 013310,
2020 (selected as Editor’s Suggestions)
5. Z. Liu, J. R. Clausen, R. R. Rao, C. K. Aidun, “A unified analysis of nano-to-
microscale particle dispersion in tubular blood flow”, Physics of Fluids, 31, 081903,
2019 (selected as Featured Article)
6. Z. Liu, J. R. Clausen, R. R. Rao, C. K. Aidun, “Nanoparticle diffusion in sheared
cellular blood flow”, Journal of Fluid Mechanics, 871, 636-667, 2019
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7. Z. Liu, J. R. Clausen, Y. Zhu, J. B. Lechman, R. R. Rao, C. K. Aidun, “Multiscale
method based on coupled lattice-Boltzmann and Langevin-dynamics for direct sim-
ulation of nanoscale particle/polymer suspensions in complex flows”, International
Journal for Numerical Methods in Fluids, 91: 228–246, 2019 (selected as Cover)
8. Z. Liu, Y. Zhu, R. R. Rao, J. R. Clausen, C. K. Aidun, “Nanoparticle transport in
cellular blood flow”, Computers & Fluids, 172, 609-620, 2018
9. D. Kim, C. Bresette, Z. Liu, D. N. Ku, “Occlusive thrombosis in arteries”, APL
Bioengineering, 3 (4), 041502, 2019 (selected as Featured Article)
10. M. T. Griffin, Y. Zhu, Z. Liu, C. K. Aidun, D. N. Ku, “Inhibition of high shear arte-
rial thrombosis by charged nanoparticles”, Biomicrofluidics 12 (4), 042210, 2018
11. F. Ahmed, M. Mehrabadi, Z. Liu, G. A. Barabino, C. K. Aidun, “Internal viscos-
ity dependent margination of red blood cells in microfluidic channels”, Journal of
Biomechanical Engineering 140 (6), 061013, 2018
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7.3 Future recommendations
The next step for nano-drug delivery after the drug reaching the vascular wall requires ex-
travasation. Besides, the clearance of nanomedicine through renal filtration also requires
the understanding of the extravasation process. Current studies on extravasation focuses on
either single particle through single vascular fenestration using molecular dynamics (MD)-
type techniques or continuum-level quantification using Starling’s laws. To better under-
stand the extravasation process at a relatively large scale while preserving the particle-scale
characteristics, a mesoscale approach based on the Langevin-dynamics can be developed.
This approach would help in designing optimal nano-pariticle/polymer for efficient extrava-
sation and understanding the drug clearance process through renal filtration.
The hemodynamics studies within patient-specific geometries mostly neglect the pres-
ence of RBCs given its excessive computational cost. As we have fully characterized the
nanoparticle diffusion in sheared cellular blood, an augmented Langevin-dynamics method
can be developed to account for the drift diffusion of nano-solutes induced by the presence
of RBC as an extra stochastic forcing term in the Langevin equation. This would further re-
duce the computational expenses imposed by the RBC membrane dynamics, and allow for
interrogation of drug delivery problems within patient-specific geometries while implicitly
resolving the effect of RBCs.
Due the presence of RBCs, the von Willebrand factor naturally shows a non-uniform
distribution in microvessels. Recent studies have reported the both the margination as well
as demargination behaviors of VWF in sheared cellular blood flows, therefore posing con-
troversies in terms of the VWF migration in blood. An important aspect that was over-
looked is that the VWF conformational change under shear is sensitive to certain shear-rate
threshold. Therefore, a systematic study considering different shear regimes would be ben-
eficial in fully understanding VWF migration behavior in cellular blood flow. Besides, as
VWF is an important clotting factor that often adheres with platelets when necessary, it is of
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clinical implication to understand its margination propensity relative to platelet to estimate
the local stoichiometric ratio of VWF versus platelet for SIPA.
During occlusive arterial thrombosis, the formed platelet-rich clot is highly porous with
”mountains-and-valleys” pattern. Understanding the emergence of such structure is of great
importance to fully understanding the rapid growth of high-shear thrombus. To tackle
this problem with computations, a continuum model augmented with constitutive relations
through particle-scale methods (e.g., the method developed in Chapter 6) can be developed.
This method would allow for capturing the microstructure with both efficiency and particle-
scale relevance. Phase-field method may be a good candidate for such studies.
Thrombolysis is an important therapy which allows recanalization of an acutely oc-
cluded vessel in an invasive manner. Current thrombolytic agents such as recombinant
ADAMTS13 and N-acetyl cysteine (NAC) are still lack efficiency partly because the lack
of understanding of the drug penetration and reaction within the thrombotic porous me-
dia. The hindered diffusion of passive nanoparticles or active swimmers within the specific
thrombus-like polymeric structure can be studied to provide guidance to the design of high-
penetration, highly-reactive drugs for more effective thrombolytic therapies.
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nucleated red blood cells,” Pflügers Archiv, vol. 390, no. 3, pp. 278–282, 1981.
209
[169] M. Abkarian, C. Lartigue, and A. Viallat, “Tank treading and unbinding of de-
formable vesicles in shear flow: Determination of the lift force,” Physical review
letters, vol. 88, no. 6, p. 068 103, 2002.
[170] D. Kim, C. Bresette, Z. Liu, and D. N. Ku, “Occlusive thrombosis in arteries,” APL
bioengineering, vol. 3, no. 4, p. 041 502, 2019.
[171] A. Malysheva, E. Lombi, and N. H. Voelcker, “Bridging the divide between human
and environmental nanotoxicology,” Nat. Nanotechnol., vol. 10, no. 10, pp. 835–
844, 2015.
[172] J. W. Yoo, D. J. Irvine, D. E. Discher, and S. Mitragotri, “Bio-inspired, bioengi-
neered and biomimetic drug delivery carriers,” Nat. Rev. Drug Discov., vol. 10,
no. 7, pp. 521–35, 2011.
[173] E. Blanco, H. Shen, and M. Ferrari, “Principles of nanoparticle design for overcom-
ing biological barriers to drug delivery,” Nat. Biotechnol., vol. 33, no. 9, pp. 941–
51, 2015.
[174] R. D. Brook, S. Rajagopalan, r. Pope C. A., J. R. Brook, A. Bhatnagar, A. V. Diez-
Roux, F. Holguin, Y. Hong, R. V. Luepker, M. A. Mittleman, A. Peters, D. Sis-
covick, J. Smith S. C., L. Whitsel, J. D. Kaufman, E. American Heart Associa-
tion Council on, C. o. t. K. i. C. D. Prevention, P. A. Council on Nutrition, and
Metabolism, “Particulate matter air pollution and cardiovascular disease: An up-
date to the scientific statement from the american heart association,” Circulation,
vol. 121, no. 21, pp. 2331–78, 2010.
[175] D. E. Newby, P. M. Mannucci, G. S. Tell, A. A. Baccarelli, R. D. Brook, K. Don-
aldson, F. Forastiere, M. Franchini, O. H. Franco, I. Graham, G. Hoek, B. Hoff-
mann, M. F. Hoylaerts, N. Kunzli, N. Mills, J. Pekkanen, A. Peters, M. F. Piepoli,
S. Rajagopalan, R. F. Storey, E. A. f. C. P. Esc Working Group on Thrombosis, Re-
habilitation, and E. S. C. H. F. Association, “Expert position paper on air pollution
and cardiovascular disease,” Eur. Heart J., vol. 36, no. 2, 83–93b, 2015.
[176] M. R. Miller, J. B. Raftis, J. P. Langrish, S. G. McLean, P. Samutrtai, S. P. Connell,
S. Wilson, A. T. Vesey, P. H. B. Fokkens, A. J. F. Boere, P. Krystek, C. J. Campbell,
P. W. F. Hadoke, K. Donaldson, F. R. Cassee, D. E. Newby, R. Duffin, and N. L.
Mills, “Inhaled nanoparticles accumulate at sites of vascular disease,” ACS Nano,
vol. 11, no. 5, pp. 4542–4552, 2017.
[177] S. S. Hossain, Y. Zhang, X. Liang, F. Hussain, M. Ferrari, T. J. Hughes, and P. De-
cuzzi, “In silico vascular modeling for personalized nanoparticle delivery,” Nanomedicine,
vol. 8, no. 3, pp. 343–357, 2013.
210
[178] A. L. Zydney and C. K. Colton, “Augmented solute transport in the shear flow of a
concentrated suspension,” PhysicoChemical Hydrodynamics, vol. 10, no. 1, pp. 77–
96, 1988.
[179] E. C. Eckstein, D. G. Bailey, and A. H. Shapiro, “Self-diffusion of particles in shear
flow of a suspension,” J. Fluid Mech., vol. 79, no. 01, p. 191, 1977.
[180] V. Breedveld, D. Van den Ende, A. Tripathi, and A. Acrivos, “The measurement of
the shear-induced particle and fluid tracer diffusivities in concentrated suspensions
by a novel method,” J. Fluid Mech., vol. 375, pp. 297–318, 1998.
[181] N. H. L. Wang and K. H. Keller, “Augmented transport of extracellular solutes
in concentrated erythrocyte suspensions in couette-flow,” J. Colloid Interf. Sci.,
vol. 103, no. 1, pp. 210–225, 1985.
[182] K. Yeo and M. R. Maxey, “Anomalous diffusion of wall-bounded non-colloidal
suspensions in a steady shear flow,” Europhys. Lett., vol. 92, no. 2, pp. 24 008–
24 008, 2010.
[183] M. Gross, T. Kruger, and F. Varnik, “Fluctuations and diffusion in sheared athermal
suspensions of deformable particles,” Europhys. Lett., vol. 108, no. 6, pp. 68 006–
68 006, 2014.
[184] A. Kumar and M. D. Graham, “Mechanism of Margination in Confined Flows of
Blood and Other Multicomponent Suspensions,” Phys. Rev. Lett., vol. 109, no. 10,
p. 108 102, 2012.
[185] C. K. Aidun and D. W. Qi, “A new method for analysis of the fluid interaction with
a deformable membrane,” Journal of Statistical Physics, vol. 90, no. 1, pp. 145–
158, 1998.
[186] A. J. Wagner and I. Pagonabarraga, “Lees-edwards boundary conditions for lattice
boltzmann,” J. Stat. Phys., vol. 107, no. 1/2, pp. 521–537, 2002.
[187] J. F. Morris and J. F. Brady, “Self-diffusion in sheared suspensions,” J. Fluid Mech.,
vol. 312, pp. 223–252, 1996.
[188] R. N. Zia and J. F. Brady, “Single-particle motion in colloids: Force-induced diffu-
sion,” J. Fluid Mech., vol. 658, pp. 188–210, 2010.
[189] J. F. Brady and J. F. Morris, “Microstructure of strongly sheared suspensions and
its impact on rheology and diffusion,” J. Fluid Mech., vol. 348, pp. 103–139, 1997.
[190] M. Wang and J. F. Brady, “Spectral ewald acceleration of stokesian dynamics for
polydisperse suspensions,” J. Comput. Phys., vol. 306, pp. 443 –477, 2016.
211
[191] S. Pednekar, J. Chun, and J. F. Morris, “Bidisperse and polydisperse suspension
rheology at large solid fraction,” Journal of Rheology, vol. 62, no. 2, pp. 513–526,
2018. eprint: https://doi.org/10.1122/1.5011353.
[192] A. Kumar and J. J. L. Higdon, “Dynamics of the orientation behavior and its con-
nection with rheology in sheared non-brownian suspensions of anisotropic dicol-
loidal particles,” Journal of Rheology, vol. 55, no. 3, pp. 581–626, 2011.
[193] A. S. Popel and P. C. Johnson, “Microcirculation and hemorheology,” Annu. Rev.
Fluid Mech., vol. 37, pp. 43–69, 2005.
[194] L. Mountrakis, E. Lorenz, and A. G. Hoekstra, “Scaling of shear-induced diffu-
sion and clustering in a blood-like suspension,” Europhys. Lett., vol. 114, no. 1,
pp. 14 002–14 002, 2016.
[195] W. Xue and G. S. Grest, “Shear-induced alignment of colloidal particles in the
presence of a shear flow,” Phys. Rev. Lett., vol. 64, no. 4, pp. 419–422, 1990.
[196] A. Kumar and J. J. L. Higdon, “Origins of the anomalous stress behavior in charged
colloidal suspensions under shear,” Phys. Rev. E, vol. 82, p. 051 401, 5 2010.
[197] P. Siegle, I. Goychuk, and P. Hanggi, “Origin of hyperdiffusion in generalized
brownian motion,” Phys. Rev. Lett., vol. 105, no. 10, p. 100 602, 2010.
[198] G Antonini, G Guiffant, D Quemada, and A. Dosne, “Estimation of platelet diffu-
sivity in flowing blood,” Biorheology, vol. 15, no. 2, pp. 111–117, 1978.
[199] F. R. Da Cunha and E. J. Hinch, “Shear-induced dispersion in a dilute suspension
of rough spheres,” J. Fluid Mech., vol. 309, pp. 211–223, 1996.
[200] S. S. Virani, A. Alonso, E. J. Benjamin, M. S. Bittencourt, C. W. Callaway, A. P.
Carson, A. M. Chamberlain, A. R. Chang, S. Cheng, F. N. Delling, et al., “Heart
disease and stroke statistics—2020 update: A report from the american heart asso-
ciation,” Circulation, E139–E596, 2020.
[201] D. N. Ku, D. P. Giddens, C. K. Zarins, and S. Glagov, “Pulsatile flow and atheroscle-
rosis in the human carotid bifurcation. positive correlation between plaque location
and low oscillating shear stress.,” Arteriosclerosis: An Official Journal of the Amer-
ican Heart Association, Inc., vol. 5, no. 3, pp. 293–302, 1985.
[202] R. Virchow, Gesammelte abhandlungen zur wissenschaftlichen medicin. Grote, 1862.
[203] D. N. Ku and C. J. Flannery, “Development of a flow-through system to create
occluding thrombus,” Biorheology, vol. 44, no. 4, pp. 273–284, 2007.
212
[204] D. M. Wootton and D. N. Ku, “Fluid mechanics of vascular systems, diseases, and
thrombosis,” Annual review of biomedical engineering, vol. 1, no. 1, pp. 299–329,
1999.
[205] M. J. Davies and A. Thomas, “Thrombosis and acute coronary-artery lesions in sud-
den cardiac ischemic death,” New England Journal of Medicine, vol. 310, no. 18,
pp. 1137–1140, 1984.
[206] B. Savage, F. Almus-Jacobs, and Z. M. Ruggeri, “Specific synergy of multiple
substrate–receptor interactions in platelet thrombus formation under flow,” Cell,
vol. 94, no. 5, pp. 657–666, 1998.
[207] P. J. Wellings and D. N. Ku, “Mechanisms of platelet capture under very high
shear,” Cardiovascular Engineering and Technology, vol. 3, no. 2, pp. 161–170,
2012.
[208] H. Fu, Y. Jiang, D. Yang, F. Scheiflinger, W. P. Wong, and T. A. Springer, “Flow-
induced elongation of von willebrand factor precedes tension-dependent activa-
tion,” Nature communications, vol. 8, no. 1, pp. 1–12, 2017.
[209] W. Huber, J. Hurst, D. Schlatter, R. Barner, J. Hübscher, W. C. Kouns, and B.
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penheim, and J. O. Rädler, “Exponential size distribution of von willebrand factor,”
Biophysical journal, vol. 105, no. 5, pp. 1208–1216, 2013.
[241] H. W. Ott, A. Griesmacher, M. Schnapka-Koepf, G. Golderer, A. Sieberer, M.
Spannagl, B. Scheibe, S. Perkhofer, K. Will, and U. Budde, “Analysis of von
willebrand factor multimers by simultaneous high-and low-resolution vertical sds-
agarose gel electrophoresis and cy5-labeled antibody high-sensitivity fluorescence
detection,” American journal of clinical pathology, vol. 133, no. 2, pp. 322–330,
2010.
[242] C. Heilmann, U. Geisen, F. Beyersdorf, L. Nakamura, C. Benk, G. Trummer, M.
Berchtold-Herz, C. Schlensak, and B. Zieger, “Acquired von willebrand syndrome
in patients with extracorporeal life support (ecls),” Intensive care medicine, vol. 38,
no. 1, pp. 62–68, 2012.
[243] U. Geisen, K. Brehm, G. Trummer, M. Berchtold-Herz, C. Heilmann, F. Beyers-
dorf, J. Schelling, A. Schlagenhauf, and B. Zieger, “Platelet secretion defects and
acquired von willebrand syndrome in patients with ventricular assist devices,” Jour-
nal of the American Heart Association, vol. 7, no. 2, e006519, 2018.
[244] J. E. Sadler, “New concepts in von willebrand disease,” Annu. Rev. Med., vol. 56,
pp. 173–191, 2005.
[245] C. Loirat, J.-P. Girma, C. Desconclois, P. Coppo, and A. Veyradier, “Thrombotic
thrombocytopenic purpura related to severe adamts13 deficiency in children,” Pe-
diatric Nephrology, vol. 24, no. 1, p. 19, 2009.
216
[246] P Harrison and E. M. Cramer, “Platelet α-granules,” Blood reviews, vol. 7, no. 1,
pp. 52–62, 1993.
[247] J. M. Siegel, C. P. Markou, D. N. Ku, and S. Hanson, “A scaling law for wall shear
rate through an arterial stenosis,” 1994.
[248] D. Bluestein, L. Niu, R. T. Schoephoerster, and M. K. Dewanjee, “Fluid mechanics
of arterial stenosis: Relationship to the development of mural thrombus,” Annals of
biomedical engineering, vol. 25, no. 2, p. 344, 1997.
[249] M. J. Maxwell, E. Westein, W. S. Nesbitt, S. Giuliano, S. M. Dopheide, and S. P.
Jackson, “Identification of a 2-stage platelet aggregation process mediating shear-
dependent thrombus formation,” Blood, vol. 109, no. 2, pp. 566–576, 2007.
[250] M. Moroi, S. M. Jung, S. Nomura, S. Sekiguchi, A. Ordinas, and M. Diaz-Ricart,
“Analysis of the involvement of the von willebrand factor–glycoprotein ib interac-
tion in platelet adhesion to a collagen-coated surface under flow conditions,” Blood,
The Journal of the American Society of Hematology, vol. 90, no. 11, pp. 4413–
4424, 1997.
[251] R. R. Hansen, A. A. Tipnis, T. C. White-Adams, J. A. Di Paola, and K. B. Neeves,
“Characterization of collagen thin films for von willebrand factor binding and platelet
adhesion,” Langmuir, vol. 27, no. 22, pp. 13 648–13 658, 2011.
[252] P. Jouannot-Chesney, J.-P. Jernot, and C. Lantuéjoul, “Practical determination of
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